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PREFACE 
 
Diagnosis and treatment of cardiac rhythm disturbances in equines 
has remained virtually unchanged during the past decades. In human 
medicine, invasive cardiac testing, using electrical stimulation or 
‘pacing’ of the heart, has greatly changed the approach to arrhythmias. 
Besides diagnostic and therapeutic application, the technique also 
provides an excellent means to study arrhythmias in animal models. 
In addition to the investigation of the applicability of cardiac pacing 
in equines, this work reports results of basic research on atrial 
fibrillation, clinically the most important arrhythmia in equines. The 
study on atrial fibrillation in equines was performed in different pony 
models making use of the atrial pacing technique. 
The thesis is divided into two sections. The first section provides 
information and results about atrial pacing. It describes the application 
of temporary and permanent pacing. Section 2 applies atrial pacing to 
develop a chronic atrial fibrillation model in equines and discusses the 
consequence of pacing-induced atrial fibrillation in the equine heart. 
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ATRIAL PACING 
DESCRIPTION OF CARDIAC PACING 
Excitable properties of cardiac cells 
Like all living cells, the inside of cardiac cells has a negative 
electrical charge compared to the outside of cells (-90 mV). The 
resulting voltage difference is called the transmembrane potential. Due 
to the excitable properties of cardiac cells, each process reducing the 
resting transmembrane potential to a critical value or threshold (- 65 
mV) results in the generation of an action potential. This action 
potential arises from patterned changes in transmembrane potential 
due to sequential opening and closing of ion channels. When these 
stereotypical voltage changes 
in a single cardiac cell are 
graphed against time, the 
result is the action potential 
(Fig. 1). The action potential 
starts with a rapid, positively 
directed change in 
transmembrane potential, 
resulting in a voltage spike 
called depolarisation (phase 
0). After this fast 
depolarisation, a gradual normalization of ion concentrations occurs 
and the cell repolarises, a process that roughly corresponds to phases 
1 through 3 of the action potential. Because a second depolarisation 
cannot take place until repolarisation occurs, the time from the end of 
phase 0 to late in phase 3 is called the absolute refractory period of 
Figure 1. Four different phases, 
absolute (a) and relative (b) refractory 
period during the cardiac action 
potential. 
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cardiac tissue. As the cells gradually recover from refractoriness, they 
become excitable if a pulse of sufficient strength is delivered. The 
period after the absolute refractory period and before full recovery is 
called the relative refractory period (Fogoros, 1995; Kay, 1996). 
Stimulation at the end of the refractory period, can initiate 
tachyarrhythmias (Fishler and Thakor, 1994; Peters et al., 1994). 
For most cardiac cells, after full recovery, the resting phase (the 
period of time between action potentials, corresponding to phase 4) is 
quiescent, and there is no net movement of ions across the cell 
membrane. In some cells, a leakage of ions across the cell membrane 
causes a gradual increase in transmembrane potential during phase 4, 
which results in a spontaneous depolarisation, called automaticity. 
Cells in the sinoatrial node have the fastest phase 4 activity. The 
sinoatrial node therefore regulates heart rate and is called the natural 
pacemaker of the heart. 
The spontaneously generated electrical impulse from the sinoatrial 
node stimulates nearby cells to depolarise. Depolarisation of one 
cardiac cell tends to cause adjacent cells to depolarise. Thus, once a 
cell is stimulated the wave of depolarisation (the electrical impulse) is 
propagated across the atrium, cell by cell (Fogoros, 1995). The atrial 
depolarisation can be recognised on the surface electrocardiogram 
(ECG) by the P wave. At the atrioventricular node conduction is 
slowed, which is reflected in the PR interval on the surface 
electrocardiogram (ECG). Leaving the atrioventricular node, the His 
bundle and Purkinje fibres rapidly spread the impulse throughout the 
ventricles. On the surface ECG, the ventricular depolarisation and 
subsequent repolarisation generate a QRS complex and T wave, 
respectively.  
Besides natural depolarisation due to sinus node activity, cardiac 
cells can be stimulated artificially by electrical pulses, which is called 
pacing. The electrical stimulus generally consists of a square current 
pulse with variable amplitude, duration and interval. Only when the 
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electrical current is able to reduce the resting potential of the cardiac 
cells by a critical amount and within a critical time, a self-regenerating 
wavefront of action potentials will propagate from the site of 
stimulation across the cardiac chamber and 'capture' is being achieved 
(Trautwein, 1975). Not only the amplitude but also the duration of the 
stimulating current determines whether the threshold for stimulation 
will be reached. Currents larger in amplitude require a shorter duration 
to reach threshold and vice versa. The strength-duration curve 
describes the threshold for stimulation at different pulse widths and 
amplitudes during the excitable period of the tissue. Pacing during the 
absolute refractory period will not result in capture. Pacing during the 
relative refractory period can result in capture if the pulse has a 
sufficient strength. Caution is warranted, especially during ventricular 
stimulation, not to stimulate immediately after the end of the refractory 
period, during the 'vulnerable period', because this can initiate 
fibrillation (Fishler and Thakor, 1994; Peters et al., 1994). To avoid this 
problem most pulse generators have the possibility to 'sense' 
spontaneous electrical activity of the heart through the electrodes. 
Immediately after sensing a cardiac depolarisation, artificial stimulation 
is temporarily inhibited to minimise the risk of fibrillation induction. 
Successful myocardial stimulation is dependent on (1) a source of 
the electrical pulse (the pulse generator), (2) a conductor between the 
source of the electrical pulse and the stimulating electrode (the lead), 
(3) an electrode for pulse delivery and (4) an area of myocardium that 
is excitable. 
Pulse generator 
Three basic electronic circuits are essential for the pulse generator 
(Mond and Sloman, 1990). The timing circuit controls the pacing 
interval and the output circuit controls the charging and discharging of 
the impulse. The third major circuit is the sensing circuit, which 
analyses the electrical signals that return to the pulse generator from 
the heart via the lead and which is responsible for the recognition of 
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spontaneous intracardiac electrical signals. This sensing circuit allows 
the pacemaker to adjust its timing intervals to changes in spontaneous 
cardiac activity and prevents pacing during the vulnerable period 
because this could initiate tachyarrhythmias (Fishler and Thakor, 1994; 
Peters et al., 1994; Hayes and Osborn, 1996). 
The pulse generator can deliver pulses of different strength and 
duration at a desired rate. Different pacing protocols as overdrive 
pacing, extrastimulus pacing and burst pacing are available to fulfil 
electrophysiologic studies. During temporary stimulation, an external 
pulse generator is used for pulse delivery, while for permanent pacing 
an implantable pacemaker is applied (Fig. 2).  
Using radiofrequency signals or pulsed magnetic fields, the pulse 
generator is capable of both transmitting information to and receiving 
information from an external programmer (Kay, 1996). Consequently, 
this telemetric programmability allows changing most functions of the 
implanted pacemaker non-invasively. 
Originally pacemakers were classified with a three-letter 
identification code according to the site of the pacing electrodes and 
the mode of pacing: V = ventricle, A = atrium, D = dual, I = inhibited 
and T = triggered (Mond and Sloman, 1990; Barold and Zipes, 1992; 
Hayes and Osborn, 1996). The first letter indicates the chamber paced 
and the second the chamber sensed. Occasionally the letter S is used 
for the first or second position to indicate that a single-chamber device 
Figure 2. An implantable 
pacemaker (1) with an atrial and 
ventricular lead (2) is shown. 
Each lead possesses an 
electrode on the lead-tip (3). The 
lead can be of the active (3a) or 
passive (3b) fixation type. 
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is suitable for atrial or ventricular pacing. The third position indicates 
the response of the pacemaker when a cardiac signal is sensed, i.e. 
inhibition of pulse delivery (I), triggering of pulse delivery (T) or both 
(D). For instance, the AAI mode means that atrial pacing and atrial 
sensing occur and that an atrial stimulus will be inhibited when an 
atrial signal is sensed. The (lower) heart rate in these models can be 
chosen and will prevent a rate drop below this value. The major 
advantage of rate programming is to allow the patient to remain in 
sinus rhythm rather than in paced rhythm when intermittent 
bradycardia is present (Hayes and Osborn, 1996).  
During 1980 the code was extended to five letters to indicate other 
complex pacing functions. However, we wish to limit the discussion to 
the letter R in the fourth position, indicating that the pacemaker has 
rate modulation, which can be achieved by a build-in sensor. As an 
example, the DDIR mode indicates that rate adaptive atrial and 
ventricular pacing occurs provided that no atrial or ventricular signals 
are sensed. Depending on the kind of pacemaker, sensor activation 
occurs due to patient physical activity, changes in respiratory rate, 
changes in QT interval,… Upon stimulation of the sensor, a sensor-
driven response in heart rate occurs, better meeting the metabolic 
demands of the patient. The upper sensor-driven heart rate, which will 
be gradually achieved after continuous sensor activation, can be 
programmed. When patient activity stops, sensor stimulation is ceased 
and the pacing rate will gradually decrease. 
Electrodes 
Using properly positioned electrodes, the atria and/or ventricles can 
be selectively stimulated. In general, the electrodes can be positioned 
nearby the heart, on the epicardium or on the endocardium. In man, 
transcutaneous atrial or ventricular pacing can be performed in 
emergency situations using relatively high currents (Barold and Zipes, 
1992). But this technique can be painful in conscious patients due to 
stimulation of cutaneous nerves and pacing-induced skeletal muscle 
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contractions. Transoesophageal atrial pacing implies a markedly lower 
threshold and can be performed without general anaesthesia or 
sedation (Tucker and Wilson, 1993; Kantharia and Mookherjee, 1995). 
The technique is relatively non-invasive and well tolerated. Ventricular 
capture is inconsistent or often intolerably painful, however, thus 
seriously limiting the therapeutic and emergent application of the 
procedure. After a thoracotomy and incision of the pericardium, 
electrodes can be attached directly on the atrial and/or ventricular 
epicardium. Resistance for electrical stimulation is low and thresholds 
are more easily reached. Because even low currents remain effective 
to provoke myocardial excitation, stimulation itself is not painful 
making this technique suitable for pacing in the conscious patient. The 
necessity of a thoracotomy, however, limits the technique to temporary 
pacing during cardiac surgery or to permanent pacing with an 
implanted device (Amsel and Walter, 1992). In humans and small 
animals, the most widely used approach for cardiac pacing is 
transvenous endocardial pacing, where a lead or catheter, with 
electrodes on its tip, is introduced through a vein and advanced into 
the atrial or ventricular cavity. Correct positioning of the electrode can 
be guided by fluoroscopy, echocardiography, intracavitary electrogram 
morphology and application of testing stimuli. When the lead is 
connected to an electrocardiographic device, simultaneous recording 
of the intracavitary electrogram and the surface ECG can reveal the 
position of the electrode. After introduction of the electrode into the 
vein, the 'intravenous’ electrogram will be characterised by absent or 
minimal deflections. When the electrode enters the right atrium or the 
right ventricle, the largest intra-cardiac electrogram deflections will 
coincide with, respectively, the P waves or QRS complexes on the 
surface ECG. When the lead tip is assumed to be located in the 
desired chamber, testing stimuli with a sufficient strength can be 
applied to confirm its position: intra-atrial or intraventricular stimulation 
will produce a P wave or QRS complex on the surface ECG, 
respectively.  
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To achieve permanent pacing, two types of transvenous leads have 
been developed to preserve endocardial contact. Leads with an active 
fixation invade the endocardium with screws or small jaws, while leads 
with a passive fixation promote fixation to the endocardium by indirect 
means. The latter can be obtained by little tines or fins to enhance 
entanglement in myocardial trabeculae (Mond and Sloman, 1990; 
Barold and Zipes, 1992). In general, the ventricular lead can be of the 
passive or active fixation type, while the atrial lead should include an 
active fixation mechanism to remain in a stable position. 
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CARDIAC PACING IN HUMAN MEDICINE 
Therapeutic pacing 
Permanent pacing 
Although pacemaker implantation can be utilized to prevent 
induction of certain tachyarrhythmias (Osborn, 1996), the major 
therapeutic indications for permanent cardiac pacing are 
bradyarrhythmias due to third-degree or second-degree AV block, 
sinus node dysfunction or neurocardiogenic syncope (Barold and 
Zipes, 1992; Ross and Mandel, 1995; Ellenbogen and Peters, 1996; 
Hayes and Osborn, 1996). Formerly, pacemaker implantation was 
performed with epicardial lead placement and therefore required major 
surgery. A considerable evolution during the past decades, however, 
has greatly simplified the implantation procedure. Today, virtually all 
leads are transvenously inserted, making cardiac pacing a relatively 
simple and safe method that is widely used in human medicine 
(Holmes and Hayes David, 1990). Because major surgery is avoided, 
the transvenous approach can be performed without general 
anaesthesia (Barold and Zipes, 1992).  
The pacing system consists of a pacemaker and 1 or 2 leads to 
perform single chamber (atrial or ventricular) or dual chamber pacing. 
Recent pacemakers are equipped with a build-in sensor that detects 
patient activity, thus providing an exercise-dependent rate response. 
Temporary pacing 
Temporary cardiac pacing can be accomplished transcutaneously, 
via the oesophagus, transvenously and epicardially. Temporary 
cardiac pacing serves as a lifesaving therapy in the acute 
management of medically refractory bradyarrhythmias (Wood and 
Ellenbogen, 1996). Temporary pacing is also indicated prophylactically 
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in patients with a high risk of developing high-degree AV block, severe 
sinus node dysfunction, or asystole in acute myocardial infarction, after 
cardiac surgery, during cardiac catheterisation, and occasionally 
before implantation or replacement of a permanent pacemaker (Barold 
and Zipes, 1992). Rapid temporary pacing can be used to terminate 
atrial flutter, AV reentry tachycardia or AV nodal reentry tachycardia, 
and sustained ventricular tachycardia (Barold and Zipes, 1992; 
Kantharia and Mookherjee, 1995; Ross and Mandel, 1995; Osborn, 
1996). Finally, temporary pacing can be applied to prevent 
bradycardia-dependent ventricular tachycardia (torsade de pointes). 
Non-therapeutic pacing: the electrophysiological study 
The approach to the diagnosis of cardiac rhythm disturbances 
starts with a detailed history, clinical examination of the patient and an 
ECG recording. Further examinations include exercise testing and 
long-term ECG recordings. However, during the past decades, 
invasive electrophysiologic studies have proven to be of great benefit 
in the management of cardiac arrhythmias.  
To perform an electrophysiologic study, in general, one or more 
temporary pacing catheters have to be transvenously introduced into 
the cardiac chamber. Fluoroscopy and intracavitary electrogram 
recordings are applied for proper catheter positioning (Ross and 
Mandel, 1995). Although two simple things are being done, i.e. pacing 
and recording from localized areas within the heart, complex 
programmed electrical stimulation protocols are often used. These 
pacing protocols apply two general types of programmed electrical 
stimulation: incremental pacing and extrastimulus pacing. With 
incremental pacing (or burst pacing) the heart is stimulated at a 
constant rhythm in excess of the spontaneous heart rate. The 
extrastimulus technique consists of introducing one or more premature 
impulses, each at its own specific coupling interval. 
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During an electrophysiological study, automaticity and conductivity 
of the sinoatrial (SA) node, and conductivity and refractoriness of the 
atrioventricular (AV) node and His-Purkinje system are assessed. By 
rapid atrial pacing, the automaticity and conductivity of the SA node 
can be assessed. Rapid atrial pacing depolarises the SA node faster 
than it can be depolarised by its intrinsic automaticity. When the 
overdrive pacing is abruptly stopped there is often a relatively long 
pause before the SA node recovers and begins depolarising 
spontaneously again. A diseased SA node tends to have a grossly 
prolonged recovery time (Zipes, 1992; Fogoros, 1995).  
By delivering a properly timed extrastimulus with a short coupling 
interval, myocardial refractoriness can be determined. If the coupling 
interval between the last paced or spontaneous beat and the 
extrastimulus is too short, the stimulus will fall in the refractory period 
and no depolarisation will be initiated. However, a stimulus given after 
the refractory period will cause an extrasystole or even initiate 
tachycardia or fibrillation. The longest coupling interval not resulting in 
a propagated cardiac depolarisation indicates the effective refractory 
period of that tissue (Fogoros, 1995; Ross and Mandel, 1995). 
Initiation of tachyarrhythmias is a potential hazard of cardiac 
pacing. However, initiation of these tachyarrhythmias is often 
attempted to assess the existence of an appropriate anatomic 
substrate to encompass a reentrant circuit. Programmed electrical 
stimulation also allows to terminate many reentrant arrhythmias. 
Consequently, the electrophysiologic study has become vitally 
important in the evaluation and treatment of reentrant 
tachyarrhythmias. 
Complications that can be encountered with temporary or 
permanent pacing include vascular thrombosis, embolisation, 
infection, lead fracture, cardiac perforation or failure of the pacing 
system (Brinker and Midei, 1996). 
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CARDIAC PACING IN EQUINE MEDICINE 
Therapeutic pacing 
Permanent pacing 
In 1973, Berg et al. described the permanent implantation of a 
ventricular pacemaker in a young donkey with third-degree AV block. 
A thoracotomy was performed under general anaesthesia and an 
epicardial electrode was implanted on the left ventricle. The 
pacemaker was inserted subcutaneously caudal to the left elbow. After 
6 weeks, however, capture was lost, whereby pacemaker function 
could not be restored. The donkey died 3 weeks later. In 1979, Brown 
reported a horse with third-degree AV block. In an attempt to implant a 
permanent pacemaker during general anaesthesia, the horse 
developed ventricular fibrillation and died. Five years later, Le 
Nihouannen et al. (1984a; 1984b) reported two techniques for 
experimental pacemaker implantation in equines. Under general 
anaesthesia, they performed a thoracotomy in a pony to place 2 
epicardial electrodes on the left ventricle and subsequently implanted 
a pacemaker underneath the ascendant pectoral muscle. During a 60-
day follow-up period, the horse could be successfully paced. In 
another horse, an implantable passive fixation lead was transvenously 
inserted through the jugular vein into the right ventricle under 
radioscopic control. This procedure was performed in the standing, 
sedated animal. Implantation of a pacemaker was not reported in this 
animal. In 1986, Reef et al. performed a single chamber (ventricular) 
pacemaker implantation in a horse with third-degree AV block. Under 
general anaesthesia, a passive fixation lead was inserted in the jugular 
vein and placed in the right ventricular apex under ultrasonographic 
control. The pacemaker pocket was created dorsal to the jugular vein. 
The pacemaker was programmed to maintain a ventricular rate of 
45/min. However, due to this fixed heart rate, the horses’ performance 
was limited. Sixteen months after the implantation, a second lead with 
GENERAL INTRODUCTION 
16 
active fixation was implanted in the right atrium under general 
anaesthesia and the pacemaker was updated to a dual chamber 
model, allowing AV sequential pacing of the ventricles. This type of 
pacemaker delivered a ventricular stimulus each time an atrial 
depolarisation was sensed. Because in this horse with third degree AV 
block the sinus node still functioned properly, AV sequential pacing 
allowed the ventricular rate to ‘follow’ the atrial rate, resulting in a 
physiologic rate response to exercise or stress. About 3 years after the 
initial implantation, this horse suddenly died. At post mortem, extensive 
thrombi, a suppurative endocarditis and suspicion of a terminal 
bacteraemia were present (Hamir and Reef, 1989). In 1993, Pibarot et 
al. described the implantation of a dual chamber pacemaker in a 
donkey with complete AV block. Epicardial electrodes were implanted 
on the left atrium and the left ventricle under general anaesthesia. Due 
to a high post-operative ventricular threshold, the dual chamber 
system had to be programmed to a single chamber (ventricular) 
pacing mode to preserve battery life. After a 12-month follow-up 
period, successful ventricular pacing could still be achieved. 
Temporary pacing 
The first report about temporary pacing in a horse was published in 
1967 by Taylor and Mero. They reported transvenous endocardial 
ventricular pacing using an external pacemaker in a foal with third-
degree AV block. An electrode was introduced through the jugular vein 
and right ventricular pacing was applied during 45 minutes. A similar 
technique was used in some of the above-described animals with 3rd 
degree AV block to avoid Adams-Stokes attacks prior to the 
permanent implantation of pacemaker (Brown, 1979; Reef et al., 1986; 
Pibarot et al., 1993). 
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Non-therapeutic pacing 
Permanent pacing 
With a pacemaker, the effect of a sustained tachycardia can be 
imitated, arrhythmias can be generated and their inducibility verified, 
and furthermore, electrophysiologic measurements e.g. determination 
of the refractory period, can be made. This allows studying the 
pathophysiology of acute or long-term arrhythmias and developing 
different therapeutic strategies. Pacemaker implantation has been 
used in many animal-based research protocols using dogs (Allworth et 
al., 1995; Morillo et al., 1995; Elvan et al., 1996; Yue et al., 1997), 
goats (Wijffels et al., 1995), sheep (Willems et al., 2000) or pigs (Qi et 
al., 2000). However, no literature data were found concerning 
permanent pacemaker implantation in equines for diagnostic or 
investigational purposes. 
Temporary pacing 
In 1977, O’Callaghan mentioned that, by analogy with human 
medicine, cardiac electro-stimulation techniques could be useful to 
investigate sinus node function, refractory periods, conduction times, 
vulnerability of the atria for fibrillation and the effect of cardiac drugs on 
conduction and refractory period in equines. Although the author 
stated that pacing techniques were under investigation in their 
institute, to the best of our knowledge, results could not be found in 
literature. 
As rapid overdrive pacing or extrastimulus pacing is able to induce 
atrial or ventricular fibrillation or flutter (Brignole et al., 1986; Fogoros, 
1995), the technique is suitable to study these arrhythmias. In 1975, in 
a preliminary note, Senta et al. reported that, using temporary atrial 
pacing, short-term periods of AF could be induced in healthy horses. 
The bouts of AF persisted from 5 seconds to more than an hour and 
allowed them to study the effect of short-term AF on the cardiac output 
(Kubo et al., 1975). In 1978, Senta and Kubo applied rapid atrial 
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pacing and extrastimulus pacing to determine the ‘vulnerable period’ 
for AF induction, which turned out to range from 0.14 to 0.42 seconds. 
Moore and Spear (1987) induced AF by rapid atrial pacing (30 stimuli 
per second) during 30 seconds in different animal species including 
mules and mature horses to study the duration of the induced AF 
episode and the ventricular response during AF.  
In equines, ventricular fibrillation has been induced in order to 
investigate different ventricular defibrillation techniques. This was 
performed by rapid pacing with stimuli applied to the ventricular 
surface during thoracotomy (Witzel et al., 1968; Geddes et al., 1974) 
or to the ventricular endocardium using a temporary pacing catheter 
(Tacker et al., 1973; Tacker et al., 1975),  
Yamaya et al. (1997a; 1997b) applied atrial overdrive pacing to 
investigate AV conductive function in horses.
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ATRIAL FIBRILLATION 
In human medicine, acute and chronic AF have been described 
extensively. The latter form is further subdivided in paroxysmal, 
persistent and permanent AF. Paroxysmal AF includes cases in which 
episodes of AF terminate spontaneously without any therapy. If AF 
persists until a successful treatment is initiated it is called persistent 
AF. When AF continues despite treatment, permanent AF is said to be 
present (Gallagher and Camm, 1998; Allessie et al., 2001).  
GENERAL ELECTROPHYSIOLOGICAL CONSIDERATIONS 
The reentry phenomenon 
Under normal circumstances, cardiac activation starts with a 
depolarisation from the sinus node. This impulse spreads throughout 
the atria, generating a P wave on the surface ECG. After a slow 
conduction through the AV node, corresponding with the P-R segment, 
the impulse conducts over the His-Purkinje network to depolarise the 
ventricles (Petch, 1986). At the start of cardiac depolarisation, each 
cell becomes activated in turn and the cardiac impulse dies out when 
all fibres have been discharged and are completely refractory. During 
this absolute refractory period, the cardiac impulse has “no place to 
go”. It must be extinguished and restarted by the next sinus impulse. 
If, however a group of fibres not activated during the initial wave of 
depolarisation recovers excitability in time to be discharged before the 
impulse dies out, they may serve as a link to reexcite areas that were 
just discharged and have now recovered from the initial depolarisation. 
Such a process is called reentry, reentrant excitation or circus 
movement (Zipes, 1992). 
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Reentry requires a pathway with unidirectional block and slow 
conduction and in order to continue, the anatomical length of the 
circuit travelled should equal or exceed the reentrant wavelength. The 
latter is equal to the mean conduction velocity of the impulse multiplied 
by the longest refractory period of the elements in the circuit. 
Conditions that depress conduction velocity or abbreviate the 
refractory period will promote the development of reentry. 
Already around 1960, Moe and co-workers (Moe et al., 1959; Moe, 
1962; Moe et al., 1964) introduced the hypothesis that atrial fibrillation 
consists of multiple reentry waves wandering around in the atria. The 
more wavelets present at the same time, the smaller the probability 
that they die out simultaneously and the smaller the chance AF 
terminates. Therefore large atria are more likely to maintain AF. A 
decreased conduction velocity and a decreased refractory period 
shorten the wavelength and allow more wavelets to coexist in the atria, 
thereby favouring AF perpetuation (Zipes, 1997). In addition of this 
pathological triad of chronic fibrillation (atrial dilatation, shortened 
refractoriness and depressed conduction), also increased 
heterogeneity in intra-atrial conduction and spatial dispersion in 
recovery of excitability may be of crucial importance (Wijffels et al., 
1995; Allessie, 1998).  
Initiation and perpetuation of AF 
In man, diverse triggers can initiate AF especially if a vulnerable 
substrate is present. These triggers include sympathetic or 
parasympathetic stimulation, bradycardia, atrial premature beats or 
tachycardia, and acute atrial stretch (Allessie et al., 2001). Also ectopic 
foci in sleeves of atrial tissue within the pulmonary veins or vena cava 
junctions can initiate AF (Haissaguerre et al., 1998; Tsai et al., 2000). 
In experimental animal models, AF induction can be triggered by rapid 
atrial pacing (Morillo et al., 1995; Wijffels et al., 1995; Elvan et al., 
1996). Moreover, it appeared that AF itself produced changes in the 
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electrophysiological properties of the myocardium that further 
promoted the AF perpetuation.  
From human medicine, it is known that any process that infiltrates, 
irritates, inflames, scars, or stretches the atria may predispose them to 
fibrillate (Gallagher and Camm, 1998). This entails that AF often is the 
result of underlying disease. The most important predisposing 
conditions in human medicine include myocardial infiltration or 
inflammation (neoplasia, pericarditis, myocarditis), atrial scars, atrial 
stretch or hypertrophy (valvular lesions, pulmonary hypertension, 
congenital heart disease), myocardial degeneration and hormonal, 
neural or metabolic imbalances (thyrotoxicosis, electrolyte 
disturbances, autonomic status, systemic infection) (Gallagher and 
Camm, 1998). Besides, AF can present without evidence of other 
cardiac or systemic disease known to promote AF, and since 1954 this 
is usually described by the term lone AF (Evans and Swann, 1954) or 
idiopathic AF. 
ATRIAL FIBRILLATION IN EQUINES 
About a century ago, irregularity of the pulse was termed pulsus 
irregularis perpetuus (Hering, 1908). The rapid but hemodynamically 
ineffectual movement of atrium or ventricle, inducible by electrical 
stimulation, was known as ‘delerium cordis’ (Hoffa and Ludwig, 1850), 
‘frémissement fibrillaire’ (Vulpian, 1874) and ‘undulatory movement’ 
(Gaskell, 1900). In 1909, Sir Thomas Lewis merged the different 
concepts under the term auricular fibrillation. But only in 1911, Thomas 
Lewis was the first to demonstrate the link between an irregular heart 
rate and atrial fibrillation. From in situ studies in horses he concluded 
that the ‘tumultuous action of the heart’, i.e. the irregularity which 
occurs in the action of the ventricles, was in reality the outcome of 
fibrillation of the auricles. As such, research in equines contributed 
significantly to the early understanding of AF (Moore and Spear, 1987). 
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Atrial fibrillation (AF) is the most common, clinically significant, 
pathological arrhythmia in the horse (Bertone and Wingfield, 1987; 
Manohar and Smetzer, 1992; Reef et al., 1995). The prevalence of AF 
in horses is described to range from 0.23 to 5.3% (Holmes et al., 
1969; Deegen, 1971; Else and Holmes, 1971; Deem and Fregin, 
1982). All breeds can be affected but AF more frequently occurs in 
large breed horses and is virtually never seen in ponies (Holmes et al., 
1969; Else and Holmes, 1971; Deem and Fregin, 1982; Reef et al., 
1988). Some authors suggest that males are more frequently affected 
(Holmes et al., 1969; Else and Holmes, 1971; Deem and Fregin, 1982; 
Reef et al., 1988; Reef et al., 1995), while others didn’t find a gender 
predilection. AF occurs at all ages and is even encountered in 
neonatal foals (Machida et al., 1989; Yamamoto et al., 1992). 
Etiology 
Horses with AF may be classified into 2 groups: one in which 
existence of underlying disease is obvious (Else and Holmes, 1971) 
and the other in which underlying disease is not apparent, so-called 
lone fibrillators (Holmes et al., 1986). Horses in the latter group tend to 
be young and generally are referred for examination because of 
exercise intolerance (Deem and Fregin, 1982).  
Underlying diseases that may predispose horses to AF include 
electrolyte imbalances (Holmes et al., 1986), respiratory disease 
(Glazier and Kavanagh, 1977; Deegen, 1986; Gelberg et al., 1991), 
gastrointestinal disorders (Reef et al., 1988) and especially heart 
disease. Horses with cardiac failure commonly develop AF (Deem and 
Fregin, 1982; Belgrave, 1990; Taylor et al., 1991; Seahorn and 
Hormanski, 1993; Blissitt, 1999). Animals with atrial dilatation are more 
predisposed to the development of AF (Else and Holmes, 1971; 
Bertone et al., 1987; Detweiler, 1989; Stadler et al., 1994) and this 
most commonly occurs secondary to mitral or tricuspid valvular 
regurgitation (Holmes et al., 1969; Else and Holmes, 1971; Kiryu et al., 
1974; Deem and Fregin, 1982; Morris and Fregin, 1982; Deegen, 
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1986; Reef et al., 1988; Blissitt, 1999). Increased atrial fibrosis has 
been reported in AF affected horses (Else and Holmes, 1971; Gerber 
et al., 1972; Button et al., 1980; Muylle et al., 1981; Nuytten et al., 
1981; Deegen, 1986). The cause of this fibrosis was thought to be 
related to local circulatory disturbances caused by arteriolar wall 
thickening (Amada and Kiryu, 1987) and to over-exertion and strain 
(Else and Holmes, 1971). From human medicine we know that atrial 
myocardial damage can be the source of atrial premature 
depolarisations and might increase the chance for AF initiation and 
perpetuation (Allessie et al., 2001). However, atrial fibrosis is also 
commonly found in horses in normal sinus rhythm (Else and Holmes, 
1971; Bertone and Wingfield, 1987). 
Besides AF secondary to other disease, horses most frequently 
present lone AF (Amada et al., 1974; Rose and Davis, 1977b; Deem 
and Fregin, 1982; Reef et al., 1988; Detweiler, 1989; Stewart et al., 
1990; Collatos, 1995). Lone AF is said to be present if no other 
abnormalities are found on clinical and biochemical examination, ECG, 
and cardiac ultrasound. Often these animals respond better to medical 
antiarrhythmic treatment. Up to 87.5% of these animals may be 
treated successfully and many return to their previous level of 
performance (Reef et al., 1988). Although some of these horses might 
present the aforementioned myocardial lesions that remain 
undiagnosed, lone AF is still said to be present because high-level 
performances can be achieved after treatment.  
The paroxysmal form of AF is occasionally encountered, usually in 
the absence of underlying cardiac disease. Occurrence of paroxysmal 
AF has been related to the presence of atrial premature 
depolarisations, increased intra-atrial pressure and increased atrial 
strain, myocardial ischemia, electrolyte disturbances such as 
potassium depletion (which might be related to administration of 
diuretics in racehorses), and changes in autonomic tone (Donald and 
Elliott, 1948; Detweiler, 1952; Glazier et al., 1959; Else and Holmes, 
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1971; Machida et al., 1989; Gallagher and Camm, 1998). Possibly due 
to a high vagal tone, paroxysmal AF has also been described in 
neonatal foals (Machida et al., 1989; Yamamoto et al., 1992) and 
during eye enucleation in a horse (Gasthuys et al., 1988). 
Hemodynamics 
During atrial fibrillation, multiple reentry wavelets meander around 
in the atria causing contraction of individual areas of myocardium 
rather than a synchronous atrial contraction. Due to the loss of 
concerted atrial contraction, filling of the ventricles occurs passively 
and is attributable mainly to the flow and pressure gradient transmitted 
from the venous and pulmonary capillary beds (Holmes et al., 1986; 
Bertone and Wingfield, 1987). As a result, ventricular preload is 
reduced and stroke volume decreases (Abildskov et al., 1971; Kubo et 
al., 1975; Deegen and Buntenkotter, 1976; Wingfield et al., 1980; 
Deem and Fregin, 1982; Miller and Holmes, 1984; Muir and McGuirk, 
1984; Deegen, 1986; Betsch, 1991; Marr et al., 1994; Marr et al., 
1995). Atrial asystole prevents presystolic atrioventricular (AV) valve 
closure, leading to AV valve regurgitation. Ventricular performance in 
AF can vary strikingly because of the influence of variations in beat-to-
beat intervals on the contractile performance (Manohar and Smetzer, 
1992). A pressure increase in right and left atrium is often present 
which might explain the occurrence of epistaxis, ventral oedema or 
lung oedema in AF horses (Else and Holmes, 1971; Muir and 
McGuirk, 1984; Bonagura, 1985; Amada and Kiryu, 1987; Bertone and 
Wingfield, 1987; Stadler et al., 1994). 
At rest, the aforementioned alterations are of little importance 
because most of the ventricular filling occurs early in diastole during 
the rapid ventricular filling phase and because reflex mechanisms act 
to maintain an adequate circulation if no other abnormalities are 
present (Oldham et al., 1967). As a result of compensatory 
mechanisms and because of the high vagal tone in horses reducing 
AV conduction, resting heart rate in horses without underlying heart 
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disease remains normal (Roos, 1924; Deem and Fregin, 1982; 
Deegen, 1986). 
During exercise, however, when tachycardia abbreviates ventricular 
diastole, booster pump function of the atria becomes very important in 
achieving adequate ventricular filling to maintain appropriate stroke 
volume (Miller and Holmes, 1984; Manohar and Smetzer, 1992). 
Moreover, AF horses present an abnormally rapid heart rate during 
excitement or exercise, further hampering cardiac performance 
(Fregin, 1971; Deegen and Buntenkotter, 1976; Steel et al., 1976; 
Maier-Bock and Ehrlein, 1978; Deegen, 1986). Accordingly, exercise 
intolerance is the most important complaint in AF affected horses. 
Symptoms 
Symptoms of AF largely vary according to the degree of underlying 
disease and the exercise load demanded from the patient. In breeding 
or pleasure horses, AF is usually an incidental finding as physical 
strain is to small to elicit complaints about performance. Obvious 
symptoms in this group of patients are usually indicative of 
concomitant congestive heart failure. Performance horses usually 
present exercise intolerance (Mitten, 1996). Increased left and right 
atrial pressures may result in lung oedema, epistaxis and ventral 
oedema. Due to the decreased ventricular function, the abnormal 
pressures, the lung oedema and possibly the occurrence of ventricular 
tachyarrhythmias, horses may show weakness, incoordination, 
collapse or sudden death (Donald and Elliott, 1948; Deem and Fregin, 
1982; Amada and Kiryu, 1987; Bertone and Wingfield, 1987). 
Occasionally, paroxysmal AF is encountered in racehorses, 
causing a sudden decrease in performance (Amada and Kurita, 1975; 
Rose and Davis, 1977a; Holmes et al., 1986; Miller et al., 1992; Hiraga 
and Kubo, 1999). In these animals AF has been suggested to occur 
without underlying heart disease.  
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Diagnosis and treatment 
Patient history most frequently includes loss of performance, 
although symptoms vary widely as described above. Similarly, a great 
variation of signs is found during clinical examination, depending on 
the degree of underlying heart disease. Cardiac auscultation reveals a 
totally abnormal rhythm with absence of the fourth heart sound (S4). 
Intensity of heart sounds can vary from beat to beat. Early systolic 
murmurs may be detected because of the lack of presystolic AV valve 
closure (Deegen, 1986; Bertone and Wingfield, 1987). Resting pulse 
rate is usually normal unless other primary heart disease is present. A 
pulse deficit is occasionally present. The jugular veins should be 
examined for signs of elevated right atrial pressure. A small portion of 
horses present with exercise-induced epistaxis, which may occur with 
minimal exercise (Deem and Fregin, 1982; Reef et al., 1988).  
A definitive diagnosis is made by electrocardiography. In normal 
horses P wave (atrial depolarisation), QRS complex (ventricular 
depolarisation) and T wave (ventricular repolarisation) are separated 
by an isoelectric line. In animals with AF, P wave is absent and the 
continuous electrical activity in the atria produces undulations of the 
isoelectric line, known as ‘f’ waves (Fig. 3). R-R intervals are irregular 
but QRS complexes are supraventricular in origin. 
On M-mode and pulsed wave Doppler echocardiography, the A 
wave, which is produced by the normal atrial contraction, is absent 
(Wingfield et al., 1980; Stadler et al., 1994). 
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AF in horses is usually treated with quinidine sulphate, a class 1A 
antiarrhythmic drug. Quinidine blocks fast sodium channels, prolongs 
action potential duration and refractory period, and depresses 
conduction velocity. Treatment is reasonably successful if there is no 
evidence of underlying heart disease and animals can return to 
previous athletic ability (Irvine, 1975; Reef et al., 1988). Best results 
are obtained with recent onset AF (Glendinning, 1965). Success rates 
of up to 87.5% have been reported (Reef et al., 1988) and recurrence 
rate varies between 20 and 30% (Deegen and Buntenkotter, 1976; 
Deem and Fregin, 1982; Reef et al., 1988). Because quinidine also 
produces hypotension (peripheral vasodilatation) and tachycardia 
(vagolytic effects), it should not be administered to horses with signs of 
congestive heart failure. Although quinidine is an antiarrhythmic drug, 
it also has proarrhythmic properties that may cause syncope as a 
result of torsades de pointes or even sudden death. In one study, 5% 
of the horses died during quinidine treatment (Morris and Fregin, 
1982). 
A dose of 20 mg/kg body weight is administered every two hours 
via a nasogastric tube until sinus rhythm is restored or a maximal daily 
dose of 80-130 g is achieved or signs of toxicity develop. In animals 
that fail to respond to treatment, quinidine treatment may be continued 
 
Figure 3. Surface ECG recordings from a horse. During sinus rhythm 
(SR) a regular rhythm with obvious P waves are present, while during 
atrial fribrillation (AF) R-R intervals become irregular and f waves (f) are 
identifiable. 
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at 6 hourly intervals or an additional digoxin treatment may be given to 
slow down ventricular rate during quinidine treatment (Reef et al., 
1995). Concurrent digoxin and quinidine treatment should be given 
cautiously as this enhances digoxin toxicity (Bertone and Wingfield, 
1987; Parraga et al., 1995). 
Up to 76% of the horses show quinidine side effects, including 
urticaria, nasal oedema, anorexia, tachycardia, weakness, ataxia, 
colic, diarrhoea, laminitis or convulsions (Morris and Fregin, 1982; 
Reef et al., 1988). ECG recordings prior to quinidine administration are 
vital: 25% increase in the width of the QRS complex indicates toxicity 
and precludes further treatment.  
Intravenous treatment with quinidine gluconate has also been 
reported but success rate is slightly lower (Gerber et al., 1971; Deegen 
and Buntenkotter, 1974; Lekeux et al., 1981; McGuirk et al., 1981; 
Muir et al., 1990). 
Following conversion to sinus rhythm, horses usually are not 
immediately returned to training. However, the recommended rest 
period is empirical, not based on clinical findings. Therefore, different 
authors recommend a period of rest after conversion ranging from a 
few days (Gerber et al., 1971; Amada and Kurita, 1975), 1 to 2 weeks 
(Bonagura, 1990; Patteson, 1996), up to 3 months (Rose and Davis, 
1977b). In horses, not treated for AF because of congestive heart 
failure, therapy is best aimed at alleviating the clinical signs of heart 
failure and, obviously, these animals should avoid any effort. 
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Horses can suffer from cardiac rhythm disturbances that can affect 
their performance or can even be life threatening. Clinically, the most 
important arrhythmia in equines is atrial fibrillation. During the past 
decades, only little progress has been made concerning arrhythmias in 
equines. In general, the surface electrocardiogram (ECG) is the only 
diagnostic aid while treatment options merely consist of a few drugs, 
such as quinidine and digoxin. Conversely, in human medicine, 
extensive facilities are available in the cardiology department. In man, 
electrophysiological studies and different cardiac pacing techniques 
have become a mainstay in the diagnosis and treatment of many 
dysrhythmias. Short-term pacing is applied with temporary catheters 
while long-term pacing can be achieved by permanent implantation of 
an electrical pulse generator. 
Besides diagnosis and treatment, cardiac pacing also provides an 
excellent means to study pathophysiology of arrhythmias in animal 
models. 
The aims of our study were investigating the applicability of atrial 
pacing in horses and subsequently using the technique to study the 
pathophysiology of atrial fibrillation in equines. Particular aims of this 
study were as follows: 
Section 1: atrial pacing 
1. Temporary pacing 
a. Development of a technique 
b. Application in the treatment of atrial flutter 
2. Permanent pacing 
a. Development of a technique 
b. Application to treat sinus node dysfunction 
Section 2: research on atrial fibrillation 
1. Development of a model for chronic atrial fibrillation in 
healthy equines 
2. Application of the model to study the pathophysiology of 
chronic atrial fibrillation
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SUMMARY 
The purpose of this study was to perform temporary atrial 
pacing and to determine the atrial strength-duration (S-D) curve, 
which displays the minimal pulse intensity necessary to achieve 
atrial capture. In seven horses atrial pacing was applied using a 
temporary pacing catheter and a pacemaker as electrical pulse 
generator. Using the stimulus reduction method, three 
approaches for atrial threshold determination were used. With 
the fixed pulse width method, at several pulse widths the 
corresponding minimal amplitudes to achieve capture were 
determined, describing a S-D curve. With the fixed amplitude 
method, the corresponding threshold pulse widths were 
determined at several fixed amplitudes. The third method proved 
to be the best one and was a combination of both 
aforementioned methods to determine 2 points of the S-D curve. 
From these two points the whole S-D curve was calculated using 
a mathematical equation. Temporary pacing can be used to 
terminate atrial flutter, to induce atrial arrhythmias or to obtain 
more information about the electrophysiologic properties of the 
heart such as the atrial refractory period, atrial vulnerability and 
atrioventricular conduction. 
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INTRODUCTION 
The excitable properties of the cardiac cells make artificial 
stimulation of the heart possible (Irnich 1989). Artificial stimulation can 
be performed by mechanical or electrical stimulation. Electrical stimuli 
are delivered by an external or an implantable pulse generator and are 
conducted to the heart by means of a lead wire with electrodes on its 
tip. The transvenous insertion of a lead or catheter electrode into the 
cardiac cavity is the most widely used method for cardiac pacing, 
although transcutaneous, transoesophageal or epicardial stimulation 
are also possible.  
The electrical stimulus, which is a square current pulse, has to 
reduce the resting potential of the cardiac cells by a critical amount 
and within a critical time in order to reach the threshold for the 
propagated response, known as the action potential (Trautwein 1975). 
The threshold for cardiac pacing can be defined as the smallest 
amount of electrical activity that produces consistent myocardial 
capture outside the refractory period of the heart (Hayes and Osborn 
1996). It is determined by its amplitude or strength and by its pulse 
width (PW) or duration. Within limits, values with a lower amplitude 
must have a longer duration, while the duration of high amplitude 
values may be shorter. These threshold values describe a hyperbolic-
like strength-duration curve (Geddes and Bourland 1985). Knowledge 
of this strength-duration relationship is fundamental to safe and 
effective cardiac pacing (Ayers et al. 1986). A threshold within normal 
limits is a means of verifying that the electrode is in a secure position 
and is in contact with viable cardiac tissue (Schuenemeyer 1986). 
Temporary cardiac pacing can be used therapeutically, as during 
third degree atrioventricular block, to prevent problems during 
anaesthesia of animals with documented conduction system disease 
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or as a treatment of atrial flutter (van Loon et al. 1997). It can also be 
used to induce atrial arrhythmias in order to study their effect on 
cardiac function, as performed by Kubo et al. (1975), Senta and Kubo 
(1978) and Moore and Spear (1987). Furthermore temporary pacing 
can provide useful information about the electrophysiologic properties 
of the heart, such as atrial refractory period, atrioventricular conduction 
(Yamaya et al. 1994, 1997a and 1997b) or atrial vulnerability (Senta 
and Kubo 1978). 
The purpose of this study was to assess the feasibility of temporary 
atrial pacing in horses, to determine the minimal pulse intensity 
necessary to achieve atrial stimulation and to evaluate different 
techniques to determine the atrial S-D curve. 
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MATERIALS AND METHODS 
Threshold values for temporary transvenous atrial pacing were 
determined in seven healthy standardbred horses. Clinical, 
electrocardiographic and echocardiographic examinations were 
normal in all horses. 
Instrumentation 
A catheter electrode or lead1, which possessed two electrodes at 
its tip, was used for bipolar stimulation of the right atrium. The lead 
was straight in 3 horses and had a J shaped tip in 4 horses. A 
pacemaker2 served as an external pulse generator and was 
connected with the electrodes of the lead. A programmer3 had 
telemetric contact with the pulse generator and was at the same time 
connected with a surface electrocardiogram (ECG). With the 
programmer, the pulse generator could be programmed to deliver 
electrical pulses with a specific interval, amplitude and duration. 
Furthermore, electrical activity of the heart could be 'sensed' through 
the same electrode in order to obtain an endocardial electrogram. The 
endocardial electrogram and the surface ECG were simultaneously 
visible on the programmer screen and could be recorded on paper.  
After local anaesthesia (xylocaine 2 %4), an introducer sheath was 
inserted in the lower third of the jugular vein using a modified 
Seldinger technique. Via the jugular vein, the catheter electrode was 
inserted into the cardiac chamber. Location of the catheter tip was 
confirmed by the ECG recordings and by echocardiography. Initially, 
while the electrode tip was still in the blood vessels, no or minimal 
electrical activity could be sensed. Once the electrode entered the 
right atrium, largest deflections on the endocardial electrogram 
coincided with the P waves on the surface ECG. Further advancement 
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of the catheter into the right ventricle produced large endocavitary 
deflections simultaneous with the QRS-complexes. 
On echocardiography, catheter movement was visible once the 
catheter entered the right atrium. Due to lung interference, the dorsal 
part of the right atrium could only be imaged partially. 
Lead positioning 
First the lead was inserted into the right atrium and advanced until 
it reached the tricuspid valve or entered the right ventricle. 
Subsequently, the lead was withdrawn until large intra-atrial deflections 
with an equal morphology were present, indicating a stable contact 
between the electrode and the endocardium. The lead was left in place 
to perform threshold measurements. When no efficacious electrode 
position was obtained during withdrawal, when diaphragmatic nerve 
stimulation occurred or when endocardial contact was lost during 
threshold measurement, the electrode was repositioned and 
measurements were repeated. 
The whole procedure was performed in the unsedated horse. 
Measurements 
In order to obtain an artificial stimulation of the heart, the 
pacemaker was programmed to deliver bipolar electrical pulses at a 
faster rate than the intrinsic heart rate, empirically at 60 beats per 
minute. The most distal electrode (tip) was used as cathode while the 
proximal electrode (ring) was the anode. If intrinsic atrial activity was 
sensed by the pulse generator, stimulation was shortly inhibited to 
avoid induction of atrial fibrillation.  
For the threshold measurements the stimulus reduction method 
was used. This means that stimulation started with strong pulses, with 
a long duration and/or high amplitude, and that gradually the intensity 
of the pulses was decreased until capture, i.e. cardiac contraction, was 
lost. The decrease of pulse intensity was not continuous but stepwise. 
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The PW varied in steps of 0.03 milliseconds (ms) between 0.03 and 
0.15 ms, in steps of 0.05 ms between 0.15 and 1 ms and in steps of 
0.1 ms between 1 ms and 1.5 ms. Variations of the amplitude were 
restricted to 0.5 volt (V), 1 V, 1.5 V, 2 V, 2.5 V, 3 V, 3.5 V, 4 V, 5 V and 
7.5 V. 
Three different ways for threshold determination were applied. With 
the constant PW method (method 1), the pulse duration was 
programmed at a fixed value. Subsequently, pacing started with stimuli 
with high amplitude. Every 4 stimuli, the pulse generator gradually 
decreased the amplitude. Capture was present as long as every 
electrical pulse was followed by a P wave on the surface ECG. When 
the pulse amplitude became too low and thus too weak, a P wave was 
not initiated, capture was lost and intrinsic heart rate reappeared. At 
that time, stimulation was aborted. The weakest pulse still able to 
achieve capture was taken as the threshold value for stimulation. The 
minimal amplitude for stimulation was successively determined at 
fixed PW of 0.8 ms, 0.6 ms, 0.4 ms, 0.3 ms, 0.2 ms, 0.12 ms and 0.06 
ms. A plot of these values, with stimulus strength (V) on the ordinate 
and duration (ms) on the abscissa, describes the strength-duration (S-
D) curve. 
With the constant amplitude procedure (method 2), the amplitude 
of the stimuli was kept constant and the PW was gradually decreased 
until capture was lost. The minimal PW for stimulation was 
successively determined at fixed amplitudes of 7.5 V, 4 V, 3.5 V, 3 V, 
2.5 V, 2 V and 1.5 V to obtain a new S-D curve. 
For the third method, only two threshold values were determined. 
The constant voltage method was used to determine the threshold PW 
at a high amplitude pulse, while the threshold amplitude for a long PW 
stimulus was determined with the constant PW method. With these 
two values the theoretical strength-duration curve was calculated using 
a hyperbolic equation, described by Lapicque (1907): 
  CHAPTER 1: Materials & methods 
  51 
 
 ÷
ø
ö
ç
è
æ +´=
t
t
1II cr  [1] 
where I is the stimulus intensity (voltage or current), t is the PW, Ir 
is the rheobase and tc is the chronaxie. 
The rheobase was defined as the lowest amplitude with indefinite 
pulse duration that just stimulates the myocardium (Irnich 1980). The 
chronaxie was the threshold pulse duration at a stimulus amplitude of 
twice that of rheobase. Using equation [1] rheobase and chronaxie can 
be calculated when 2 threshold values on the S-D curve are known. 
With the rheobase and chronaxie all points of the S-D curve can be 
computed using the same equation (Fig. 1.1). 
After determination of the S-D curve using these three methods, 
the lead was advanced again until the tricuspid valve or the right 
ventricle and was withdrawn to perform a new series of measurements 
at a second location in the atrium. Thus in each horse 6 S-D curves 
were determined. 
Statistical analysis 
Statistical comparison of methods 1 and 2 was not performed as 
variation was along the ordinate for method 1 while variation was along 
the abscissa for method 2. Therefore, accuracy and precision of 
methods 1 and 2 were compared with method 3. First method 1 and 3 
were compared. At the same fixed PW values as used in method 1, 
the threshold amplitudes were calculated for method 3 using equation 
[1] resulting in a variation along the ordinate. Subsequently, to 
compare methods 2 and 3, threshold PW values for method 3 were 
calculated for each fixed amplitude used in method 2, resulting in a 
variation along the abscissa.  
Statistical analyses were performed after a loge-transformation of 
the data to obtain a normal distribution, as indicated by the Wilk-
Shapiro/Rankit Plot (Statistix 4.15). For each PW or amplitude level 
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respectively, a paired t-test was performed to compare the accuracy of 
threshold determination of methods 1 or 2 with method 3 (Statistix 
4.1). Similarly, precision of threshold determination with methods 1 or 
2, i.e. variances at each fixed level, was compared with precision of 
threshold determination with method 3 using an F-test (Statistix 4.1). 
Correlation (Pearson's) was used to determine the degree of linear 
association between method 1 and 2 with method 3. A probability of < 
0.05 was considered significant. 
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RESULTS 
Successful atrial pacing was obtained in all horses. Adequate 
electrode positioning and determination of threshold values could be 
easily performed. The procedure was well tolerated by the unsedated 
horse and cardiac pacing initiated no adverse reactions of the horse, 
even when diaphragmatic nerve stimulation occurred.  
The J shaped catheter was found to obtain more easily a stable 
endocardial contact than the straight lead.  
Threshold values for atrial stimulation using the constant PW 
method and the constant voltage method are listed in Table 1.1 and 
1.2, respectively. Geometric mean and 95% confidence interval of 
each method and the corresponding values of the third method are 
displayed. The correlation coefficient and p-value of method 1 and 
method 2 with method 3 are recorded. In addition, Table 1.1 contains 
rheobasic voltage and chronaxie pulse duration of each horse, and the 
geometric mean values and the 95% confidence interval, obtained 
from method 3. The mean rheobase and chronaxie are indicated in 
Figure 1.1, which displays the mean S-D curve of method 3. 
Due to limitations of the system, the amplitude and PW varied 
stepwise and not continuously. This means that values are 
overestimated. Furthermore in some horses at a fixed PW of 0.06 ms, 
threshold amplitude could not be obtained because the threshold was 
higher than the maximal available strength of 7.5 V. Consequently 
capture did not occur. In these cases data were excluded from 
statistical analyses. At a fixed PW of 0.8 ms, the amplitude values of 
horse 3 might have been lower than 0.5 V but the amplitude could not 
be decreased further. Similarly for the second method, in some horses 
the PW values at a fixed amplitude of 4 V and 7.5 V might have been 
shorter than 0.03 ms but this was the shortest available PW. In some 
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horses minimal PW for stimulation could not be determined at a fixed 
amplitude of 2 V and/or 1.5 V because these values were below their 
rheobase. At an amplitude below the rheobase, even an infinitely long 
PW will not be sufficient to initiate a depolarisation. In these cases, 
data were excluded from statistical analyses. 
Statistical analyses showed that accuracy and precision at each 
PW level were similar for both methods 1 and 3 and that there was a 
linear association between the threshold values of both methods at 
each PW level (Table 1.1). 
Statistical comparison of method 2 with method 3 indicated that 
precision was similar for both methods at each amplitude level. Also, 
at each amplitude level, a linear association was found between the 
threshold values of both methods as indicated by the significant 
correlation coefficients in Table 1.2. On the other hand, accuracy 
evaluation showed that threshold values were significantly lower when 
determined with method 2 at the amplitude levels 1.5, 2 and 2.5 V 
(Table 1.2). 
Figure 1.1. This S-D curve displays the geometric mean values 
and 95% confidence interval (error bars) for all horses and all 
positions using method 3. The geometric mean values for 
rheobase and chronaxie are shown. 
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Table 1.1. Measured amplitude values (V), geometric means (GM) 
and 95% confidence intervals (95% CI) of the constant PW method, 
and the rheobase (V) and chronaxie (ms) values with their GM and 
95% CI of the third method are displayed for each horse in each 
position. Values of the GM and 95% CI of the third method are shown. 
At each PW level, similar superscript letters for the GM values of 
method 1 and method 3 indicate that no significant difference in 
accuracy exists between both methods. Correlation (Pearson's), and 
corresponding p-value, between both methods is shown at each PW 
level. Some data are missing, indicated by M, because capture could 
not be achieved at the maximal amplitude of 7.5 V. 
 
Constant pulse width method (Method 1) Method 3 
Horse Position 
0.06 ms 0.12 ms 0.2 ms 0.3 ms 0.4 ms 0.6 ms 0.8 ms rheobase chronaxie 
1 1 3 2 1.5 1.5 1 1 1 0.76 0.26 
 2 M 7.5 4 3.5 3.5 3 3 2.39 0.26 
2 1 7.5 4 3 2.5 2.5 2 2 2.25 0.11 
 2 5 3.5 3 2.5 3 2.5 2.5 2.24 0.09 
3 1 3 2.5 1 1 1 0.5 0.5 0.82 0.21 
 2 2.5 1.5 1 1 1 0.5 0.5 1.25 0.20 
4 1 5 2 2 1.5 1 1 1 0.62 0.49 
 2 7.5 7.5 3.5 2.5 2.5 2.5 2 1.65 0.17 
5 1 M 7.5 4 4 3.5 3 1.5 1.47 0.36 
 2 M 5 4 3.5 3 2.5 2 1.09 0.67 
6 1 5 2.5 1.5 1.5 1 1 1 0.80 0.25 
 2 3 2 1.5 1.5 1 1 1 0.80 0.25 
7 1 M 4 3.5 2 2 1.5 1.5 1.30 0.16 
 2 7.5 4 2.5 2 2 2 2 1.13 0.33 
Method 1 GM 4.52 
a
 3.46 
a
2.30 
a
 1.99 
a
 1.76 
a
 1.47 
a
 1.35 
a
 - - 
 95% CI 
(3.33 ; 
6.14) 
(2.53 ; 
4.73) 
(1.72 ; 
3.09) 
(1.54 ; 
2.57) 
(1.29 ; 
2.40) 
(1.03 ; 
2.09) 
(0.98 ; 
1.86) - - 
Method 3 GM 5.16 
a
 3.71 
a
2.73 
a
 2.24 
a
 1.99 
a
 1.74 
a
 1.61 
a
 1.21 0.24 
 95% CI 
(4.35 ; 
6.11) 
(2.95 ; 
4.67) 
(2.19 ; 
3.42) 
(1.79 ; 
2.80) 
(1.59 ; 
2.48) 
(1.38 ; 
2.17) 
(1.28 ; 
2.02) 
(0.94 ; 
1.56) 
(0.18 ; 
0.32) 
Correlation 0.76 0.77 0.81 0.86 0.94 0.79 0.77 - - 
p-value 0.011 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.001 - - 
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Table 1.2. Measured PW values (ms), geometric means (GM) and 
95% confidence intervals (95% CI) of the constant amplitude method 
are displayed for each horse in each position. GM values and 95% CI 
for the third method are shown. At each amplitude level, different 
superscript letters for the GM values of methods 2 and method 3 
indicate a significant difference in accuracy of both methods. 
Correlation (Pearson's), and corresponding p-value, between both 
methods is shown at each PW level. In some horses data are missing, 
as indicated by M, because capture could not be achieved at the 
maximal pulse width of 1.5 ms. 
Constant amplitude method (Method 2) 
Horse 
Positio
n 1.5 V 2 V 2.5 V 3 V 3.5 V 4 V 7.5 V 
1 0.2 0.12 0.12 0.09 0.09 0.06 0.03 
1 
2 M M 1.3 0.45 0.25 0.2 0.09 
1 M 1.2 0.45 0.25 0.2 0.12 0.06 
2 
2 M 0.9 0.65 0.15 0.15 0.12 0.06 
1 0.12 0.12 0.09 0.06 0.06 0.03 0.03 
3 
2 0.12 0.09 0.06 0.06 0.03 0.03 0.03 
1 0.2 0.2 0.2 0.12 0.09 0.09 0.03 
4 
2 0.5 0.4 0.2 0.15 0.12 0.12 0.09 
1 1.5 0.7 0.55 0.45 0.35 0.3 0.09 
5 
2 1.1 0.6 0.4 0.3 0.3 0.25 0.12 
1 0.15 0.15 0.12 0.09 0.09 0.06 0.06 
6 
2 0.12 0.09 0.06 0.06 0.06 0.06 0.06 
1 0.8 0.3 0.2 0.15 0.15 0.12 0.03 
7 
2 1 0.3 0.3 0.3 0.2 0.15 0.09 
GM 0.33 
a 0.22 
a
 0.23 
a
 0.15 
a
 0.12 
a
 0.10 
a
 0.06 
a
 
Method 2 95 % 
CI 
(0.15 ; 
0.69) 
(0.13 ; 
0.36) 
(0.13 ; 
0.39) 
(0.10 ; 
0.23) 
(0.08 ; 
0.19) 
(0.07 ; 
0.15) 
(0.04 ; 
0.07) 
GM 0.76 
b
 0.32 
b
 0.31 
b
 0.19 
a
 0.14 
a
 0.11 
a
 0.05 
a
 
Method 3 95 % 
CI 
(0.29 ; 
1.95) 
(0.20 ; 
0.52) 
(0.17 ; 
0.60) 
(0.12 ; 
0.28) 
(0.10 ; 
0.20) 
(0.08 ; 
0.16) 
(0.04 ; 
0.06) 
Correlation 0.79 0.87 0.89 0.86 0.76 0.81 0.74 
p-value 0.007 <0.001 <0.001 <0.001 0.002 <0.001 0.002 
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DISCUSSION 
During the measurements, factors that could influence the 
threshold values were avoided as much as possible. The horses were 
made used to stand in the stocks in order to avoid sympathetic 
influence. In man, increased sympathetic tone and catecholamines are 
known to decrease threshold values while increased vagal tone 
increases threshold values (Preston et al. 1967; Kay 1996). Lignocaine 
without epinephrine was used as local anaesthetic at the level of the 
jugular vein, because the sympathomimetic agent epinephrine can 
lower the threshold for stimulation (Preston et al. 1967; Furman et al. 
1977b; Wood and Ellenbogen 1996). 
In three horses, a straight lead was used while in four horses 
measurements were performed with a J tipped lead. The straight lead 
was found to remain more difficult in stable endocardial contact than 
the J shaped catheter. The J shape was thought to enhance 
entanglement in the atrial trabeculae while the catheter was withdrawn. 
The shape and surface area of the electrodes were identical in both 
leads, because these parameters influence the threshold for 
temporary pacing (Irnich 1980; Schuenemeyer 1986). Smaller 
electrodes have a larger electric field and thus a lower threshold than 
large surface electrodes (Furman et al. 1977b). 
Correct intra-atrial location of the electrodes with a stable 
endocardial contact is characterized by an endocardial electrogram 
with large monomorphic deflections concomitant with the peripheral P 
wave (Furman et al. 1977a). Since voltage threshold increases rapidly 
with increasing distance between the electrode and the excitable 
myocardium (Furman et al. 1977b), consistent capture with low 
threshold values was an additional verification for a good contact 
between electrode and myocardium. Due to areas of fibrotic 
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myocardium local variations in threshold values may occur (Furman et 
al. 1977b; Ector et al. 1985). 
Ultrasonography was helpful to position the electrode tip in the 
atrium but the dorsal part of the right atrium could not completely be 
visualized. Moreover, even when the catheter was visible on 
ultrasound, endocardial contact of the electrode tip could not always 
be assured. While in human medicine fluoroscopy is an important tool 
to localize the electrode tip, no fluoroscopic control was performed 
during this study. Due to the large equine thorax, the usefulness of this 
technique would have been limited in adult horses.  
During catheter positioning, single atrial or ventricular extrasystoles 
occurred occasionally but never initiated sustained dysrhythmias. 
Bipolar stimulation means that pulses are delivered between two 
electrodes within the heart and is most commonly applied for 
temporary pacing (Wood and Ellenbogen 1996). The most distal (tip) 
electrode is usually the cathode, while the proximal (ring) is the anode 
(Furman et al. 1977b; Chou T. C. 1986; Schuenemeyer 1986). The 
voltage threshold for bipolar pacing is slightly higher than for unipolar 
pacing although the difference is very small (Furman et al. 1977b). 
Immediately after a pulse is delivered, the endocardial electrogram 
presents a large deflection, known as the afterpotential (Kay 1996). 
During this deflection the intrinsic electrical activity of the heart is often 
not visible. Consequently, capture is not always visible on the 
intracardiac electrogram and can better be established on the surface 
ECG. 
Occasionally, diaphragmatic contractions were seen simultaneous 
with pacing rate. Stimulation of the lateral, dorsal part of the right 
atrium, at the level of the diaphragmatic nerve, was likely to be the 
cause. Decreasing the stimulation intensity, i.e. the amplitude and/or 
pulse duration, inhibited the diaphragmatic flutter. However, when 
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diaphragmatic stimulation occurred, measurements were not 
performed and the lead was repositioned to avoid this phenomenon. 
With the stimulus reduction method, stimulation intensity starts at a 
high level and decreases gradually, while the opposite is true with the 
stimulus advance method. In human medicine, the stimulus reduction 
method is mostly used because patients often depend on pacemaker 
stimulation. Threshold values determined by the stimulus advance 
method are slightly higher than those of the stimulus reduction method 
(Sylvén et al. 1982; Schuenemeyer 1986). 
For the fixed PW method, method 1, in some horses no capture 
could be obtained at 0.12 and 0.06 ms because the maximal available 
amplitude of 7.5 V was not sufficient to achieve capture. Therefore the 
left side of the curve could not always be obtained and the best results 
for the fixed PW method were obtained at the right side of the curve. 
For horse 3, voltage threshold at 0.6 and/or 0.8 ms might have been 
lower than 0.5 V but 0.5 V was the lowest available amplitude. 
For the fixed amplitude procedure, method 2, at low amplitudes 
there was a large variation in the determined PW values and in some 
horses no values could be obtained. The reason was that for some 
horses the low voltage was close to their rheobasic voltage that 
resulted in a very long PW while in other horses the PW was still very 
short. And in some horses a threshold PW could not be obtained at a 
low amplitude because that amplitude was already below their 
rheobasic voltage. Therefore the fixed amplitude method seemed 
most suitable for measurement of the left side of the curve, and less 
appropriate to obtain the right side of the curve. 
The third method, which calculated the S-D curve with Lapicque's 
law, was a combination of the aforementioned methods in order to 
simplify S-D curve determination. A point at the left side of the curve 
was determined with the most suitable method being the fixed 
amplitude method, while a point at the right side of the curve was 
measured using the most appropriate fixed PW method. From these 
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two points rheobase and chronaxie can be calculated using equation 
[1]. The rheobase is the lowest pulse intensity at infinitely long pulse 
duration still able to elicit a cardiac contraction. For practical purposes 
rheobase is usually determined as the threshold stimulus voltage at a 
pulse width of 2.0 ms (Trautwein 1975; Kay 1996). The lowest 
rheobase will be achieved when the distance between electrode and 
excitable tissue is minimal (Geddes and Bourland 1985). The 
chronaxie is tissue dependent (Ayers et al. 1986) and is a measure of 
the excitability (Trautwein 1975): the smaller the chronaxie, the more 
excitable the tissue. It describes where the S-D curve rises with 
decreasing stimulus duration (Irnich 1980; Geddes and Bourland 
1985). When the rheobase and chronaxie are known the whole S-D 
curve can be quickly synthesized using equation [1]. At all points of the 
curve this method proved to be comparable with the fixed PW method. 
The mean values of both methods were different at 0.06 ms but this 
difference was not significant (p=0.189). The reason for this difference 
was that for some horses at 0.06 ms the maximal available pulse 
amplitude of 7.5 V was not sufficient to achieve capture as indicated 
by 'M' in Table 1.1, by which method 1 underestimated the mean 
amplitude. Because method 3 calculated the threshold amplitude at 
0.06 ms, the mean value was higher and more accurate. When 
method 3 was compared with the constant amplitude procedure, mean 
values proved to be significantly different at 1.5, 2 and 2.5 V. This 
could be explained by the fact that in some horses the fixed amplitude 
was very close to the rheobasic voltage, resulting in an extremely long 
PW calculated with method 3. Controversially, for method 2 the mean 
PW at 2.5 V was longer than the mean value at 2 V. The explanation 
was that the rheobase of horse 1 in position 2 was 2.39 and thus just 
below the fixed amplitude of 2.5 V. For method 3 this resulted in a 
calculated PW of 5 ms, which caused a substantial increase of the 
mean value. This also explains the large variation along the abscissa 
in method 3. 
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Limitations of the study 
In this study temporary catheters were used for measurements. 
Such catheters have no fixation mechanism and small movements of 
the electrode tip during measurements can change threshold values. 
This can be prevented using an active fixation electrode to determine 
thresholds. Such an electrode extends a helix into the 
endomyocardium to maintain a better endocardial contact. 
During our study an implantable pacemaker was used as an 
external electrical pulse generator. However, this device was not able 
to deliver electrical stimuli of any desired amplitude or PW and 
variation was stepwise. Accuracy of the S-D curve determination could 
be increased using a device that generates pulses of any intensity and 
with a stepless variation. 
This paper describes a method to measure atrial threshold values 
in horses. These threshold values provide a guide for the required 
intensity of electrical stimuli to achieve successful cardiac pacing in 
horses. However, because the threshold values depend on the kind of 
electrode, the lead, intra-atrial location and also on individual variation, 
threshold measurements must be determined for each procedure to 
ensure adequate capture during cardiac pacing. Determination of 2 
threshold points and subsequent calculation of the S-D curve using 
Lapicque's law proved to be the easiest and fastest way to obtain the 
S-D curve. 
 
Manufacturer's address 
1 Temporary Pervenous Lead, Cordis, Miami, Florida, USA 
2 Thera D, Medtronic, Minneapolis, USA 
3 Programmer 9790, Medtronic, Minneapolis, USA 
4 Xylocaine 2 %, Faculty Vet. Medicine, Merelbeke, Belgium 
5 Analytical Software, Tallahassee FL, USA 
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SUMMARY 
A 5-year-old Warmblood mare with atrial fibrillation was 
treated with quinidine sulphate. Atrial rhythm changed into atrial 
flutter and, since toxic effects occurred, the treatment was 
discontinued. Seven months after the occurrence of atrial flutter, 
treatment with a rapid atrial pacing technique restored normal 
sinus rhythm. One year after the pacing therapy the horse was 
still in sinus rhythm and was brought back into training. At 
present, 5 years after the pacing procedure, sinus rhythm is still 
maintained and no complaints are reported. 
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INTRODUCTION 
Atrial fibrillation is a common type of cardiac arrhythmia in horses. 
Treatment is mostly attempted by oral administration of quinidine 
sulphate and is reported to be successful in more than 80 % of the 
cases. In some horses however, quinidine treatment changes atrial 
fibrillation into atrial flutter without restoration of normal sinus rhythm 
(Deem and Fregin 1982). In human medicine, medical therapy of 
persistent atrial flutter is often disappointing and in those cases a rapid 
atrial pacing technique can be used to obtain a normal sinus rhythm 
(Jordaens and others 1993). 
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CASE HISTORY AND CLINICAL FINDINGS 
A 5-year-old Warmblood mare experienced a severe episode of 
exertional rhabdomyolysis. At the same time a cardiac arrhythmia with 
severe bradycardia (pulse rate of 16/min) and a cardiac murmur were 
detected. Since the mare was too weak for transportation, she was 
kept at rest and was referred to the clinic one month later.  
On presentation the horse was in a good condition. The body 
temperature was normal. Faecal consistency was rather soft. There 
was no pathologic pulsation of the jugular veins. The pulse rate was 
24/min and irregular. A systolic cardiac murmur grade III/VI was 
audible over the tricuspid valve area. Electrocardiography revealed 
atrial fibrillation. On echocardiography, subjective assessment 
indicated a right atrial enlargement. Doppler echocardiography showed 
a mild tricuspid valve insufficiency. No valvular abnormalities were 
seen on B-mode or M-mode. Blood analysis was normal. The LDH 
and LDH1 iso-enzymes were within normal limits. 
Since there were no signs of congestive heart failure, a treatment 
with oral quinidine sulphate was started. After a test dose of 11 mg/kg, 
the horse was given 22 mg/kg quinidine sulphate every 2 hours for 6 
doses. Therapy was continued with 22 mg/kg every 6 hours. On the 
third day of treatment atrial rhythm had changed into atrial flutter. On 
the same day intoxication signs occurred and therapy had to be 
discontinued. During the following days the atrial flutter and the heart 
murmur remained unchanged. Atrial flutter rate was 185/min, which 
corresponds to a flutter cycle length (CL) of 324 ms. Ventricular rate 
was 24/min. Atrioventricular conduction was 4:1 but the conduction 
was irregular. 
The horse returned home and was kept at rest. Seven months after 
the onset of atrial flutter, the horse was represented and a treatment 
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with an intracardiac pacing technique was attempted. At that time a 
systolic cardiac murmur grade III/VI was still present over the tricuspid 
valve area. A distinct jugular pulsation was visible. Electrocardiography 
revealed atrial flutter with a flutter CL of 300 ms and a ventricular rate 
of 24/min with severe second degree AV block. The atrioventricular 
conduction was approximately 4:1. On echocardiography the right 
atrial dilatation was more pronounced. Left atrial diameter was normal. 
On Doppler echocardiography, the tricuspid valve insufficiency was 
more significant. 
Pacing procedure 
The mare was prepared for cardiac catheterisation. No sedation 
was used. The left external jugular vein was used to introduce a 
bipolar pacing catheter (U.S.C.I., Bard, Ireland) into the right ventricle. 
Into the right external jugular vein a quadripolar pacing catheter 
(U.S.C.I., Bard, Ireland) was inserted and advanced into the right 
atrium. Exact positioning of each catheter was obtained both by 
evaluation of the intracardiac electrocardiogram of each electrode and 
by echocardiographic control. Subsequently, testing stimuli were 
applied (Medtronic 5345 DDD Temporary Pulse Generator, Medtronic 
Inc., U.S.A.) to the atrial and ventricular catheter to check 'capture', i.e. 
whether stimulation initiated a P-wave and a QRS-complex 
respectively. A burst of atrial stimuli, 4 - 15 seconds in duration, was 
given and the effect on ECG was evaluated. The initial stimulation CL 
was 350 ms which was slightly greater than the flutter CL of 300 ms. 
Subsequently, as no effect occurred, the CL of pacing bursts was 
gradually shortened by 30 ms. At a stimulation rate of 230 times per 
minute, i.e. a pacing CL of 260 ms, atrial flutter changed into atrial 
fibrillation (Fig. 2.1) and the pacing technique was discontinued. 
During the next five days, electrocardiographic examination was 
performed twice daily. Since there was no spontaneous restoration of 
sinus rhythm, a treatment with quinidine sulphate was attempted. After 
three oral doses of 22 mg quinidine sulphate per kg every two hours, 
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stable atrial flutter waves reoccurred and persisted during the next 
days. 
Before the application of a second overdrive pacing, the horse was 
twice orally treated with quinidine sulphate (22 mg/kg). After this 
treatment plasma quinidine level was 4·2 µg/ml. Due to quinidine the 
flutter CL was now 460 ms. First pacing attempts at a stimulation CL 
of 360 ms were unsuccessful. Immediately after a pacing burst with a 
CL of 330 ms, a change in flutter rate occurred. At that time lead II and 
lead III of the surface ECG resembled very closely atrial fibrillation, 
while the intracardiac ECG showed a clear flutter wave with a CL of 
365 ms (Fig. 2.2). 
Figure 2.1. During atrial fibrillation intra-atrial waves are completely 
chaotic and the surface ECG presents typical f-waves (f).  
(trace 1: atrial electrogram; trace 2: lead II of the surface ECG) 
Figure 2.2. Clear atrial flutter waves on intra-atrial ECG (arrows) 
corresponding to P-waves on the surface ECG (P). After a burst of 
stimuli (small arrows) with capture (P') a change in the atrial rhythm 
occurs: the surface ECG resembles atrial fibrillation with f-waves (f), 
while the intracardiac ECG shows atrial flutter with regular flutter waves 
(arrow-heads). (trace 1: atrial electrogram; trace 2: lead II of the surface 
ECG) 
Intracardiac overdrive pacing as a treatment of atrial flutter in a horse 
72 
After an overdrive pacing with a CL of 300 ms, flutter waves 
continued for a short period and changed suddenly into a normal sinus 
rhythm (Fig. 2.3). On the ECG a second degree atrioventricular (AV) 
block was present. The whole pacing procedure was well tolerated by 
the unsedated horse and one week later it was discharged and kept at 
rest. An electrocardiographic and echocardiographic control was 
performed every three months. 
One year later the mare was re-evaluated. For the previous three 
months she had been trained everyday for one hour without any 
complaints. Electrocardiographic examination revealed a sinus rhythm 
with a second degree AV block. The jugular pulsation had disappeared 
completely. The systolic murmur over the tricuspid valve area had 
evolved to grade I/VI. The right atrium was still dilated but its diameter 
was reduced. On Doppler echocardiography the tricuspid valve 
insufficiency was less pronounced. At present, 5 years after the pacing 
procedure, sinus rhythm is still maintained and the owner reports no 
complaints.
Figure 2.3. After overdrive pacing flutter waves continued for a short 
period (arrows) and changed suddenly into a normal sinus rhythm 
(arrow-heads). (trace 1: atrial electrogram; trace 2: lead II of the surface 
ECG) 
CHAPTER 2: Discussion 
  73 
DISCUSSION 
Horses suffering from atrial fibrillation but without other significant 
cardiac disease usually respond well to quinidine sulphate treatment. 
A success rate of more than 80 % is reported (Deem and Fregin 1982, 
Reef and others 1988). In these horses, conversion to sinus rhythm 
sometimes occurs after a short period of atrial flutter (Betsch 1991). 
However, in some horses (Matsuda 1992), as in the present case, 
conversion to sinus rhythm does not occur and atrial flutter persists. 
Atrial flutter is a cardiac arrhythmia that tends to be relatively resistant 
to medical therapy (Peters and others 1994). Furthermore, because of 
the vagolytic action and the ability to slow the flutter rate, quinidine 
therapy can facilitate AV conduction sufficiently to result in a 1:1 
ventricular response to the atrial flutter causing ventricular tachycardia 
or ventricular fibrillation (Fregin 1982, Zipes 1992). This could be an 
explanation for those horses dying during quinidine therapy as has 
been reported in literature (Deem and Fregin 1982, Betsch 1991). 
Being a reentrant arrhythmia, atrial flutter can be successfully 
entrained and interrupted by overdrive pacing (Kantharia and 
Mookherjee 1995, Osborn 1996). In human medicine, rapid atrial 
pacing is generally considered to be a simple and safe method (Amsel 
and Walter 1992). Through a venous access a bipolar electrode has to 
be positioned into the right atrium. In humans accurate positioning is 
usually performed during fluoroscopy. Since this is barely possible in 
mature horses, successful positioning was obtained by monitoring the 
intracardiac ECG to search for the largest endocavitary P-wave 
deflection and by simultaneous B-mode echocardiography. Since rapid 
stimulation of the ventricle through an incorrect positioned atrial 
catheter could cause ventricular fibrillation, exact catheter localisation 
is essential.  
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Optimal pacing rate in humans is reported to be 35 - 50 % higher 
than the mean atrial flutter rate, i.e. at a stimulation CL of 66 - 75 % of 
the flutter CL (Hii and others 1992, Kantharia and Mookherjee 1995). 
In this horse restoration of sinus rhythm was obtained at a stimulation 
CL of 65 % of the mean flutter CL. 
In humans, rapid atrial stimulation can change atrial flutter into 
atrial fibrillation especially at higher stimulation rates (Hii and others 
1992, Zipes 1992, Osborn 1996). If atrial fibrillation occurs, overdrive 
pacing must be discontinued since it is useless in cases of atrial 
fibrillation. Atrial fibrillation however, is generally better tolerated than 
atrial flutter (Tucker and Wilson 1993). In humans, 10 - 80 % of the 
pacing-induced cases of atrial fibrillation convert spontaneously to 
sinus rhythm. Patients remaining in atrial fibrillation, as this horse, are 
believed to have a more diseased or abnormal myocardium or cardiac 
conduction system (Kantharia and Mookherjee 1995).  
During a period the surface ECG resembled atrial fibrillation, while 
the intracardiac ECG revealed atrial flutter. This finding might indicate 
that some of the horses, which are thought to suffer from atrial 
fibrillation, have in fact atrial flutter. 
It is well known that a long period of atrial flutter or atrial fibrillation 
in combination with atrial dilatation worsens the prognosis for 
treatment (Reef and others 1988, Collatos C. 1995, Kantharia and 
Mookherjee 1995, Stadler and others 1994). Exact measurement of 
the right atrial diameter is difficult because of a lack of good 
echocardiographic landmarks. In the present case however, subjective 
assessment of the right atrial diameter was made by means of 
videotape analysis of ultrasound images taken by the same 
investigator. Although these assessments might not represent the 
exact diameter, they were thought to be an acceptable criterion to 
evaluate the evolution of the right atrial dimension. 
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Since antiarrhythmic drugs are believed to improve the results of 
pacing, quinidine was given prior to the second and successful 
application of atrial overdrive pacing. 
Because temporary asystole can occur immediately after a burst of 
atrial stimuli, a back-up pacing catheter was inserted into the right 
ventricle of the horse for safety reasons. If asystole would have 
appeared, this catheter could deliver stimuli to the ventricle in order to 
restore a normal ventricular rate. 
This is the first report of successful intracardiac overdrive pacing 
therapy in the horse. It illustrates that a medically resistant and 
chronically persistent atrial flutter, even in the presence of a marked 
atrial dilatation, may be converted to sinus rhythm by means of 
intracardiac overdrive pacing. The pacing technique is well tolerated 
and could be used to investigate the electrophysiological properties of 
the heart.
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SUMMARY 
The purpose of the present study was to develop a feasible 
and safe technique for dual chamber pacemaker implantation in 
healthy horses. Implantation was performed in a standing, 
tranquillized horse and ponies. Atrial and ventricular leads were 
transvenously inserted through the cephalic vein and a 
subcutaneous pacemaker pocket was created between the lateral 
pectoral groove and the manubrium sterni in 6 equids. 
Positioning of each lead was guided by echocardiography and by 
measuring the electrical characteristics of the lead. The 
implantation procedure lasted about 4 hours in each animal and 
was well tolerated. In all animals dual chamber pacemaker 
function was obtained and these results remained good 
throughout the follow-up period. At the time of implantation atrial 
and ventricular sensing were between 2.1 and 7.2 mV and 7.8 and 
16.8 mV, respectively, and atrial and ventricular pacing 
thresholds at 0.5 ms varied from 0.5 to 0.7 V and 0.3 to 1.0 V, 
respectively. Six months after the implantation sensing values 
varied from 2 to 10 mV for the atrial lead and from 2 to 16 mV for 
the ventricular lead, while pacing thresholds at 0.5 ms varied 
from less than 0.5 to 2.5 V for the right atrium and from less than 
0.5 to 5.0 V for the right ventricle. Atrial lead dislodgement 
occurred in 2 animals, requiring insertion of a new lead. 
Ventricular lead dislodgement was not observed.
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INTRODUCTION 
A cardiac pacemaker is an implantable device that delivers battery-
supplied electrical stimuli through electrodes in contact with the 
myocardium in order to produce an artificially triggered depolarisation 
of the atria and/or ventricles.1,2 The electrodes can be attached to the 
epicardial surface, which necessitates a thoracotomy, or can be 
attached to the endocardium, by means of transvenous lead insertion.3 
The pacing system contains 1 or 2 leads to perform single chamber or 
dual chamber pacing. Compared with a single chamber pacemaker, 
dual chamber systems ensure a more physiological cardiac function.2,4 
This system not only allows a physiological rate-responsiveness, but 
also re-establishes atrioventricular (AV) synchrony which preserves 
the contribution of the atrial contraction to the ventricular filling, 
preventing systemic and pulmonary venous congestion, decreasing 
mitral valve regurgitation and thus increasing cardiac output.5 
Transvenous lead placement makes cardiac pacing relatively 
simple and safe and is widely used in human medicine. In small 
animal medicine, permanent pacing has gained considerable 
importance in the management of bradycardias caused by third 
degree atrioventricular (AV) block, high grade second degree AV block 
(Mobitz type II), sick sinus syndrome or persistent atrial standstill.2,4,6-10 
Besides the therapeutic use in cases of rhythm disturbances, 
pacemakers can also be used for diagnostic or investigational 
purposes. With a pacemaker, electrophysiological measurements can 
be made and arrhythmias can be artificially induced. Many animal-
based studies, using sheep 11,12, goats 13-16, pigs 17,18 and especially 
dogs 19-23, have been described but the authors found no published 
data on equids. 
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To our knowledge, dual chamber pacemaker implantation in horses 
has only been described twice for the treatment of a third degree AV 
block and the applied techniques were quite diverse. In 1986, Reef et 
al. implanted a dual chamber pacemaker in the ventral neck region of 
a horse using transvenous electrodes through the jugular vein.25 This 
horse survived for 3 years.26 In 1993, Pibarot et al. described the 
implantation of an atrioventricular pacemaker in a donkey using 
epicardial electrodes.27 They created a subcutaneous pacemaker 
pocket on the lateral chest wall. 
The purpose of the present study was to develop a reproducible 
technique for dual chamber pacemaker implantation in healthy equids 
and to investigate the feasibility and safety of the procedure.
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MATERIALS AND METHODS 
Animals 
This study was approved by the Ethics committee of the Faculty of 
Veterinary Medicine, Ghent University. 
Five ponies and a Thoroughbred horse were selected. Body weight 
and height at the withers ranged between 250 and 440 kg, and 1.25 m 
and 1.55 m, respectively (Table 3.1). All animals were healthy as 
indicated by the clinical and biochemical exam. There were no 
abnormalities on electrocardiographic (ECG) and echocardiographic 
examination. 
Table 3.1. The height at the withers and the characteristics of the 
leads (Medtronic, Minneapolis, MN) are displayed for each animal. The 
last column indicates how long the pacemaker had been implanted at 
the time of submission of the paper. 
horse 
height 
(m) lead 
lead 
length 
(cm) 
polarity fixation 
steroid- 
eluting 
model 
number 
implantation 
time 
(months) 
atrial 58 bipolar screw-in yes 4068 
1 1.25 
ventr. 58 bipolar screw-in yes 4068 
12 
atrial 52 bipolar screw-in no 4058M 
2 1.32 
ventr. 58 unipolar tined no 6971 
44 
atrial 52 bipolar screw-in no 4058M 
3 1.25 
ventr. 52 unipolar tined no 6971 
46 
atrial 85 bipolar screw-in yes 4068 
4 1.37 
ventr. 85 bipolar screw-in yes 4068 
29 
atrial 52 bipolar screw-in no 4058M 
5 1.30 
ventr. 52 unipolar screw-in no 4057M 
27 
atrial 58 bipolar screw-in no 4058M 
6 1.55 
ventr. 110 bipolar screw-in yes 4068 
19 
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Equipment 
Dual chamber (DDD) pacemakersa were used for implantation. 
Table 3.1 displays the different lead types that were used. Unipolar as 
well as bipolar transvenous leads were implanted. For the right 
ventricle, leads with an active (screw-in) or passive (tines) fixation 
were used, whereas for right atrial pacing only active fixation leads 
were applied. Five out of 10 active fixation leads were of the steroid-
eluting type (Table 3.1). The length of the implanted leads varied 
between 52 cm and 110 cm. In the lead body, a stylet could be 
inserted to supply stiffness and to provide shapeability. During 
implantation a base apex ECG was continuously recordedb. Cardiac 
ultrasonographyc was performed from the right cardiac window. In 
order to measure electrical characteristics, including capture threshold 
at 0.5 ms, lead impedance and sensing voltage of P waves and R-
waves, the lead was connected to a pacing system analyserd using 
sterile connector cables. The cathode was connected with the distal 
(tip) electrode. The anode was connected to the proximal (ring) 
electrode for a bipolar lead or with the subcutaneous tissue for a 
unipolar configuration. After implantation lateral radiographs of the 
chest were obtained to verify the lead position. After 1, 2 and 3 days, 
after 1 and 2 weeks, after 1, 2 and 6 months and every 12 months, an 
electrocardiographic and echocardiographic examination were 
performed. Lead position was verified by echocardiography and 
special attention was paid for the presence of any irregularity near the 
lead tip, on the lead body or on cardiac valves that might indicate 
inflammatory reaction of a fibrinous layer. Color flow Doppler of the 
tricuspid valve was performed to detect valvular regurgitation. At the 
same time pacemaker function was analysed using a telemetric 
pacemaker programmere connected to a surface ECG. Atrial and 
ventricular sensing threshold was measured during sinus rhythm. 
Subsequently, atrial and ventricular pacing and sensing were analysed 
during atrial, ventricular and dual chamber pacing at a pacing rate of 
60 beats per minute. For these measurements the sensed and paced 
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atrioventricular interval were programmed to 350 ms, the atrial and 
ventricular blanking were 100 ms and 28 ms, respectively, the post-
ventricular atrial refractory period was 150 ms and the ventricular 
refractory period was 300 ms. During the whole follow-up period 
horses were kept in stalls and every two weeks they were given free 
access to an arena. The pacemaker was intermittently active to 
perform cardiac studies, including echocardiographic examinations 
and blood pressure measurements. Except from horse 1, which 
developed chronic laminitis, each horse completed treadmill exercise, 
including performing at walk, trot, canter and gallop, with heart rates 
up to 175 beats per minute. Horse 2, 3, 4, 5 and 6 completed 12, 4, 
16, 12 and 6 treadmill sessions, respectively. Treadmill exercise and 
free access to an arena started 2 months after implantation. 
Implantation procedure 
The animals were given 15 µg/kg detomidinef IV and 3 µg/kg 
buprenorphineg IV and remained in standing position during the 
implantation. The horses were placed in stocks to allow the surgeons 
to sit in a safer position in front of the horse. If the horse showed any 
discomfort during the implantation, 7 µg/kg detomidine was 
administered IV. The ventral neck and pectoral region was clipped. 
The region at the level of the lateral pectoral groove was surgically 
prepared and was blocked with 2 per cent lidocaineh. An incision of 
about 8 cm was made along the lateral pectoral groove and the 
cephalic vein was exposed by blunt dissection. A suturei was placed 
around both ends of the exposed vein but only the distal part of the 
vessel was ligated, preventing blood from the leg entering the surgical 
site. Between the 2 sutures, a partial venotomy was made (Fig. 3.1). 
The vein lumen was opened with a vein lifter and the atrial lead, with a 
straight stylet inserted, was introduced in cardiac direction. The lead 
was advanced until it became ultrasonographically visible in the right 
atrium. Subsequently, the ventricular lead, with a straight stylet 
inserted, was also advanced in the cephalic vein. The lead became 
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visible in the right atrium and, under echocardiographic guidance, the 
lead tip was maneuvered into the right ventricular apex. If the lead was 
fitted with an active fixation mechanism the helix was extended into 
the myocardium by rotation of a connector pin at the external part of 
the lead. The lead was connected to the PSA for measurement of 
electrical variables. Electrical variables for the right ventricular lead 
were acceptable when the capture threshold did not exceed 1 Volt (V) 
at 0.5 ms pulse width, the lead impedance was between 400 and 1000 
Ohms and the sensed R wave was at least 4.0 mV.3,5,28 For the active 
fixation leads 5 minutes were allowed to meet the above-mentioned 
implantation criteria. If electrical parameters did not match these 
criteria, the lead was repositioned until an acceptable location was 
reached. The stylet was removed and the lead was further inserted 
into the vein for about 4 cm to provide sufficient slack. The ventricular 
lead was secured to the underlying tissuej using an anchoring sleeve 
to protect the lead insulation. 
For atrial lead positioning, the stylet was first removed to be curved 
manually while the lead was left in the right atrium. Re-insertion of this 
Figure 3.1. The circle, pointed out by 
the large arrow, indicates the place for 
the venotomy and the location of the 
pacemaker pocket. The course of the 
cephalic vein (t) and the jugular vein 
(v) are shown. 
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curved stylet provided a J shape to the lead and supplied body. After 
connection of the PSA and under echocardiographic control, the lead 
was slowly manipulated to obtain contact with the endocardium. Once 
in the right position the helix of the active fixation mechanism was 
extended into the endocardium and electrical parameters were 
checked. A good atrial position was achieved when the capture 
threshold at 0.5 ms did not exceed 1.5 V, lead resistance was between 
400 and 1000 Ohms and P wave sensing was at least 1.5 mV.3,5,28 
After withdrawal of the stylet, pacing was performed at 5 V and 0.5 ms 
to check if no diaphragmatic stimulation occurred. If the electrical 
characteristics did not match the implantation criteria or if 
diaphragmatic stimulation occurred, the lead was repositioned. If the 
lead was properly positioned, it was advanced slightly into the vein and 
the proximal part was secured to the underlying tissue using the 
anchoring sleevej. Gentle traction was applied to the ventricular and 
the atrial lead to verify if lead migration occurred and electrical 
variables were again examined. Subsequently the proximal part of the 
cephalic vein was ligatedi. Between the lateral pectoral groove and the 
manubrium sterni, a subcutaneous pacemaker pocket was created by 
blunt dissection (Fig. 3.1). The pacemaker was connected to both 
leads and inserted in the pocket taking care that no acute angulations 
of the electrodes occurred. Redundant leads were looped along the 
sides of the device or underneath it. The pocket was irrigated with 
antibioticsk, and the subcutaneous tissue and skin were closed in a 
routine manner. Flunixin megluminel (0.3 mg/kg IV q8h) and sodium 
ceftiofurm (2 mg/kg IV q24h) were given during 5 days. Oral 
trimethoprim sulphadiazin treatmentn (1 mg/kg trimetoprim and 5 
mg/kg sulphadiazin PO q12h) was continued for 10 days. During this 
recovery period, recumbency of the horse was prevented by attaching 
the horse to the stable wall.
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RESULTS 
The whole implantation procedure took about 4 hours and was well 
tolerated. The cephalic vein could be easily exposed and its diameter 
was sufficiently large to bare both the atrial and the ventricular lead. 
Positioning of the atrial or ventricular lead often initiated ectopy. 
However, these arrhythmias were always short lasting and self-
terminating. The pacemaker leads could clearly be visualized on 
echocardiography and on chest radiographs. On the ultrasonographic 
image, the lead body appeared as a smooth, linear, hyperechoic 
structure, while the lead tip was characterized by more irregular 
hyperechoic reflections (Fig. 3.2). However, even if the lead tip was 
clearly identifiable on echocardiography, the presence of endocardial 
Figure 3.2. Right parasternal long-axis echocardiogram optimized to 
view the right ventricle (RV). The lead body (s) is visible as a smooth 
hyperechoic structure underneath the tricuspid valve. The lead tip (Ü) is 
localized in the right ventricular apex and shows more irregular 
reflections (RVFW = right ventricular free wall; RA = right atrium; RV = 
right ventricle; IVS = interventricular septum; displayed depth = 12 cm). 
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contact could not always be ascertained and had to be confirmed by 
determination of electrical variables. During ventricular lead positioning 
echocardiographic control was useful to follow the lead entering into 
the right ventricular apex and to avoid it migrating towards the 
pulmonary artery. With a straight stylet inserted, the lead easily 
entered the right ventricular apex (Fig. 3.2) and an acceptable position 
was readily accomplished. Atrial lead positioning was more difficult. 
The atrial lead had to curve in the right atrium towards the atrial wall in 
order to allow the helix to be extended into the myocardium. On 
echocardiography the most dorsal parts of the right atrium could not 
completely be imaged and the visualization of both the atrial and the 
ventricular lead in the right atrium complicated ultrasonographic 
guidance. Therefore, echocardiography served mainly to prevent atrial 
lead fixation too close to the tricuspid valve and lead positioning was 
performed relying mainly on the measurements of electrical variables. 
Although satisfactory electrical characteristics were often readily 
achieved after extension of the helix, withdrawal of the stylet 
sometimes resulted in an immediate loss of capture or sensing, 
indicating that active fixation of the lead had not been accomplished. 
Several attempts were sometimes necessary to achieve active fixation 
of the atrial lead. Furthermore diaphragmatic stimulation occasionally 
occurred at 5 V and 0.5 ms, which also necessitated lead 
repositioning. However, lead implantation criteria could always be met 
(Table 3.2). 
On post-operative radiographs the ventricular lead tip was visible in 
the right ventricular apex in all animals. The atrial lead tip was 
identifiable in the right atrium and was located in the cranial region of 
the right atrium in pony 3 and in the horse, in the mid portion in pony 2 
and in the caudal part in pony 1, 4 and 5. 
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Table 3.2. The electrical characteristics of the atrial and ventricular lead at 
the time of implantation and 6 months after the implantation, including the 
stimulation threshold at 0.5 ms pulse duration, shown in volts (V) and milli-
ampere (mA), the lead impedance (Ohm, W) and the sensing amplitude (mV), 
are shown for each horse. (* indicates the values of the re-implanted lead) 
 
  atrial lead ventricular lead 
horse time threshold 
(0.5 ms) 
impedanc
e 
sensin
g 
threshold 
(0.5 ms) 
impedanc
e 
sensin
g 
  V m
A 
Ù mV V m
A 
Ù mV 
implantatio
n 
0.6 1.5 410 2.1 0.5 1.1 440 11.2 
1 
6 months < 0.5 < 0.8 587 2.8 < 0.5 < 0.8 610 8 
implantatio
n 
0.5 1.0 490 3.5 0.6 1.5 415 8.9 
2 
6 months 1 1.3 741 2.8 5.0 6.7 752 2 
implantatio
n 
0.7 1.7 420 3.9 0.6 0.7 860 16.8 
3 
6 months 2 3.4 592 2 1.5 1.3 1116 15.7 
implantatio
n 
0.7 1.6 440 2.6 1.0 1.6 620 7.8 
4 
6 months 0.5 0.7 741 4.2 0.5 0.6 791 16 
implantatio
n 
0.5 0.8 405 7.2 0.3 0.6 520 16.1 
5* 
6 months 0.5 1.3 396 5.6 1.6 1.9 855 8.2 
implantatio
n 
0.6 0.9 450 6 0.9 1.5 610 13.6 
6* 
6 months 2.5 3.9 634 10 < 0.5 < 0.6 784 8 
 
In all animals the dual chamber pacemaker was successfully 
implanted and atrial and ventricular sensing and pacing were all 
achieved, allowing an effective atrial, ventricular and dual chamber 
pacing function (Fig. 3.3). In the Thoroughbred horse (animal 6), at a 
heart rate of 30 to 35 beats per minute, the normal intrinsic AV interval 
was about 400 ms, which is within normal limits. Due to a maximal 
programmable AV interval of the pacemaker of 350 ms, however, in 
the dual chamber pacing mode ventricular pacing occurred at slow 
heart rates although AV conduction in that horse was normal. 
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All animals had a normal wound healing with formation of a small 
seroma during the first days post-implantation. Ligation of the cephalic 
vein caused no circulatory problems and the position of the pacemaker 
did not impede equids in lying down or performing treadmill exercise. 
In none of the horses was treadmill exercise associated with lead 
dislodgement. Atrial lead dislodgement occurred 2 days after 
implantation in pony 5 causing a loss of atrial capture and atrial 
sensing. On echocardiography the lead tip was identified in the right 
ventricle near the tricuspid valve and radiographs were taken to 
confirm the lead displacement. The pacemaker pocket was reopened 
and after retraction of the helix, the lead was removed and replaced by 
a new one. In the horse the atrial lead dislodgement occurred 1 month 
Figure 3.3. Print from the pacemaker programmer showing a surface 
ECG (1), calibrated at 0.1 mV/mm, a simultaneous intra-atrial and 
intraventricular ECG (2), calibrated at 1 mV/mm, and a marker channel 
(3) indicating atrial pacing (AP) and ventricular pacing (VP). The 
pacemaker is programmed at dual chamber pacing and sensing (DDD-
mode) at 60 beats per minute with an atrioventricular interval of 350 ms. 
Each atrial and ventricular stimulus is followed by a P wave and QRS 
complex on the surface ECG, respectively, indicating successful dual 
chamber pacing 
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after implantation. At that time treadmill exercise had not been 
performed. Atrial capture could no longer be obtained, even at 1.5 ms 
and 7.5 V. Atrial sensing dropped from 8 mV on the previous day, to 
1.4 mV on the day of dislodgement. On cardiac ultrasound the 
dislodged lead tip was identifiable in the right atrium near the tricuspid 
valve. The lead, which was of the steroid-eluting type, was withdrawn 
and a new non-steroid-eluting lead was inserted in the contra-lateral 
cephalic vein. After positioning and fixation of this new lead, the 
proximal part was tunnelled subcutaneously and connected to the 
pacemaker, restoring normal pacemaker function. Ventricular lead 
dislodgement was never observed. 
Long-term follow-up revealed no abnormalities on 
echocardiographic examinations. The appearance and position of 
each lead remained identical. The lead body surface remained smooth 
and no irregularities were detected near the lead tip. The tricuspid 
valve showed no valvular lesions or valvular regurgitation. In all 
animals atrial and ventricular sensing remained possible and both 
chambers could be successfully stimulated with acceptable threshold 
values, indicating a good pacemaker function (Table 3.2). Arrhythmias, 
other than occasional second-degree atrioventricular block, were not 
seen. In the horse, diaphragmatic stimulation occasionally occurred 
during atrial pacing. Pony 1 had to be euthanized 1 year after 
implantation because of a chronic laminitis. Necropsy revealed that 
both the atrial and the ventricular lead tip were closely attached to the 
myocardium and were surrounded by a small amount of fibrous tissue. 
There were no lesions on the tricuspid valve. A small fibrous layer was 
present on the proximal intravascular part of the lead. A firm fibrous 
capsule surrounded the pacemaker box. 
Dual chamber pacemaker implantation via the cephalic vein in healthy equids  
92 
DISCUSSION 
The described standardized technique for dual chamber 
pacemaker implantation in horses proved to be efficient and safe. The 
whole procedure could be performed in the standing horse and was 
well tolerated. Successful sensing and pacing of the atrium as well as 
the ventricle were obtained on long-term follow-up. 
Transvenous implantation of a permanent pacemaker is the 
preferred method in both human and small animal medicine.2,10 In 
contrast to epicardial lead placement it is much less invasive, cheaper 
and more rapidly accomplished. A transvenous approach avoids major 
surgery and can be performed without general anesthesia,4,6 which is 
an advantage in animals with compromised cardiovascular system in 
which general anesthesia is associated with considerable risk of 
adverse events29,30 The occurrence of a lethal ventricular fibrillation 
during general anesthesia has been described in a horse during an 
attempt to implant a pacemaker.31 In equids requiring pacemaker 
implantation because of a symptomatic bradycardia, administration of 
detomidine could worsen cardiac function because of its negative 
chronotropic effect. In these animals, a temporary pacing catheter 
should therefore be inserted into the right ventricular apex prior to 
sedation, to allow pacing during the implantation procedure. 
The only way to perform transvenous pacemaker implantation in 
equids is to use a superficial vein that is located close to the heart and 
that is large enough to accommodate 2 leads. The vein will be ligated. 
Furthermore the pacemaker pocket has to be located close to the vein 
and close to the heart to avoid the use of extremely long leads and be 
implanted at a safe location in order to allow recumbency and 
exercise. For these reasons, the cephalic vein at the level of the lateral 
pectoral groove was chosen for lead insertion. The left as well as the 
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right cephalic vein were used without a noticeable difference in the 
procedure. Although the jugular vein, which was used by Reef et al.25, 
is also close to the heart, the authors preferred the smaller cephalic 
vein to be ligated permanently. Consequently, both jugular veins were 
preserved and venous access was facilitated during subsequent 
experimental studies. Furthermore, in large breed dogs with lead 
insertion in the jugular vein excessive neck motion is suspected to be 
a contributing factor in the higher incidence of lead dislodgement in 
these animals. 7,10 The placement of the lead and pacemaker pocket 
near the manubrium sterni was thought to be more stable than 
localization in the neck. The lateral thoracic vein is large enough to 
bare 2 leads, but its subcutaneous part is too remote from the heart. 
Moreover, creating a pacemaker pocket near this vein could impede 
the use of a girth or recumbency of the horse. 
Although complications of the pacemaker pocket were not 
encountered, the subcutaneous position of the pocket implies a 
possible risk for injury by biting, rubbing or trauma. 
The requisite length of the ventricular lead was about 50 cm for the 
ponies and about 55 cm for the Thoroughbred horse. Because of the 
availability of a 110 cm lead, this lead was implanted in the right 
ventricle of the Thoroughbred horse and redundant lead was looped 
along the sides of the pacemaker. The atrial lead had to be at least 45 
cm for the ponies and 50 cm for the Thoroughbred horse. Passive as 
well as active fixation leads were used. Passive fixation leads possess 
tines or fins to enhance entanglement within the trabeculae of the 
myocardium and were applicable for implantation in the right ventricle. 
Active fixation leads penetrate the myocardium by grasping screws 
and they were used for implantation in the right ventricle and the right 
atrium. Passive fixation leads were never used in the right atrium 
because we feared that lead dislodgement would occur more easily. 
To avoid lead tip distortion, a straight stylet was fully inserted into 
the lead during introduction and while advancing the lead, to supply a 
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degree of stiffness and shapeability to the lead. Echocardiography 
facilitated atrial and ventricular lead positioning, but measurements of 
electrical parameters were crucial for final adjustments during lead 
placement because they allow selection of the optimal electrode 
stimulation and sensing site.2 For the electrical measurements the 
distal (tip) electrode of the lead was always connected with the 
cathode, because cathodal stimulation is less likely to induce 
arrhythmias.32 The same acceptance values for the electrical 
parameters of the atrial and ventricular lead were taken as in human 
medicine. Because the short- and long-term success of the pacing 
system is related to the initial lead position, effort was expended to 
obtain the best possible initial location in terms of both stability and 
electrical performance.3 For the active fixation leads, 5 minutes were 
sometimes allowed for the lead to meet the implantation criteria, 
because it is common for capture thresholds to decrease significantly 
shortly after active fixation.3,33 
The ventricular lead was positioned first because it may supply 
back-up pacing in animals with severe bradycardia and because it is 
usually considered the most important of the leads.3 Ventricular lead 
placement was performed with a straight stylet inserted in the lead 
body to guide the lead tip straight toward the right ventricular apex. 
Except from an occasional insertion of the tip between the right 
ventricular wall and a papillary muscle or a migration towards the 
pulmonary artery, the lead tip readily moved into the right ventricular 
apex to remain in a stable position. The active as well as the passive 
fixation leads remained well in place and lead dislodgement was never 
encountered. 
Atrial lead positioning was much more difficult. First because the 
atrial lead had to bend with its tip toward the atrial endocardium by 
using a curved stylet and second because a firm endocardial contact 
had to be obtained with the active fixation mechanism. Even when 
acceptable electrical parameters were obtained after extension of the 
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helix, atrial capture was sometimes lost when the stylet was 
withdrawn. Possibly the helix only partially entered the myocardium, or 
the lead tip was located parallel to the endocardium instead of 
perpendicular, preventing the helix to enter the myocardium 
sufficiently. Furthermore, the presence of large atrial trabeculae might 
have interfered with the lead fixation. In contrast with the ventricular 
lead, the exact anatomical position of the atrial lead in the right atrium 
could not always be determined. However, any atrial position that 
allows adequate pacing and sensing thresholds can be used as long 
as no extracardiac stimulation occurs with pacing.5 
Occasionally, diaphragmatic stimulation was observed during atrial 
pacing at 5 V and 0.5 ms. Stimulation of the lateral, dorsal part of the 
right atrium, at the level of the right diaphragmatic nerve, was likely to 
be the cause.34 When diaphragmatic stimulation occurred the lead 
was always repositioned. 
Fluoroscopy is used during pacemaker implantation in humans and 
small animals, and could have been helpful during the implantation in 
horses. Especially during atrial lead placement, fluoroscopy might 
have been useful to identify the typical to-and-fro motion of the lead tip 
with atrial activity. However, ultrasonography proved to be sufficient 
and is also used in human medicine when fluoroscopy is contra-
indicated, as in pregnant women.3,35-37 Post-operative 
echocardiographic examinations are useful, not only to check lead 
position but also to look for strands or vegetative lesions, because the 
latter can often be found in cases of lead infection. 38-40 
Once satisfactory lead position was obtained, the lead was 
advanced slightly into the vein to impart a small bend and thereby 
allow for movements of the neck and foreleg that might otherwise 
exert traction on the lead.1,2,19 However, care was taken not to enter 
the lead too far in the vein. Too large a loop may predispose to ectopy, 
lead displacement or myocardial perforation at the tip.2,3 When 
securing the outer part of the lead to the underlying tissue and when 
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closing the pocket, special care was taken not to damage the lead 
insulation. 
After lead implantation, the tissue around the lead tip becomes 
inflamed due to the presence of foreign material in the body and due 
to the pressure of the lead-electrode system in contact with the 
myocardium.2,41 With time the inflammatory reaction subsides leaving 
a thin capsule of fibrous tissue between the electrode and the active 
myocardium supplying an extra fixation of the lead tip to the 
myocardium.41 However, the inflammatory reaction can be excessive, 
causing the capture threshold to rise, sometimes above the output of 
the pacemaker, causing exit block. In this context the use of a steroid-
eluting electrode may offer benefits in terms of subacute and chronic 
thresholds.3 Such an electrode elutes small amounts of 
dexamethasone from its tip which attenuates the local inflammatory 
reaction and which reduces the thickness of the fibrous capsule that 
surrounds the electrode, lowering the chronic threshold for 
stimulation.3,33 This study suggests that lower chronic threshold values 
are observed with the steroid-eluting leads (Table 3.2). 
The main complication of the transvenous implantation technique is 
a lead displacement during the early postoperative period 4,6,7,10 as it 
was seen in pony 5. Therefore exercise should be restricted during the 
first weeks after implantation because at that time a fibrous connection 
of the lead tip is not yet achieved.4,6 In the horse lead dislodgement 
occurred 1 month after implantation. Such a late dislodgement was 
probably related to the animal's movement and was caused by 
inadequate fixation of the anchoring sleeve to the lead or to the 
surrounding tissue, insufficient slack, or a poor fixation of the lead tip 
to the endocardium.41 The latter could have been influenced by the 
use of the steroid-eluting electrode in this horse because the elution of 
dexamethasone could have reduced the thickness of the fibrous 
capsule surrounding the lead tip.  
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The maximal programmable AV interval for the pacemaker was 
limited to 350 ms. In a dual chamber pacing mode, this means that, if 
the pacemaker hasn't sensed a ventricular depolarization within 350 
ms following an atrial event, a ventricular stimulus will be delivered. At 
slow heart rates, horses with a normal AV conduction can present a 
PR interval of more than 350 ms. This implies that, even in the 
presence of a normal AV conduction, dual chamber pacing can give 
rise to unnecessary ventricular pacing due to the restricted 
programmable AV interval. When the heart rate increases slightly, 
however, PR interval reduces to below 350 ms and inappropriate 
ventricular pacing ceases. 
We can conclude that the implantation of a dual chamber 
pacemaker using endocardial leads via the cephalic vein is feasible 
and safe in healthy equids and can be performed on the standing 
animal. The advantage of the described method is that the cephalic 
venous access and the subcutaneous implantation of the pacemaker 
near the manubrium sterni require only minor surgery and can be 
performed under local anesthesia, avoiding a general anesthesia. The 
cephalic venous approach preserves both jugular veins, facilitating 
experimental studies after pacemaker implantation. The subcutaneous 
position of the pacemaker permits post-operative reprogramming. No 
major complications were encountered in this study and the implanted 
pacemakers did not impede the ability of the horse and ponies to lie 
down, nor to perform treadmill exercise. Limitations of the technique 
included the lack of fluoroscopy and the limited echocardiographic 
visualization of the high right atrium, which hampered atrial lead 
positioning. Implantations were performed in healthy animals and 
further studies are required to investigate the applicability of the 
technique in clinical patients who would need temporary pacing prior to 
sedation. The use of transvenous endocardial leads can imply an 
increased risk for lead dislodgement. Therefore regular examination of 
pacemaker function should be performed in a horse with symptomatic 
bradycardia, especially if the animal is intended to perform exercise. 
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Although no problems were encountered with pacemaker pockets in 
this study, the subcutaneously positioned pocket could be injured by 
external trauma. Besides the implantation of a pacemaker in animals 
with extreme bradycardia, this relatively simple technique also 
provides an excellent tool to collect information about cardiac 
arrhythmias and electrophysiological characteristics of the equine 
heart. In combination with various drugs, the influence of these drugs 
on electrophysiological properties of the heart could be studied. 
Furthermore, arrhythmias can be artificially induced which makes 
research about their effect on heart function and about the application 
of a feasible therapy possible. 
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b Cardiolife TEC-7511K, Nihon Kohden, Tokyo, Japan 
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d PSA Model 5309, Medtronic, Minneapolis, MN 
e Programmer 9790®, Medtronic, Minneapolis, MN 
f Domosedan®, Pfizer Animal Health, Nossegem, Belgium 
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h Xylocaine 2%®, Astra Pharmaceuticals, Brussels, Belgium 
i Vicryl 4/1, Johnson & Johnson, Dilbeek, Belgium 
j Mersutures 4/1, Johnson & Johnson, Dilbeek, Belgium 
k Kanacillin Trifortis Vet®, Continental Pharma, Brussels, Belgium 
l Finadyne®, Shering-Plough, Brussels, Belgium 
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SUMMARY 
A 5-year-old gelding presented with syncope at termination of 
exercise. A 24-hour ECG recording revealed intermittent pauses 
in the sinus rhythm of up to 10 seconds indicating sinus node 
disease. Especially at termination of exercise, pauses in sinus 
rhythm were repeatedly present. A dual chamber rate-adaptive 
pacemaker was successfully implanted. Rate-adaptive pacing 
based on a build-in activity sensor, prevented excessive post-
exercise bradycardia and syncope, allowing the horse to return to 
work.
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INTRODUCTION 
Cardiac pacing is the treatment of choice for many symptomatic 
bradycardias due to high-degree atrioventricular (AV) block, sick sinus 
syndrome (SSS) or persistent atrial standstill (Sisson 1989, Sisson and 
others 1991, Darke 1992, Roberts and others 1992, Neu and Mulch 
1994, Kittleson and Kienle 1998, Flanders and others 1999). The 
implantation of a pacemaker is a relative safe and simple procedure, 
commonly used, not only in human clinical practice, but also in small 
animals (Klement and others 1984, Darke 1992, Flanders and others 
1999). One of the most important technologic advances in implantation 
technique has been the development of endocardial leads that can be 
introduced into the heart from a peripheral vein. Single chamber and 
dual chamber pacemaker models are available with a variety of 
programmable pacing modalities. Current pacemakers can vary their 
pacing rate in response to changes in activity. These types are called 
rate-adaptive, rate-modulated or sensor-driven pacemakers and are 
often used in patients with sick sinus syndrome (Barold and Zipes 
1992). 
In equines, little information is available concerning therapeutic 
pacemaker implantation. In 1986, Reef et al. performed a successful 
transvenous implantation of a single chamber model in a horse 
suffering from third-degree AV block. Sixteen months after the 
implantation, this model was upgraded to a dual chamber model and 
continued to function for another 2 years. In 1993, Pibarot et al. 
implanted a dual chamber pacemaker, using epicardial leads, in a 
donkey with complete heart block. To the best of our knowledge, no 
data are available in literature related to the applicability of rate-
responsive pacing in equines for symptomatic sinus node dysfunction. 
We report our experience with the transvenous implantation of a rate-
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adaptive dual chamber pacemaker in a horse with syncope due to sick 
sinus syndrome. 
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CASE REPORT 
History and clinical findings 
A 5-year-old gelding was used for dressage and for recreation. 
During a ride, shortly after a gallop, the horse suddenly collapsed. 
After a few seconds, the horse was able to stand up again, but still 
presented a weak gait. The horse was immediately transferred to the 
Faculty of Veterinary Medicine, Ghent University. At admission, the 
horse showed a normal behaviour and no abnormalities were seen at 
walk. During the clinical examination the pulse rate was 22 beats per 
min (bpm) and slightly irregular. A grade 2/6 holodiastolic murmur was 
detected over the aortic valve region. Respiratory rate and lung 
auscultation were normal. No abnormalities were found on 
neurological examination. Complete blood count and biochemical 
profile were normal. 
Electrocardiography and cardiac ultrasound 
An electrocardiogram showed a heart rate of 24 beats per minute 
with a sinus arrhythmia and an occasional second degree AV block. 
An echocardiogram, including M-mode and colour flow Doppler 
showed mild aortic regurgitation. Left ventricular diameter was normal 
and fractional shortening was 33%. During lunging, the horses’ heart 
rate increased but immediately after exercise, heart rate dropped very 
quickly to below 35 bpm and on several occasions pauses in sinus 
rhythm up to 7 seconds were detected, without a ventricular escape 
beat occurring. An incremental exercise test on a treadmill revealed a 
maximal heart rate of 183 bpm. A 24-hour ECG showed sinus 
bradycardia and occasional second degree AV block. Several 
episodes of sinus arrest or sinus exit block up to 10 seconds in 
duration were observed without any ventricular escape beat (Fig. 4.1). 
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Diagnosis 
On the basis of the history, the clinical findings and the ECG 
results, the diagnosis of SSS with a mild degree of chronotropic 
incompetence was made. As no other reasons for syncope were 
found, collapse of the horse was attributed to the sinus node 
dysfunction. 
Treatment and clinical course 
A dual chamber rate-adaptive pacemaker was implanted with a 
previously described technique (van Loon and others 2001). In brief, 
the horse was placed in the stocks and heart rate was continuously 
monitored (Cardiolife TEC-7511K, Nihon Kohden, Tokyo, Japan). 
Before application of sedatives, a temporary bipolar pacing catheter 
(Temporary Pervenous Lead, Cordis, Florida, USA) was inserted in the 
jugular vein and was positioned in the right ventricular apex. During 
the whole implantation procedure, ventricular inhibited pacing was 
performed at 30 bpm (Investigational model 7218, Medtronic, 
Minneapolis, USA). After placement of the temporary ventricular 
pacing catheter, 15 µg/kg detomidine IV (Domosedan; Pfizer Animal 
Health) and 3 µg/kg buprenorphine IV (Temgesic; Schering-Plough) 
were administered IV and local anaesthetic was injected at the level of 
the lateral pectoral groove. The cephalic vein was exposed from the 
Figure 4.1. A 24-hour ECG recording with two simultaneous precordial 
traces demonstrates sinus bradycardia, sinus arrhythmia and a sinus 
arrest of 10 seconds without any ventricular escape beat. The duration 
(ms) of each R-R interval is displayed. 
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surrounding tissue and through a venotomy 2 endocardial bipolar 
screw-in leads were inserted. Guided by echocardiography from the 
right hemithorax (Vingmed CFM 800 SV, GE Vingmed, Horten, 
Norway) and by the intracardiac electrogram, the ventricular 
(CapsureFix 4068 - 110cm, steroid eluting, Medtronic, Minneapolis, 
USA) and the atrial active fixation lead (Stela BS45, bipolar, screw-in, 
atrial endocardial lead, 52 cm, Ela Medical, France) were properly 
positioned and the screw was extended into the endomyocardium. For 
the ventricular lead, the threshold for stimulation was 0.6 V at a pulse 
width of 0.5 ms with an impedance of 600 Ohm at 5 V. The ventricular 
intracardiac signal was sensed at 6.2 mV. The atrial lead presented a 
threshold of 0.4 V at 0.5 ms and an impedance of 620 Ohm at 5 V, 
with a sensing voltage of 5.5 mV. The proximal part of both leads was 
ligated to the surrounding tissue and connected with the pacemaker, 
positioned in a subcutaneous pacemaker pocket between the lateral 
pectoral groove and the manubrium sterni. The temporary pacing 
catheter was disconnected and removed. With a lower rate of 30 bpm, 
the pacemaker was programmed in the DDI mode, which indicates 
dual chamber pacing, dual chamber sensing and inhibition of pacing 
upon atrial or ventricular sensing. 
After the implantation, radiography and fluoroscopy confirmed the 
lead position. The horse remained at rest and was not allowed to lie 
down for 2 weeks following the implantation. Flunixin meglumine (0.3 
mg/kg IV q8h; Finadyne; Shering-Plough) and sodium ceftiofur (2 
mg/kg IV q24h; Excenel; Upjohn) were given during 5 days. On the 5th 
day the horse presented a temperature of 39.2 °C and sodium 
ceftiofur was continued for another 5 days. Threshold and sensing 
values were closely monitored. Between 2 and 3 weeks after the 
implantation, the horse showed an intermittent fever ranging from 38.1 
to 38°6. Appetite remained normal and no abnormalities were seen at 
the surgical site or on cardiac ultrasound. During this period however, 
atrial threshold increased up to 7.5 V at 0.5 ms. The fever was thought 
to be caused by an inflammatory reaction at the lead tip and 1 mg/kg 
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oral prednisolone therapy was started (daily for 5 days and every other 
day for 2 weeks). Fever disappeared and atrial threshold values 
normalized. 
Two months after the implantation, the rate adaptive function of the 
pacemaker was activated by programming the DDIR mode (Fig. 4.2). 
Exercise tests at walk, trot and canter were performed, first on a 
treadmill, afterwards while the horse was ridden by the owner, to 
search for programming values emulating as close as possible a 
normal heart rate response both at rest and during exercise. The 
lowest heart rate was set at 30 bpm and the paced AV interval was 
programmed at 300 ms. This implicated that the upper sensor-driven 
heart rate of the pacemaker was 150 bpm. A high threshold for rate 
adaptation and a low rate response produced the best results. An 
acceleration time of 1 minute was chosen, which means that, after 
sensor activation, a slow increase in rate occurs over 1 minute of time. 
A deceleration time of 2.5 min was selected, which resulted in a 
gradual decrease in heart rate over 2.5 min after cessation of sensor 
Figure 4.2. Surface ECG (1) and marker channel (2) obtained while the 
pacemaker is in DDIR mode with a paced AV interval of 350 ms. The first 
complex is still a native beat and atrial (AS) and ventricular sensing (VS) 
occur. Because sinus node activity decreases, atrial pacing (AP) occurs 
in the second beat but, as normal AV conduction appears within 350 ms, 
no ventricular pacing occurs. Because of the slow native heart rate atrial 
pacing continues in the third and fourth complex, but as the AV 
conduction slows, no ventricular depolarisation occurs within the paced 
AV interval of 350 ms and a ventricular stimulus (VP) is delivered. 
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activation. The latter feature prevented the post-exercise 
bradyarrhythmia, which was repeatedly shown in this horse, and was 
thought to be essential in preventing exercise-induced syncope in this 
animal (Fig. 4.3).  
The horse returned home. Performance was reported to be normal 
and syncope was not observed. 
Four months after the initial implantation the horse returned to the 
clinic because of traumatic injury of the pacemaker pocket. Although a 
normal dual chamber rate adaptive pacemaker function remained 
present, the pacemaker had to be removed due to contamination of 
the pocket. This was performed under general anaesthesia and during 
temporary right ventricular pacing. During this operation, curettage of 
the pocket was performed. The atrial and ventricular lead were 
thoroughly rinsed and were inserted in a new pocket, created in the 
deeper fascia. After the operation, continuous oral clenbuterol 
treatment (0.8 µg/kg bid, Ventipulmin, Boeringer Ingelheim) was 
started. A long-term antibiotic treatment (ceftiofur 2 mg/kg IM q24h) 
Figure 4.3. Two post-exercise recordings, each with a surface ECG and a 
marker channel. Without the pacemaker the horse shows a sinus arrest 
or sinus exit block of 7 seconds. With the pacemaker in DDIR mode, rate-
adaptive pacing prevents post-exercise bradyarrhythmia. (AS = atrial 
sensing; VS = ventricular sensing; AP = atrial pacing; asterisks indicate 
paced P waves). 
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was given in order to try to resolve pocket and lead infection and to 
avoid the occurrence of endocarditis. After 4 weeks however, 
fistulation of the pocket recurred. After sedation and analgesia, during 
temporary ventricular pacing, the pocket was opened. After 
unscrewing of the lead helix, both leads could be removed with gentle 
traction. Clenbuterol treatment was continued until, four weeks later, 
after wound healing, a reimplantation was performed on the contra-
lateral side. Electrical characteristics for the atrial lead (Stelid BS45D 
52 cm, bipolar, ELA Medical, France) were a threshold of 1.0 V at 0.5 
ms with an impedance of 438 Ohm at 5 V, and a sensing voltage of 
5.2 mV. For the ventricular lead (Sweet Tip Rx, 4245-59 cm, bipolar, 
CPI, Guidant, St.-Paul, USA), a threshold of 1.6 V at 0.5 ms, a lead 
impedance of 346 Ohm and a ventricular sensing voltage of 3.2 mV. 
The pacemaker pocket was created slightly more dorsal, underneath 
the m. cutaneus colli. The horse presented a normal recovery period 
and returned to his normal work 2 months post-implantation. At the 
time of submission of this paper, 4 months after the second 
implantation, the owner reported no complaints and successful dual 
chamber rate-adaptive pacemaker function remained present. 
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DISCUSSION 
A syncopal episode is defined as a sudden temporary loss of 
consciousness associated with a deficit of postural tone with 
spontaneous recovery. Syncope in horses is uncommon and therefore 
has been virtually unstudied (Crisman 1998). 
Sick sinus syndrome (SSS) is a term given to a number of 
abnormalities of the sinoatrial (SA) node, including persistent 
spontaneous sinus bradycardia, sinus arrest or SA exit block, 
combinations of SA and AV conduction disturbances or alternation of 
paroxysms of atrial tachyarrhythmias and periods of slow atrial and 
ventricular rates (bradycardia and tachycardia syndrome) (Kapoor 
1992, Zipes 1992). Little is known about sinus node disease in horses 
and its relation to syncope. 
In this horse, periods of sinus arrest or sinus exit block up to 10 
seconds in duration were seen at rest. Because long periods of sinus 
arrest were repeatedly demonstrated in the post-exercise period and 
because the horse had presented syncope at termination of exercise, 
this bradyarrhythmia was the most likely explanation for the syncopal 
episode. In humans, postexertional asystole is known to cause 
syncope (Hirata and others 1987, Huycke and others 1987, Kapoor 
1989, O'Connor and others 1999, Crisafulli and others 2000). SSS in 
human patients generally requires permanent pacemaker implantation 
and represents the most common indication for pacemaker 
implantation (Barold and Zipes 1992, Ellenbogen and Peters 1996). In 
human patients with SSS, it has been proven that atrial based pacing 
systems (single chamber or dual chamber) are superior to ventricular 
based pacing (Barold and Zipes 1992, Benditt and others 1995) and 
this modality was applied in the horse. However, as atrial lead 
dislodgement represents a potential hazard of endocardial leads 
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(Sisson 1989, Sisson and others 1991, Darke 1992, Flanders and 
others 1999), a dual chamber system was implanted. The ventricular 
lead in this system was considered as an extra safety factor because it 
would preserve a normal ventricular rate at any time, even if the atrial 
lead would be dislodged. The use of a rate-adaptive pacing system 
further expands the treatment possibilities. The described pacemaker 
was fitted with a sensor, a piezoelectric ceramic crystal, which detects 
mechanical vibration of the pacemaker box induced by body 
movements or muscle contractions. Upon sensor activation, pacing 
rate is gradually increased to a maximal level. At termination of 
activity, the pacing rate is slowly decreased. Especially the gradual 
decrease in heart rate was thought to be of importance in this horse to 
avoid symptomatic bradycardia at termination of exercise, allowing the 
horse to be ridden again. 
The pacemaker pocket was created at the level of the pectoral 
muscles. This implies that pacemaker vibrations will easily occur even 
with slight body movements. Therefore, by programming the threshold 
for rate adaptation at the highest value, the rate adaptive function was 
set to react slowly and only after vigorous pacemaker vibration, 
allowing only large sensor signals to increase heart rate. Furthermore, 
the rate response, which determines the extent to which an increase in 
the patient’s activity raises the pacing rate, was set to its lowest value. 
A long acceleration time of 1 minute was chosen and the deceleration 
time was set at 2.5 min. These values resulted in the best rate-
adaptive pacing results and avoided excessive pacing, especially at 
low activities.  
The subcutaneous position of the pacemaker pocket implies that it 
is vulnerable to external trauma. However, deeper localisation of the 
pacemaker implies a greater distance between the pulse generator 
and the programming instrument and may prevent post-operative 
programming (Fox and others 1986). During the second implantation, 
the pacemaker pocket was created slightly more dorsal and 
Dual chamber rate-adaptive pacemaker implantation in a horse with suspected SSS 
116 
underneath the m. cutaneus colli, to obtain a better protection against 
traumatic injury but still allow telemetric programming.  
Due to pocket laceration, the pacing system is contaminated. In an 
ultimate attempt to preserve the leads in the horse, extensive 
debridement of the pocket and long-term antibiotic treatment were 
implemented. Although this approach has been described in humans 
(Hurst and others 1986) and dogs (Sisson and others 1991), antibiotic 
treatment alone rarely is sufficient to cure infection, and removal of the 
generator and the leads is usually indicated (Morgan and others 1979). 
In such patients, a new system may be placed at the time of removal 
of the infected hardware or a two-step approach may be taken with 
temporary pacing bridging the time between explantation and the new 
implant (Lewis and others 1985). However, as SSS in the horse was 
not an acute life-threatening situation (Barold and Zipes 1992), 
temporary pacing was not performed. Instead the horse was treated 
with the b2-adrenoreceptor agonist clenbuterol in an attempt to 
decrease the probability of symptomatic bradycardia (Young and 
others 1999) during the period of pocket healing. 
Administration of the a2 adrenergic agonist detomidine is 
associated with the occurrence of bradycardia, sinus block and second 
degree AV block (Clarke and Taylor 1986, Short and others 1986). As 
drug-induced chronotropic and dromotropic suppression was expected 
to be emphasized in this horse, administration of detomidine probably 
would have resulted in syncope due to marked bradycardia. 
Temporary pacing of the right ventricle allows avoiding syncope by 
preserving a minimal ventricular rate and should be initiated prior to 
administration of sedatives. In animals suffering from 3rd degree AV 
block temporary ventricular pacing can also be applied as a lifesaving 
therapy in expectation of a more definitive treatment, i.e. pacemaker 
implantation. 
The DDIR pacing mode was selected for permanent programming, 
which means AV sequential, non-P-synchronous, rate-modulated 
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pacing with dual chamber sensing. As AV conduction was normal in 
this horse, P synchronous pacing (DDDR) was not required. Also in 
humans with SSS, DDIR pacing is frequently used (Barold and Zipes 
1992). The paced AV interval, i.e. the time allowed to elapse between 
a paced atrial and ventricular complex (if no spontaneous ventricular 
depolarisation occurs), was programmed at 300 ms. With this value 
the maximal achievable fully pacemaker dependant heart rate was 150 
bpm. Programming of a shorter AV interval would allow a completely 
paced heart rate of 180 bpm. However, at slow resting heart rates, the 
AV interval in this horse varied between 300 and 420 ms, which is a 
normal value in horses. As AV conduction was normal, in the presence 
of a short paced AV interval, unnecessary ventricular pacing would 
occur at rest, resulting in impaired hemodynamics at rest (Reynolds 
1996) and a reduced battery life. Although the maximal paced heart 
rate was 150 bpm, during maximal treadmill exercise the horse 
showed a natural rate of 183 bpm, indicating that a considerable 
chronotropic response was still present. 
We can conclude that dual-chamber pacemaker implantation is a 
feasible therapy in horses. Rate-adaptive pacing proved to be 
applicable in horses and was effective to prevent syncope due to post-
exertional bradyarrhythmia in this horse. 
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SUMMARY 
A transvenous screw-in electrode was implanted in the right 
atrium of a healthy pony and connected with an implantable 
pulse generator programmed to deliver bursts of electrical 
stimuli to the atrium. Initially, cessation of burst pacing resulted 
in short (less than 1 minute) self-terminating episodes of atrial 
fibrillation. As burst pacing continued, the episodes of induced 
atrial fibrillation became longer. After 3 weeks of continuous 
atrial pacing, atrial fibrillation became sustained (56 hours). This 
model of pacing-induced atrial fibrillation can be used to study 
the mechanisms leading to atrial fibrillation, its perpetuation and 
therapy. Our preliminary observations support the concept that 
once atrial fibrillation starts it sets up changes in the electrical 
characteristics of the atrium that favour its own perpetuation.
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INTRODUCTION 
Atrial fibrillation (AF) is the most important symptomatic arrhythmia 
in horses. It can occur as a result of myocardial disease or valvular 
insufficiency, but in horses AF is frequently encountered without 
structural heart disease (lone AF). AF produces adverse 
hemodynamic effects since atrial contraction is absent and no longer 
contributes to optimal ventricular filling. During atrial fibrillation 
electrical activity is continuous and chaotic. The rapid irregular atrial 
rate is caused by multiple reentrant circuits that produce fibrillating 
wavefronts sweeping across the myocardial surface (1). In the healthy 
atrial myocardium the arrhythmia quickly extinguishes itself unless a 
critical amount of contiguous myocardial surface is present (1). This 
may explain why AF is more frequently seen in animals with a large 
heart (e.g. horses) and occurs less in animals with a small heart (1-3). 
To study the pathophysiology of AF and possible therapies, many 
animal models have been developed. Most of them were performed in 
dogs and have been developed in short-term settings. In these models 
AF has been maintained by pharmacological or electrical stimulation of 
the vagal nerve, or after surgically-induced mitral regurgitation or 
sterile pericarditis (3-6). Recently, chronic AF models have been 
developed in dogs (5) and goats (7) by means of rapid atrial pacing or 
intermittent burst pacing. We investigated whether chronic atrial burst 
pacing in a pony might also lead to an increased atrial vulnerability, 
thus yielding a model of sustained AF. In the present study an 
electrical pulse generator was connected to an electrode positioned in 
the right atrium to deliver bursts of electrical stimuli to the atrial 
myocardium. The pulse generator was subcutaneously implanted 
facilitating prolonged atrial pacing. 
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MATERIALS AND METHODS 
A 6-year-old pony mare, weighing 250 kg and measuring 125 cm at 
the withers, was used for implantation of an electric pulse generator 
(Itrel II 7424 multi-programmable neurological pulse generator, 
Medtronic, Minneapolis). Clinical examination was normal. The 
electrocardiogram (ECG) revealed a sinus rhythm (SR) and no 
abnormalities were found on echocardiography. 
The day of implantation antibiotic prophylaxis was started (15 
mg/kg Trimethoprim-Sulfadiazin IV, Borgal®, Hoechst Roussel Vet, 
Brussels, Belgium). During the whole implantation procedure the pony 
remained in standing position and was given 20 mg/kg detomidine IV 
(Domosedan®, Pfizer Animal Health, Nossegem, Belgium) and 2 
µg/kg buprenorphine IV (Temgesic®, Schering-Plough, Brussels, 
Belgium). A base-apex ECG (Cardiolife TEC-7511K, Nihon Kohden, 
Tokyo, Japan) was connected and cardiac ultrasonography was 
performed from the right hemithorax. The region of the left lateral 
pectoral groove was surgically prepared and injected with local 
anaesthetic. An incision was made along the tract of the cephalic vein. 
The vein was exposed by blunt dissection of the connective tissue 
over a length of approximately 3 cm. The distal part of the vein was 
ligated (Vicryl 4/1, Johnson & Johnson, Dilbeek, Belgium). After a 
venotomy, a bipolar, active fixation lead (CapSureFix® 4568, 
Medtronic, Minneapolis) was introduced in the vein and advanced 
towards the heart. When entrance of the lead tip in the right atrium 
was visualised on echocardiography, a curved stylet was inserted in 
the lead body to provide a J shape and to supply stiffness. The 
external part of the lead was connected with a pacing system analyser 
(Pacing System Analyser Model 5309, Medtronic, Minneapolis). With 
the pacing system analyser electrical pulses of variable intensity could 
be generated and lead impedance and intrinsic cardiac activity could 
be measured. Subsequently the lead was slowly manoeuvred until 
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contact with the atrial endocardium was achieved. An appropriated 
atrial position was obtained when the atrium could be stimulated with 
electrical pulses not exceeding 1.5 Volt (V) at 0.5 ms pulse width, the 
lead impedance was between 400 and 1000 Ohms and the sensed P 
wave was at least 1.5 mV (8, 9). At a stimulation threshold of 0.5 ms, 
2.4 mA and 1 V with a resistance of 420 Ohms, and a P wave sensing 
of 11 mV, the helix of the active fixation mechanism was extended by 
rotation of a connector pin at the external part of the lead and the stylet 
was withdrawn. Subsequently, the proximal part of the cephalic vein 
was ligated and the external part of the lead was secured to the 
underlying muscle with nonabsorbable material (Mersutures 4/1, 
Johnson & Johnson, Dilbeek, Belgium). Between the lateral pectoral 
groove and the manubrium sterni a subcutaneous pocket was created 
by blunt dissection. After connection of the lead to the pulse generator, 
the latter was inserted in the pocket, which was closed in a routine 
manner. Antibiotic treatment (Tribrissen Oral Paste, Mallinckrodt 
Veterinary, Brussels, Belgium) was continued for 2 weeks. 
Four weeks after implantation the stimulator was activated with a 
programmer (Model 7432 Console Programmer, Medtronic, 
Minneapolis) and was programmed to apply intermittent burst pacing. 
Each burst consisted of a 2-second lasting train of electrical stimuli (20 
Hz, 2 Volt in amplitude and 0.5 ms pulse width). Every 4 seconds a 
burst was delivered to the right atrial myocardium. 
Measurements were made on the day pacing was started (day 0), 
after 1 and 3 days and after 1, 2 and 3 weeks. A surface ECG was 
recorded with a base apex lead and a unipolar lead at the left side of 
the thorax, 8 cm above the olecranon. The duration of the induced AF 
episodes was measured by switching the pulse generator off after a 
burst was delivered, and by recording the time needed for SR to 
restore. After restoration of SR, the pulse generator was switched on 
and off again to measure new AF episodes to obtain a mean value 
and range for the AF duration. On day 0 the pulse generator was 
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turned on and off 20 times, while on the following examinations, this 
was only performed for 3 to 5 times. The number of times an atrial 
response occurred after cessation of the burst was recorded.  
This research was approved by the Ethical Committee of the 
Faculty of Veterinary Medicine. 
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RESULTS 
After full recovery of the pony, the safety of the stimulation program 
was tested. Burst pacing did not provoke any adverse reactions of the 
pony. During electrical pacing small stimulation spikes were present 
on the surface ECG and atrial capture occurred. 
Characteristics of the pacing-induced atrial arrhythmia 
During the experiment, the configuration of the atrial responses 
changed. This was best visualised on the unipolar ECG. On day 0 a 
rapid repetition of electrically induced atrial depolarisations (P' waves) 
separated by isoelectric segments was seen during and sometimes 
after the burst, indicating that rapid atrial responses with organised 
atrial activation were present, rather than AF (Fig. 5.1). On day 0, only 
in12 out of 20 bursts, rapid atrial responses were present after 
cessation of the burst. 
Figure 5.1. Surface ECG (unipolar lead on the upper trace and lead II on 
the lower trace) on day 0. During the burst, small spikes, resulting from 
the pacing stimulus artefact, and rapid atrial responses are present. The 
electrically induced atrial depolarisations, P' waves (arrows), are 
separated by isoelectric segments. After cessation of the burst atrial 
responses continue during 3 seconds before restoration of sinus rhythm 
(SR). 
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From day 1 onwards, clear identification of separate P' waves was 
no longer possible and the surface ECG showed fibrillation waves and 
an irregular ventricular response, suggesting that AF was present 
during and after the burst (Fig. 5.2). From this day onwards, every 
burst was followed by an episode of AF. 
Duration of the pacing-induced atrial arrhythmia 
The day burst pacing was started (day 0), the induced rapid atrial 
responses were very short lasting and always self-terminating within a 
few seconds. Over 20 attempts the mean duration of these responses 
was 1.5 seconds with a range of 0.5 to 3 seconds. After 1 day of 
pacing the induced AF episodes were short with a mean of 2 seconds 
ranging from 0.5 to 10 seconds (over 5 inductions) (Fig. 5.3). During 
the study we observed a progressive increase in the AF duration. On 
day 3 the mean duration of the induced AF episodes after 5 bursts 
was 10 seconds (range 2 to 20 seconds). After 1 and 2 weeks of 
pacing respectively, the mean AF duration had further increased to 6 
minutes (range 4 to 8 minutes over 3 attempts) and 10 minutes (range 
4 to 15 minutes over 3 attempts). After 3 weeks of burst pacing there 
was no restoration of SR after inactivation of the stimulator and 
Figure 5.2. Surface ECG (unipolar lead on the upper trace and lead II on 
the lower trace) after 1 day of burst pacing. The pulse generator is just 
turned off. AF is present. 
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sustained AF, i.e. AF lasting for more than 24 hours, was present. The 
pulse generator was left inactive and daily ECG examinations 
indicated that fibrillation continued. Finally after 56 hours of AF, SR 
restored spontaneously. 
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AF duration (min)
Figure 5.3. Duration of AF in the ordinate (logarithmic scale) versus the 
time atrial burst pacing is applied. The longer burst pacing is continued, 
the longer the induced AF episodes. On day 21 sustained AF is present. 
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DISCUSSION 
Atrial burst pacing with an implantable pulse generator induced 
episodes of atrial arrhythmia in a healthy pony. Initially the atrial 
arrhythmia resembled rapid repetitive responses. However, episodes 
were very short and not every burst was followed by atrial responses. 
Chronic burst pacing resulted in a changed morphology of the atrial 
response on the surface ECG: fibrillation waves instead of rapid atrial 
responses became obvious. The vulnerability of the atria to fibrillation 
increased and the duration of the induced AF episodes progressively 
prolonged. Three weeks of burst pacing resulted in sustained AF (> 24 
hours). 
As AF consists of multiple reentry wavelets, its persistence 
depends on the number of wavelets that can coexist in the atria (10). 
When a small number of wavelets are present, the probability that they 
die out all together is high, and the arrhythmia is likely to terminate 
itself. The higher the number of wavelets, the smaller the chance they 
all extinguish simultaneously and the longer AF will persist. The 
number of wavelets simultaneously present during AF depends on the 
amount of atrial tissue mass and the wavelength of the atrial impulse 
(3,7) being the product of conduction velocity and refractory period. In 
this context, the small size of the pony's heart and therefore the limited 
amount of atrial tissue may be the underlying reason that the initially 
induced AF episodes were short (1). In the clinical setting, AF is also 
encountered more frequently in large breed horses and rather rarely in 
ponies. Furthermore, many horses have lone AF, i.e. AF without 
identifiable heart disease, while species with a relatively small heart 
like humans, dogs and even ponies often present AF in the setting of 
an underlying heart disease that caused atrial dilatation (1). A 
progressive increase in AF duration due to chronic burst pacing has 
also been observed in dogs and goats. Wijffels et al. (7) reported that 
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chronic burst pacing and AF itself caused a marked shortening in atrial 
refractoriness, a process referred to as electrical remodeling. The 
decreased atrial refractory period shortens the wavelength of the atrial 
impulse and allows more fibrillation waves to coexist in the atria. AF 
therefore seems to lead to its own progression. Besides a shortening 
in refractory period, in dogs burst pacing resulted in a slowing of intra-
atrial conduction, and thus a shortened wavelength (11), and in an 
atrial enlargement (5), both leading to an increased AF stability. These 
elements might also have contributed to the progressive increase in 
the AF duration in our pony. The above-mentioned observations 
support the theory that recent onset AF is more likely to convert to 
sinus rhythm than long standing AF (12). 
On day 0, the rapid repetition of P' waves, separated by isoelectric 
segments, might have been due to a local reentry in the atrium. But 
from day 1 onwards, fibrillation waves were visible on the surface ECG 
indicating the presence of AF. A change in configuration of the atrial 
response and an increase in the rate of fibrillation have been 
encountered in goats (7). It was suggested that during the onset of AF 
the atrium was activated uniformly by broad activation waves, while 
after chronic burst pacing activation of the atrium had become more 
complex, by multiple wavelets. 
AF is inducible by delivering a single extra-stimulus with a short 
coupling interval or a burst of electrical stimuli to the right atrium (2,11, 
13-17). Until now the inducibility of atrial fibrillation in horses has only 
been studied with temporary catheters and external pulse generators 
able to deliver extra-stimuli or bursts of electrical stimuli to the right 
atrium over a short period of time (2,18). The major limitation of this 
approach is the short duration of the induced AF episodes and the 
inability to study the effects of chronic AF over longer periods of time. 
By the transvenous implantation of a programmable pulse generator 
under local anaesthesia this problem can be overcome. During our 
study, burst pacing was only performed during 3 weeks, but, by leaving 
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the burst program activated, AF can be maintained as long as 
necessary. In the near future these devices will not only be able to 
deliver bursts of electrical stimuli but will also allow programmed 
electrical stimulation with different driving cycle lengths and various 
coupling intervals of the extrastimuli. This will allow to study the 
electrical atrial characteristics in more detail. Furthermore, this 
approach would lead to the development of reliable methods to induce 
atrial fibrillation. This in term will allow evaluating the effect of different 
interventions on the inducibility and therefore the prevention of atrial 
fibrillation. These interventions can include the administration of drugs 
but also the use of pacing algorithms to prevent atrial fibrillation. 
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SUMMARY 
We describe the development and the different features of an 
experimental model of chronic atrial fibrillation (AF) in equines. In 
4 healthy ponies a dual chamber pacemaker, with an adapted 
pacemaker program, was implanted transvenously in the 
standing animal. This adapted pacemaker induced episodes of 
AF by delivering a 2 second burst of electrical stimuli (42 Hz) as 
soon as sinus rhythm was detected. Simultaneous with a surface 
ECG, the intra-atrial electrogram could be recorded to determine 
the atrial electrogram morphology. Programmed electrical 
stimulation (PES) was used to determine the atrial effective 
refractory period (AERP) and the rate adaptation of the AERP, the 
sinus node recovery time (SNRT) and the corrected SNRT, AF 
vulnerability, AF cycle length and AF duration. 
This experimental AF model can be used to study the 
pathophysiology of chronic AF in equines.
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INTRODUCTION 
Atrial fibrillation (AF) is a common arrhythmia in horses (Bertone 
and Wingfield, 1987; Manohar and Smetzer, 1992; Reef et al., 1995) 
with a prevalence ranging from 0.6% to 5.3 % (Holmes et al., 1969; 
Deegen, 1971; Else and Holmes, 1971; Deem and Fregin, 1982). AF 
can occur as ‘lone’ AF, i.e. without underlying heart disease, or it can 
be the result of cardiac pathology. It has been reported that up to 80% 
of the horses with AF show histopathological lesions on post mortem 
examination (Else and Holmes, 1971; Kiryu et al., 1974; Kiryu et al., 
1977; Deem and Fregin, 1982; Deegen, 1986; Bertone and Wingfield, 
1987). On the other hand, about 20% of the horses with AF exhibit no 
or only minor histopathological lesions, and many of the described 
lesions also occur in horses without AF (Else and Holmes, 1971; Kiryu 
et al., 1974; Kiryu et al., 1977; Deem and Fregin, 1982; Bertone and 
Wingfield, 1987). Furthermore, Reef et al. (1988) reported that about 
57% of the horses with AF had no detectable underlying heart disease. 
Knowledge of AF in horses is mainly based on findings in horses 
with naturally occurring AF (Muir and McGuirk, 1984; Marr et al., 
1995). It is however impossible to determine whether an animal 
developed AF due to, possibly distinct, cardiac pathology or whether it 
represents a real case of ‘lone’ AF. If for instance atrial dilatation or 
structural changes are found, these could be the cause as well as the 
consequence of AF. An experimental equine model of chronic AF is 
therefore needed to study the pathophysiology of this arrhythmia. 
In recent years, numerous animal models have been developed to 
study the pathophysiology of human AF (Janse et al., 1998). In most 
animal models, acute AF has been studied by applying electrical 
stimulation of the atria and by pharmacological or electrical stimulation 
of the vagal nerve, surgically-induced mitral regurgitation or sterile 
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pericarditis. These experiments were mainly performed in dogs 
(Shimizu et al., 1991; Benditt et al., 1994; Sideris et al., 1995; 
Sokoloski et al., 1997), sheep (Cooper et al., 1993; Maixent et al., 
2000) or pigs (Leistad et al., 1993; Leistad et al., 1996). The major 
limitation of these models has been their failure to sustain AF over 
prolonged periods. During recent years, however, long-term AF 
models have been developed in dogs (Morillo et al., 1995; Elvan et al., 
1996; Yue et al., 1997), goats (Wijffels et al., 1995), sheep (Willems et 
al., 2000) and pigs (Qi et al., 2000). 
The aims of the present study were to develop a reproducible 
model of chronic AF in healthy equines and to describe the different 
features of this model. The application of this model could provide 
useful information about the pathophysiology of this arrhythmia in 
equines. 
An equine model of chronic atrial fibrillation: methodology 
142 
MATERIALS AND METHODS 
Equine model of AF 
Animal handling was carried out according to The European 
Directive for Protection of Vertebrate Animals Used for Experimental 
and Other Scientific Purposes. The research was approved by the 
Ethics Committee of the Faculty of Veterinary Medicine, Ghent 
University. 
Four healthy ponies, aged between 3 and 6 years and between 
1.25 m and 1.37 m in height, were selected. Biochemical analysis, 
clinical examination, electrocardiography and echocardiography were 
used to exclude animals with structural heart disease. 
In all animals, a dual chamber pacemaker was implanted using a 
previously described technique (van Loon et al., 2001). In brief, the 
animals were placed in stocks and detomidine (15 µg/kg IV, 
Domosedan, Pfizer Animal Health) and buprenophine (3 µg/kg IV, 
Temgesic, Schering-Plough) were administered. A base-apex 
electrocardiogram (ECG) was continuously recorded (Cardiolife TEC-
7511K, Nihon Kohden). After local anaesthesia (lignocain 2%, 
Xylocaine 2%, Astra Pharmaceuticals), a skin incision was made at 
the level of the lateral pectoral groove in order to expose the cephalic 
vein. Through a venotomy, 2 electrode leads (Medtronic) were 
introduced and positioned in the right atrium and right ventricular apex. 
Exact positioning of each lead was guided by ultrasonography 
(Vingmed CFM 800 SV) from the right cardiac window, and by 
determining the electrical characteristics of each lead with a pacing 
system analyser (PSA Model 5309, Medtronic), including the threshold 
for stimulation, the lead impedance, and the voltage of the intracavitary 
signals. Care was taken not to stimulate the diaphragm during high 
output atrial pacing. 
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After correct positioning, fixation of distal end of the lead to the right 
atrium (screw) and the right ventricle (screw or tines) was achieved. 
The proximal ends of the leads were secured to the underlying tissue 
and were connected to a dual chamber pacemaker (Thera D(R), 
Medtronic). The pacemaker box was positioned in a subcutaneous 
pocket between the lateral pectoral groove and the cranial part of the 
sternum. After implantation lead position was verified using 
radiography and fluoroscopy. Flunixin meglumine (0.3 mg/kg IV q8h; 
Finadyne, Shering-Plough) and sodium ceftiofur (2 mg/kg IV q24h; 
Excenel, Upjohn) were given for 5 days. Oral trimethoprim 
sulphadiazine treatment (1 mg/kg trimethoprim and 5 mg/kg 
sulphadiazine PO q12h; Tribrissen Oral Paste, Mallinckrodt Veterinary) 
was continued for 10 days. A recovery period of at least 1 month was 
allowed. 
After full recovery, the normal pacemaker program was modified 
into a custom made ‘fibrillation’ program (Medtronic). This fibrillation 
program continuously analyses the intra-atrial and intraventricular 
electrogram. Below a ventricular rate of 80 beats per minute (bpm), an 
algorithm was activated that analysed atrioventricular synchrony. Sinus 
rhythm (SR) was defined as 1/1 AV synchrony during 3 to 4 
consecutive heart cycles. Upon SR detection, a 2 second burst of 
stimuli (42 Hz) was delivered to the right atrium at twice the threshold 
for stimulation. If, due to burst pacing, rapid irregular atrial activity 
lasting for more than 1 second was present, AF was considered to be 
induced (Wijffels et al., 1995). As a result of repeated pacing, the heart 
was kept continuously in AF. The actual time of burst delivery was 
stored in the pacemakers’ memory and could be used to assess the 
duration of the AF paroxysms. 
Electrophysiological measurements 
In all animals, baseline electrophysiological measurements were 
performed, using a telemetric programmer (Programmer 9790, 
Medtronic), which allowed simultaneous recording of a surface ECG 
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and an intracardiac electrogram. The resting heart rate was recorded 
to calculate the sinus cycle length (SCL). To determine the threshold 
for stimulation, pacing was performed slightly faster than sinus rate, 
0.5 ms pulse width and high amplitude. Every 8 stimuli, amplitude was 
decreased. Capture was present as long as every atrial or ventricular 
stimulus was followed by a P wave or QRS complex, respectively. The 
lowest output which still captured the atrium or ventricle was taken as 
the threshold for stimulation. Pacemaker output was subsequently 
programmed at twice threshold both for electrophysiological 
measurements and for atrial burst pacing. 
To determine the atrial effective refractory period (AERP), 
programmed electrical stimulation (PES) was performed at twice the 
threshold amplitude. During pacing (S1-S1) with an interval of 1000 
ms, an extrastimulus (S2) was introduced with a coupling interval 
below the expected refractory period. If no capture of the extrastimulus 
occurred, i.e. if the S2 was not followed by a P wave on the surface 
ECG, the S1-S2 interval was slightly prolonged in steps of 8 ms and 
the procedure was repeated, until capture of the extrastimulus 
occurred. The longest S1-S2 interval that was not followed by an atrial 
depolarisation was taken as the AERP (Fogoros, 1995; Morillo et al., 
1995). This measurement of AERP was performed at pacing cycle 
lengths (CL) of 1000, 800, 600, 500, 400 and 333 ms. 
To determine the sinus node recovery time (SNRT), at each pacing 
CL, the pacemaker output was inhibited for a short period until an 
intrinsic atrial depolarisation occurred. The time between the last 
paced beat and the first spontaneous atrial depolarisation was 
recorded. In each animal, this measurement was repeated 3 times at 
each pacing rate. The longest recorded time was taken as the SNRT 
(Zipes, 1992). The corrected SNRT (cSNRT) was calculated by 
subtracting the SCL from the SNRT. The ratio of SNRT and SCL, 
another index used in human medicine to assess sinus node function, 
was determined (SNRT/SCL X 100). 
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To establish baseline AF characteristics, the fibrillation program 
was briefly switched on and the duration of 3 pacing-induced but self-
perpetuating AF paroxysms was recorded. To determine the atrial 
fibrillation cycle length (AFCL) during AF, the atrial electrogram of an 
AF episode was recorded on paper. Over a time-window of 1 to 18 
seconds, consecutive atrial depolarisations were counted to calculate 
the mean AFCL. From the recorded atrial electrogram, the AF 
morphology was determined using the criteria described by Wells et al. 
(1978). These authors defined more organized AF, with atrial 
potentials separated by isoelectric segments as Type I AF. Recordings 
with a similar electrogram morphology but with a disturbed baseline 
were designated Type II, while Type III AF comprised those with a 
chaotic pattern without discrete electrograms, indicating a more 
complex activation pattern. The term Type IV was reserved for cases 
in which the level of organisation varied over the short period of 
recording, alternating between Type III and either Type I or II. 
When these baseline electrophysiological measurements had been 
determined, the fibrillation program was permanently enabled during 5 
days to verify if AF could be maintained successfully. During this 
period the ponies were stabled. Daily, the animals’ behaviour was 
monitored simultaneous with a telemetric ECG recording. On day 5, a 
re-study was performed determining AF duration, AFCL and AF 
morphology.
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RESULTS 
Pacemaker implantation succeeded in all animals. One animal 
presented atrial lead dislodgement 2 days after implantation, resulting 
in a loss of atrial capture and atrial sensing. The pacemaker pocket 
was reopened in this animal and the atrial lead was replaced by a new 
one. Successful dual chamber pacing was achieved in all animals with 
a mean atrial and ventricular threshold for pacing of 1 ± 0.7 V and 1.9 
± 2.1 V respectively. 
Baseline electrophysiologic measurements 
The mean resting heart rate during sinus rhythm was 42 ± 5 bpm 
which means a SCL of 1439 ms ± 185 ms. 
A representative example of an AERP measurement is given in 
Figure 6.1. In the upper part atrial pacing is performed at 75 bpm, i.e. 
at a S1-S1 CL of 800 ms. An extrastimulus (S2) is delivered 281 ms 
after the last S1. This short coupling interval does not result in atrial 
capture (no P wave). However, an extrastimulus with an S1-S2 
coupling interval of 289 ms did capture the atrium as evidenced by a 
clear P wave on the surface ECG. Consequently, for this horse the 
AERP was 281 ms. In all animals, the AERP was determined at 
different atrial pacing rates in order to obtain a rate adaptation curve 
for the AERP (Fig. 6.2). We observed a marked shortening of the 
refractory period at increasing pacing rates. At a driving CL of 1000 ms 
(60 bpm), AERP was 287 ± 29 ms. During pacing with an S1-S1 CL of 
333 ms (180 bpm) AERP was 234 ms ± 20 ms. 
The mean SNRT was 1946 ± 175 ms. The cSNRT was 508 ms ± 
167 ms and the mean ratio of SNRT to SCL was 137% ± 16%.
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Figure 6.1. In panel A and B, a marker channel (upper trace) and a 
surface ECG (lower trace) are displayed from the same animal. Atrial 
pacing (S1) is performed at 75 bpm, which means at a cycle length of 
800 ms. Each pacing stimulus (S1) is followed by a P wave on the 
surface ECG, indicating capture occurs. In panel A, an extrastimulus (S2) 
is delivered 281 ms after the last S1 but no capture occurs. In panel B, 
the S1-S2 interval of 289 ms initiates a P wave (¯). In this animal the 
AERP at a pacing CL of 800 ms is 281 ms. After each test, sinus rhythm 
re-establishes and the spontaneous atrial depolarisation is sensed by the 
atrial lead (AS). 
Figure 6.2. Mean values (± standard error) for the AERP at different 
driving CL in four healthy ponies are displayed on an AERP rate 
adaptation curve. AERP shortens at shorter driving CL. 
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Atrial fibrillation study 
Activation of the ‘fibrillation’ program resulted in an immediate 
detection of SR and automatically a 2 second 42 Hz burst of atrial 
stimuli was delivered (Fig. 6.3). During the bursts, AF was induced as 
evidenced by the rapid and irregular rate of the f-waves on the surface 
ECG and the irregular ventricular rhythm. During application of burst 
stimuli, due to saturation, the intra-atrial electrogram could not be used 
to evaluate the atrial rhythm. After cessation of the burst, AF was only 
short lived and terminated mostly within 3 seconds. On the intra-atrial 
electrogram, the rapid atrial rate during AF became apparent (Fig. 
6.3).  
Figure 6.3. A simultaneous recording of the atrial electrogram (0.2 
mV/mm), marker channel and surface ECG (0.05 mV/mm) is displayed. 
The marker channel indicates when atrial pacing (AP) or when sensing of 
spontaneous atrial and ventricular activity occurs (AS, VS). The fibrillation 
program is activated. Upon sinus rhythm detection, a burst (42 Hz) is 
delivered to the atrium and capture occurs (¯). The induced AF episode 
is recognized by the pacemaker and inhibits the delivery of a new burst.  
CHAPTER 6: Results 
  149 
The fibrillation program was enabled and AF duration, AFCL and 
atrial electrogram morphology were measured first at baseline and 
again after 5 days of continuous AF maintenance (Fig. 6.4). In the 
normal atria, the induced AF episodes were always self-terminating 
and the mean AF duration was 3 seconds ± 1 seconds. After 5 days of 
repeated induction of AF the mean AF duration had increased to 182 
seconds (range 6-600 seconds). The mean AFCL was calculated from 
the atrial electrogram. In acute AF, AFCL was 247 ms ± 33 ms. Due to 
5 days of maintained AF, the AFCL shortened to 212 ms (± 27 ms). At 
baseline, the induced AF episodes were of Type I (n=3) or Type II 
(n=1). After 5 days of AF, complexity of AF had increased. Type I AF 
had changed into Type II (n=1) or Type III (n=1) and Type II was 
transformed into Type III. 
Both burst pacing and electrophysiological measurements did not 
elicit any behavioural reaction of the animal. When observing the 
animal at rest in a stable it could not be determined when sinus rhythm 
or AF was present, or when automatic burst pacing occurred. 
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Figure 6.4. Due to a 5-day period of AF maintenance AFCL shortens, 
the atrial electrogram becomes more complex and AF duration 
increases 
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DISCUSSION 
Main findings 
Implantation of a pacemaker, modified with a fibrillation program, 
proved to be an effective means of inducing AF in healthy equines. 
Besides repetitive AF induction, electrophysiological parameters, 
essential for the development and perpetuation of AF, such as the 
AERP, SNRT, AF duration, AFCL and atrial electrogram morphology, 
could be studied. As the ponies were apparently completely oblivious 
to pacing, all measurements could be performed in the conscious, 
unsedated animal, avoiding any drug-related interference. This also 
implied that the fibrillation program could remain active day and night 
in order to maintain AF continuously. In this study, a 5-day period of 
repeated AF induction increased the AF duration, shortened the AFCL 
and increased the complexity of the atrial electrogram morphology.  
AF research in horses 
With a prevalence ranging from 0.6 to 5.3%, AF represents the 
most important arrhythmia affecting performance in horses (Holmes et 
al., 1969; Deegen, 1971; Else and Holmes, 1971; Deem and Fregin, 
1982). AF is frequently associated with cardiac disease. However, as a 
number of horses lack evidence of valvular or structural heart disease 
and because many of them return to their previous level of exercise 
after AF conversion, lone AF is thought to be present in these animals. 
However, only few experimental studies investigating the 
pathophysiology of AF have been performed in equines. Senta et al. 
(1975) and Senta and Kubo (1978) have reported that temporary rapid 
atrial pacing could induce short-term paroxysms of AF, perpetuating 
for a few seconds up to 90 minutes. In 1975, this technique was used 
to induce short-term AF episodes in 7 healthy horses to study the 
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effect of AF on the cardiac output (Kubo et al., 1975). However, 
because the induced AF episodes were always short and self-
terminating, cardiac output measurements had to be completed 
immediately after burst pacing. Moore and Spear (1987) applied atrial 
burst pacing at a rate of 1800 bpm to induce short episodes of AF in 
goats, calves, cows and also mules and mature horses to study AF 
duration and ventricular response during AF.  
Only recently, we described the first model of chronic AF in a 
healthy pony by implantation of a neurostimulator (van Loon et al., 
2000). This electrical pulse generator, connected with a right atrial 
screw-in electrode, was subcutaneously implanted. Every 4 seconds, 
this pulse generator delivered a 2 second burst of electrical stimuli (20 
Hz) to the right atrium. Initially cessation of burst pacing resulted in 
short self-terminating paroxysms of AF. Three weeks of burst pacing 
resulted in a sustained AF episode of 56 hours.  
Besides the automatic maintenance of AF for a prolonged period of 
time, the major advantage of the currently described model with the 
fibrillation pacemaker is the ability to study different 
electrophysiological characteristics, critical in the development and 
perpetuation of AF (Morillo et al., 1995; Wijffels et al., 1995; Elvan et 
al., 1996). 
Pathophysiology of AF 
From human medicine, we know that AF is triggered by ectopic 
beats, bradycardia or precursor arrhythmias such as atrial tachycardia 
or atrial flutter (Allessie et al., 2001). Recently, it has been shown that 
most of the ectopic foci originate from atrial musculature extending in 
the pulmonary veins or the superior caval vein (Jais et al., 1997; 
Haissaguerre et al., 1998; Tsai et al., 2000). Whether such foci exist in 
horses is yet unknown. The role of autonomic balance on the 
occurrence of AF still remains unclear. These triggers may initiate 
reentry wavelets, which, meandering through both atria, may interact 
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with anatomical and/or functional obstacles leading to fragmentation 
and consequently a source of new wavelets (Allessie et al., 2001). On 
the other hand, dying out of existing wavelets can be caused by fusion 
with another wavelet, by reaching the border of the atrium and 
because the advancing depolarisation wave meets an area where the 
myocardium has not recovered its excitability from a foregoing 
activation (Allessie et al., 1985). During AF, a critical number of 
wavelets is required for self-perpetuating fibrillation. If the number of 
wavelets simultaneously present in the atria is too small, AF may be 
short-lived. The more wavelets present at the same time in the atria, 
the smaller the statistical chance that they die out simultaneously and 
the more stable AF becomes (Moe, 1962; Wijffels et al., 1995). The 
number of wavelets depends mainly on the atrial size and on the 
wavelength of the excitation waves. The larger the atria, the more 
wavelets they can contain and the more susceptible they become for 
AF. Besides, the atria can include a higher number of wavelets when 
the wavelength of each wavelet is decreased. As wavelength is 
defined as the product of refractory period and conduction velocity, a 
decrease in these parameters results in a shorter wavelength and an 
increased AF stability. AF by itself, once initiated, results in a 
shortening of the AERP, a process referred to as electrical remodeling, 
and thereby leads to its own progression (Wijffels et al., 1995).  
In our study, AERP was determined by applying extrastimuli to the 
right atrium. When a premature pulse is delivered with a short coupling 
interval, the tissue is still in the refractory state and the impulse will fail 
to propagate. The longest coupling interval without propagation of the 
impulse reflects the effective refractory period (ERP) of that tissue 
(Fogoros, 1995; Ross and Mandel, 1995). If the coupling interval was 
any longer, the tissue would be recovered and depolarisation would 
occur. In the normal pony atria, we determined the AERP at different 
driving cycle lengths, which demonstrated an AERP shortening at 
higher heart rates. In other animal models it has been shown that 
repetitive induction of AF caused a decrease in AERP and that the 
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decrease was more pronounced at slower pacing rates (Morillo et al., 
1995; Wijffels et al., 1995; Elvan et al., 1996; Willems et al., 2000). In 
dogs and goats, pacing-induced decrease in AERP and shortening of 
the wavelength are known to increase AF inducibility and AF 
perpetuation. In the present model, the induced AF paroxysms were 
initially short. Five days of repetitive AF induction and presumptive 
electrical remodeling resulted in an increased AF duration. 
Furthermore, our ponies showed a decrease in AFCL and thus a 
higher rate of fibrillation, which was probably related to a pacing-
induced decrease in AERP (Morillo et al., 1995). The higher rate of 
fibrillation and the more chaotic nature of AF resulted in an increased 
complexity of the atrial electrogram (Fig. 6.4). 
In dogs, it has been shown that changes in sinus node function 
might develop as a consequence of AF (Elvan et al., 1996). Using 
overdrive suppression, the sinus node function can be established by 
determining the sinus node recovery time (SNRT). In human medicine, 
atrial pacing is performed near the sinus node at a rate slightly faster 
than the basic sinus rate for at least 30 seconds and than abruptly 
stopped. Due to overdrive pacing, the sinus node can present a pause. 
The interval from the last paced atrial complex to the first spontaneous 
sinus node depolarisation represents the degree of overdrive 
suppression induced by pacing. In humans, the procedure is 
performed at a series of pacing rates and the longest interval observed 
is considered to be the SNRT for that patient (Zipes, 1992; Fogoros, 
1995). Because the SNRT largely depends on the basic sinus cycle 
length (BCL) a correction (c) can be made: cSNRT = SNRT – BCL. To 
measure sinus node function the tip of the catheter should be located 
close to the sinus node. In the present study, the atrial lead tip was 
clearly visible on radiography and fluoroscopy but its position in 
relation to the sinus node was not exactly known. However, as the lead 
is chronically implanted and thus remains at the same place, several 
measurements over time might be compared with each other to detect 
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changes due to AF. As far as the authors know, normal values for 
SNRT and cSNRT in equines have not been reported yet. 
Clinical implications 
The present study demonstrated the feasibility of developing a 
reproducible chronic AF model in equines. As lone AF represents a 
substantial part of the clinical AF cases (Bertone and Wingfield, 1987; 
Reef et al., 1988), the transvenous approach for pacemaker 
implantation in healthy subjects, providing a closed-chest animal 
model and avoiding surgery-related complications such as pericarditis, 
closely resembled the natural state of AF in equines. Therefore, the 
present model may enhance the possibility of expanding our 
understanding of the pathophysiology of AF in equines. Furthermore, 
this model may facilitate developing new therapeutic strategies. 
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SUMMARY 
In 4 healthy ponies a dual chamber pacemaker, with an 
adapted pacemaker program, was implanted transvenously. The 
implantation procedure was performed in the standing, sedated 
animal. With this pulse generator atrial fibrillation was maintained 
during 6 months by applying intermittent burst pacing. 
Electrophysiologic measurements, determination of intracardiac 
pressure and echocardiography were performed before, during 
and after the 6-month fibrillation period. All blood pressures and 
echocardiographic examinations were performed in sinus rhythm 
during regular atrial pacing. As a result of maintained AF, atrial 
refractoriness decreased and the rate of fibrillation increased. 
Additionally, a slight increase in right atrial pressure and a 
significant left atrial dilatation became apparent. Non-invasive 
assessment of atrial shortening fraction indicated a total loss of 
atrial contractile function as a result of fibrillation, which resulted 
in a decreased stroke volume. During the fibrillation period, the 
duration of the induced atrial fibrillation paroxysms increased 
progressively and became persistent in one animal. Duration of 
the fibrillation episodes was associated with atrial diameter, atrial 
refractory period and rate of fibrillation. 
After restoration of SR, the electrophysiological parameters 
returned to normal within 10 days. Atrial size and atrial 
contractile function normalized only after 1 to 2 months of SR. All 
fibrillation-induced alterations were reversible within 2 months 
after cardioversion. 
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INTRODUCTION  
Atrial fibrillation (AF) is the most frequently encountered arrhythmia 
affecting performance in the horse. Although AF can originate from 
underlying cardiac disorders such as valvular dysfunction or congenital 
disorders, this arrhythmia can also affect young healthy horses without 
detectable heart disease (Amada et al., 1974; Rose and Davis, 1977; 
Deem and Fregin, 1982; Reef et al., 1988; Detweiler, 1989; Stewart et 
al., 1990; Collatos, 1995). Especially animals from the latter group 
often respond well to antiarrhythmic treatment and frequently return to 
their previous athletic ability (Irvine, 1975; Amada and Kurita, 1978; 
Reef et al., 1988). Knowledge about AF in horses mainly has been 
gathered from animals with naturally occurring AF. In these animals, 
however, the exact duration of the arrhythmia is generally unknown 
and it is usually not clear whether these horses present, possibly 
distinct, underlying cardiac pathology. When abnormalities such as 
atrial dilatation are found in an animal with spontaneously occurring AF 
it remains to be discussed whether these are cause or consequence 
of AF. 
More information about the pathogenesis of AF in horses might be 
obtained under more controlled, experimental situations. In the 
seventies, Senta et al. were able to induce short bouts of AF in healthy 
horses by applying rapid atrial pacing (Senta et al., 1975; Senta and 
Kubo, 1978). This technique was subsequently used to study the 
influence of acute AF on cardiac output (Kubo et al., 1975). Recently, 
an identical experimental protocol was used to study the effectiveness 
of an antiarrhythmic drug on acute AF in healthy horses (Ohmura et 
al., 2000). However, the major limitation of both studies was the short 
duration of the induced AF episodes, ranging from a few minutes to 
about one and a half hour.  
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We recently described 2 experimental models to maintain long-
term AF in healthy equines (van Loon et al., 2000; van Loon et al., 
2001). In these models, an implanted electrical pulse generator was 
able to maintain AF continuously by rapid atrial pacing. 
The major objective of the present study was validating the 
applicability of such a model and studying the consequence of long-
term AF on electrophysiologic and echocardiographic parameters and 
on intra-cardiac blood pressures in healthy ponies.
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MATERIALS AND METHODS 
Animal handling was carried out according to The European 
Directive for Protection of Vertebrate Animals Used for Experimental 
and Other Scientific Purposes. The research was approved by the 
Ethics Committee of the Faculty of Veterinary Medicine, Ghent 
University. 
Animals 
Four ponies, two mares and two geldings, between 3 and 6 years 
old and between 1.25 m and 1.37 m at the withers, were selected for 
the study. Body weight ranged from 250 to 275 kg. These animals 
showed no abnormalities on clinical and biochemical examination. 
Electrocardiography and echocardiography, including M-mode and 
colour flow Doppler, were normal in all animals.  
A dual chamber pacemaker (Thera (D)R, Medtronic) was implanted 
in each animal as described previously (van Loon et al., 2001). After 
full recovery (at least 1 month), a fibrillation program was uploaded 
into the pacemakers’ memory. This adapted pacemaker repeatedly 
induced episodes of AF by delivering a 2 second burst of electrical 
stimuli (42 Hz) as soon as sinus rhythm (SR) was detected, whereas 
no stimulation occurred during the induced AF episodes. 
Transcutaneous programming allowed enabling or disabling the 
fibrillation program at any time. With the fibrillation pacemaker, AF was 
maintained during 180 days in each animal. 
Experimental protocol 
Measurements were performed before AF induction (control 
values), during the 6 months of AF (effect of AF) and after this AF 
period when SR was restored (reversibility). First, control 
measurements were performed in all animals. At this stage, the 
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fibrillation program was only briefly enabled to induce AF paroxysms in 
order to study baseline AF characteristics. After the baseline 
measurements, the fibrillation program was permanently enabled 
during 6 months to maintain AF. During this period, the fibrillation 
program was only temporarily disabled to allow SR to restore. 
Subsequently, electrophysiologic studies, echocardiography and 
invasive blood pressure monitoring were performed. When these 
measurements were completed, the fibrillation program was enabled 
again. After the 180 days of AF, the fibrillation program was 
permanently disabled to study the reversibility. During this phase, the 
program was only briefly enabled to restudy AF features.  
Electrophysiology 
Electrophysiologic measurements were performed using a 
telemetric programmer (Programmer 9790, Medtronic, Minneapolis), 
which allowed simultaneous recording of the surface ECG and the 
intracardiac electrogram. Electrophysiological studies were performed 
at days -2, -1, 0 (control values), at days 5, 10, 20, 30, 60, 120, 180 
(AF values), and at days 190, 210 (recovery values). 
At baseline and during the reversibility study, first the 
measurements during SR were performed and afterwards the 
fibrillation program was temporarily enabled to study AF features. 
During the fibrillation period (day 0 – 180), first the AF characteristics 
were documented. After disabling the fibrillation program and 
spontaneous cardioversion, measurements during SR were carried 
out. 
Measurements during SR 
Heart rate at rest was determined from a surface ECG and the 
sinus cycle length was calculated. The threshold for stimulation was 
determined at 0.5 ms and pacemaker output was programmed at 
twice diastolic threshold. 
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Regular atrial pacing was started at 60 beats per minute (bpm), 
which corresponds to a pacing cycle length of 1000 ms. After 2 min of 
pacing, the stimulator output was temporarily inhibited until a 
spontaneous atrial depolarisation occurred. The time between the last 
paced beat and the first spontaneous atrial depolarisation was 
recorded to assess the sinus node recovery time (SNRT). This 
measurement was performed 3 times. Subsequently, programmed 
electrical stimulation was applied to determine the atrial effective 
refractory period (AERP). During regular atrial pacing an extrastimulus 
with a short coupling interval was delivered early in atrial diastole. If 
the extrastimulus was not captured, the coupling interval was slightly 
prolonged and the procedure was repeated, until capture of the 
extrastimulus occurred. The longest coupling interval not followed by 
an atrial depolarisation was taken as the AERP (Fogoros, 1995; 
Morillo et al., 1995) at that specific pacing rate. The number of atrial 
depolarisations that followed the first captured extrastimulus was 
recorded to assess atrial vulnerability. 
The above-mentioned measurements were all performed at atrial 
pacing rates of 60, 75, 100, 120, 150 and 180 bpm, corresponding to a 
pacing CL of 1000, 800, 600, 500, 400 and 333 ms, respectively. The 
longest time from all the SNRT measurements at the different pacing 
rates was taken as the SNRT of that day (Zipes, 1992). The corrected 
SNRT (cSNRT) was calculated by the following formula: 
 cSNRT = SNRT – sinus cycle length 
Measurements during AF 
During AF, mean ventricular rate at rest was calculated. The atrial 
electrogram was recorded on paper. The local atrial fibrillation cycle 
length (AFCL) was calculated by measuring the interval between the 
steepest negative deflections in an 18-second window, averaged to 
obtain the mean AFCL (Morillo et al., 1995). Shorter time windows 
were used in case of shorter AF paroxysms. From the recorded atrial 
CHAPTER 7: Materials & methods 
  169 
electrogram, the AF morphology was determined using the criteria 
described by Wells et al. (1978). These authors defined more 
organized AF, with atrial potentials separated by isoelectric segments 
as Type I AF. Recordings with a similar electrogram morphology but 
with a disturbed baseline were designated Type II, while Type III AF 
comprised those with a chaotic pattern without discrete electrograms, 
indicating a more complex activation pattern. The term Type IV was 
reserved for cases in which the level of organisation varied over the 
short period of recording, alternating between Type III and either Type 
I or Type II AF.  
Subsequently, the fibrillation program was disabled, and the time 
until sinus rhythm restored spontaneously was recorded as the AF 
duration. Sustained AF was defined as AF of more than 24 hours 
(Wijffels et al., 1995). 
Echocardiography 
Echocardiography was performed on days –2, -1, 0 (control 
period), at days 10, 30, 60, 120, 180 (during the induced AF period), 
and at days 190, 210, 240 (recovery period after AF). 
It should be emphasized that all echocardiographic examinations 
were not performed during fibrillation, but were completed immediately 
after spontaneous restoration of sinus rhythm, while regular atrial 
pacing at a rate of 60 or 75 bpm was performed. Care was taken that 
no diaphragmatic stimulation appeared during atrial pacing. When 
second-degree atrioventricular block occurred, measurements during 
and following AV block were discarded. Cardiac ultrasound was 
performed from the left and the right thoracic window (Vingmed CFM 
800 SV, General Electric, Horten, Norway). Ten cardiac cycles were 
measured for each variable to obtain a mean value. 
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Left ventricular and aortic measurements 
During atrial pacing at 75 bpm, standard echocardiographic 
measurements were performed (Patteson et al., 1995). Left ventricular 
internal diameter (LVID) and interventricular septal thickness (IVS) 
were determined during systole (syst) and diastole (diast) from the right 
parasternal short axis M-mode view. In addition to M-mode views, B-
mode echocardiograms were obtained because the ventricular lead 
occasionally produced an acoustic shadow on the M-mode images. A 
small dropout on the B-mode image still allowed calliper positioning by 
extrapolation of the endocardial border. Left ventricular fractional 
shortening (FS) was calculated from established methods 
(Feigenbaum, 1986). Fractional wall thickening (FWT) was calculated 
for the IVS from the formula: 
 100
IVS
IVSIVS
FWT
diast
diastsyst ´
-
=  
Systolic and diastolic left ventricular internal area (LVA) was 
measured by planimetry from the right parasternal short axis 
ventricular B-mode images at chordal level. Left ventricular fractional 
area change (FAC) was calculated from the formula: 
 100
LVA
LVALVA
FAC
diast
systdiast ´
-
=  
Systolic aortic diameter was measured by 2-D echocardiography 
from the right parasternal long-axis left ventricular outflow-tract view at 
the level of the sino-tubular junction using both the leading-edge to 
leading-edge method (Sahn et al., 1978) and the inner-edge technique 
(Schiller et al., 1989).  
Doppler studies 
For the aortic outflow, pulsed wave Doppler spectra were recorded 
from the left parasternal long-axis 5-chambered view (Long et al., 
1992) with the sample volume placed in the centre of the aorta. 
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Velocity time integral (VTI) and peak velocity (Vmax) were measured 
from the Doppler waveforms. Stroke volume was calculated using the 
equation: 
 Stroke volume = VTI x aortic cross section area 
 
Aortic cross sectional area was calculated using the equation: 
2
2
diameter systolic aortic
3.14area sectional cross Aortic ÷
ø
ö
ç
è
æ´=  
The leading-edge to leading-edge aortic systolic diameter was used 
for cardiac output calculation. 
Colour flow Doppler from the tricuspid valve and the mitral valve 
was performed from a left and right parasternal view, respectively 
(Blissitt and Bonagura, 1995) to assess valvular regurgitation. 
Left atrial measurements 
Left atrial diameters were measured during regular atrial pacing at 
a rate of 60 and 75 bpm. Left atrial internal diameters were measured 
from 2-D long-axis left and right parasternal images, optimised to 
produce the largest diameter of the left atrium using standardised 
imaging techniques (Long et al., 1992). On the left parasternal views, 
lung artefacts sometimes blurred delineation of the left atrial lateral 
wall. Therefore, attention was paid that the coronary vein remained 
visible throughout the cardiac cycle. Left atrial diameter was measured 
along a line, parallel to the closed mitral valves, and callipers were 
placed between the lateral atrial wall near the dorsal part of the 
coronary vein and the interatrial septum. During a single cardiac cycle, 
left atrial diameter was measured at specific points in time. Left atrial 
diameter was determined just prior to atrial contraction, which was at 
the onset of the P wave on the surface ECG (LADp). Subsequently, 
diameter was measured during maximal atrial contraction (LADa), at 
the end of ventricular diastole (LADdiast) and at the end of ventricular 
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systole (LADsyst). Shortening fraction of the left atrium was calculated 
using the equation: 
100
LAD
LADLAD
fraction shortening atrialLeft 
p
ap ´
-
=  
Invasive blood pressure recordings 
Right heart catheterisation was performed on day 0 (control), day 
30 and 180 (AF period), and day 210 and 240 (reversibility). 
Similar to echocardiography, all catheterisations were not 
completed during AF, but were carried out while regular atrial pacing at 
an arbitrary rate of 75 bpm was performed. Measurements were not 
made during or following second-degree atrioventricular block. Ten 
cardiac cycles were measured for each variable to obtain a mean 
value. 
Cardiac catheterisation was performed in the unsedated animal, 
using a high-fidelity catheter-tip micromanometer (MTC catheter, PPG 
Biomedical Systems Divisions, Best, The Netherlands). Catheter 
calibration against a mercury manometer was performed prior to the 
study. Via an 8.5-F introducer sheath (Intro-flex, Baxter, Germany), the 
catheter was inserted in the jugular vein and advanced into the right 
ventricle. Correct catheter position was confirmed by the characteristic 
pressure trace (van Loon et al., 1994; Nollet et al., 1999). The 
pressure module (Servomed 104, Hellige, Freiburg im Breisgam, 
Germany) automatically calculated the first derivate of the obtained 
pressure recording. Surface ECG, pressure (mm Hg) and rate of 
pressure change (dP/dt) were simultaneously recorded on paper. After 
ventricular measurements had been completed, the catheter was 
slowly withdrawn into the right atrium to obtain atrial recordings. During 
the entire procedure, the animals’ head position was kept at the same 
level. 
For each cardiac cycle, different variables were calculated from the 
pressure recordings. For the right ventricle, pressure during atrial 
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contraction (RVa), pressure at end-diastole (RVdiast), peak systolic 
pressure (RVsyst), and the maximal rate of pressure change (RVdP/dt) 
were calculated. For the right atrium, pressure was determined just 
prior to atrial contraction, which was at the onset of the P wave on the 
surface ECG (RAp), at maximal atrial contraction (RAa-wave), at AV 
valve closure (RAc-wave), and at AV valve opening (RAv-wave). The 
maximal rate of pressure change during the atrial contraction (RAdP/dt) 
was recorded. The pressure difference generated by right atrial 
contraction was calculated from the following formula: 
 Pressure difference = RAa-wave – RAp  
Statistical analyses 
Statistical analyses for each parameter were done with repeated 
measures analysis of variance (Proc Mixed, SAS v8, SAS Institute 
Inc., SAS Campus Drive, Cary, NC, USA). Time was considered a 
repeated measure, and horse a random effect. An autoregressive 
covariance structure of order 1 was included in the analyses to take 
into account correlations between measurements at different time 
point intervals. A probability of < 0.05 was considered significant.
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RESULTS 
AF model 
In all animals, SR and AF were recognised by the fibrillation 
program. Burst pacing induced paroxysms of AF. The fibrillation 
program successfully maintained AF during 6 months. Burst pacing did 
not elicit any adverse reaction of the animal. 
Electrophysiology (Table 7.1) 
In each animal, threshold for stimulation remained stable 
throughout the study. 
Heart rate at rest recorded during SR showed a slight, significant 
increase at days 5, 10 and 120, while the difference was not significant 
at any other day. Because of the short duration of the AF paroxysms 
during the control period and the recovery phase, ventricular rate 
recorded during AF could not be documented accurately. AF resulted 
in a slight increase in heart rate, but throughout the whole AF period, 
no significant change in rate was recorded.  
SNRT and cSNRT showed no significant changes as a result of AF 
maintenance. The number of atrial depolarisations that followed the 
first captured extrastimulus during AERP determination, did not 
increase significantly due to repeated AF induction. 
At baseline, an adaptation of AERP to pacing rate was observed 
with shorter AERP values at increasing pacing rate (Fig. 7.1). At a 
driving CL of 800 ms (75 bpm) AERP was 281 ± 31 ms while at a CL 
of 333 ms (180 bpm) AERP shortened to 229 ± 20 ms, a difference of 
52 ms.  
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Table 7.1. Mean values for electrophysiologic measurements are given. 
AERP (ms) was measured at different pacing cycle lengths between 1000 
and 333 ms. During every AERP measurement the number of atrial 
depolarisations following the first captured extrastimulus was recorded  
(+: 1 atrial depolarisation; ++: 2 to 5 depolarisations; +++: more than 5 
depolarisations). 
 
  Control values Atrial fibrillation period Recovery 
Day -2 -1 0 5 10 20 30 60 120 180 190 210 
SR 42 46 43 51* 54* 51 48 47 57* 49 46 43 Heart 
rate  
AF NA NA NA 55 63 56 54 56 57 54 NA NA 
SNRT (ms) 1983 1848 1761 1613 1705 1626 1910 1551 1596 1769 1964 1945 
cSNRT 
(ms) 
136 140 126 136 151 138 150 120 150 144 150 140 
1000 ++ +++ ++ + + ++ ++ ++ + ++ ++ + 
800 ++ +++ + +++ ++ ++ ++ + ++ ++ ++ ++ 
600 +++ +++ ++ + ++ ++ ++ ++ ++ ++ ++ ++ 
500 +++ ++ ++ + ++ ++ ++ ++ ++ ++ ++ ++ 
400 ++ +++ ++ ++ + ++ + ++ ++ ++ ++ ++ 
Atrial 
depol  
333 +++ +++ +++ ++  ++ ++ ++ ++ ++ ++ ++ ++ 
1000 284 283 275 250* 240* 238* 236* 225* 233* 229* 275 279 
800 283 281 279 252* 240* 240* 240 227* 231* 227* 275 283 
600 272 273 264 248 236* 240 236 230 228 229 266 270 
500 258 258 258 235* 229* 231 227* 223* 225* 226 258 260 
400 244 244 250 225* 211* 223* 217 219 219 214 242 248 
AERP 
(ms) 
333 233 229 235 211* 203* 197* 203* 203* 207 203* 233 235 
NA: not available; SR: sinus rhythm; AF: atrial fibrillation; (c)SNRT: (corrected) 
sinus node recovery time (ms) 
* indicates significant difference compared to control values with p< 0.05 
Figure 7.1. Mean values for 
the AERP at different pacing 
CL, describing the rate 
adaptation of AERP. 
Measurements of day 0 
(control) and day 180 (AF) are 
displayed. 
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Repeated AF induction resulted in a significant decrease in AERP 
(Fig. 7.2), although a large inter-individual variation existed. From day 
5 onward, the AERP decrease was significant and a plateau was 
reached after about 2 months of AF. The AF-induced decrease in 
AERP was more pronounced at slower pacing rates (-46 ms) than at 
higher pacing rates (-31 ms) (Fig. 7.1). At baseline, the difference 
between the AERP determined at CL of 800 and 333 ms was 52 ms, 
while the difference was 23 ms after 6 months of AF. Subsequently, 
the AERP rate adaptation curve was attenuated. After termination of 
AF at day 180, within 10 days, AERP values returned to baseline and 
the normal rate adaptation of atrial refractoriness recurred. 
AF characteristics 
At baseline, AF paroxysms showed a mean AFCL of 247 ± 36 ms 
(Fig. 7.3). Atrial depolarisations could be clearly identified. Three 
animals presented Type I AF and one animal Type II fibrillation (Fig. 
7.4). As a result of maintained AF, an obvious decrease in AFCL 
occurred. Two months of AF resulted in an AFCL of 170 ± 16 ms and 
after 6 months of AF, AFCL had further shortened to 159 ± 16 ms. 
AFCL was directly proportional to AERP but there was an obvious 
inter-individual variation. Pony 4 showed a slight decrease in AFCL 
although AERP values remained virtually unchanged. Maintained AF 
resulted in a more complex atrial electrogram. Type I AF changed into 
Type II (n=1) or Type III (n=2). Type II AF changed into Type III (n=1) 
(Fig. 7.4). At baseline, AF paroxysms were short (Fig. 7.5) with a 
mean duration of 2 ± 0.5 seconds. Repeated AF induction resulted in a 
progressive increase in AF duration. After 4 months, mean AF duration 
was 57 hours, ranging from 18 minutes (Pony 3) to 9 days (Pony 4). 
Because of maintained fibrillation during 180 days, AF duration ranged 
from 60 minutes (Pony 3) to 12 hours (Pony 1) and became persistent 
in Pony 4, requiring defibrillation. 
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Figure 7.2. Mean AERP 
values (± standard error) at a 
pacing CL of 800 ms  
(* indicates significant 
difference compared to 
control values). 
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Figure 7.3. Mean AFCL (± 
standard error) during the 
study. 
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Figure 7.5. AF duration 
for each animal is 
displayed throughout 
the study. AF was 
maintained from day 0 
to day 180. 
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Echocardiography 
Left ventricle – Aorta (Table 7.2) 
Following maintained AF, left ventricular internal diameter at end-
diastole (LVIDdiast) decreased and internal diameter at end-systole 
(LVIDsyst) increased although both differences were not significant. Left 
ventricular fractional shortening, however, was significantly decreased 
from day 10 onward (Fig. 7.6). Similar results were obtained for left 
ventricular internal area. A non-significant decrease in diastolic area 
and increase in systolic area, and a significant decrease in left 
ventricular area change were observed. Interventricular septal 
thickness during systole decreased significantly, while diastolic septal 
thickness showed no significant changes. Septal fractional wall 
thickening was not significantly decreased. 
No change was observed in the aortic systolic diameter at sino-
tubular junction, determined with the leading-edge to leading-edge 
method as well as with the inner-edge technique. 
Pulsed wave and colour flow Doppler (Table 7.2) 
As a result of experimentally induced atrial fibrillation, spectral 
Doppler recordings from the aortic outflow showed a significant 
decrease in both maximal velocity and velocity time integral from day 
10 onward. Because no change in aortic systolic diameter was 
observed throughout the study, the significant decrease in velocity 
time integral is accompanied by a significant decrease in stroke 
volume (Fig. 7.6). 
No evidence of significant tricuspid or mitral valve dysfunction was 
observed at either baseline or restudy on colour flow Doppler.
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Table 7.2. Echocardiographic measurements of left ventricular internal 
diameter (LVID; cm) and area (LVA; cm) with calculated left ventricular 
fraction shortening, of interventricular septal thickness (IVS; cm) and of aortic 
diameter (cm) and flow. 
  Control values Atrial fibrillation period Recovery 
Day -2 -1 0 10 30 60 120 180 190 210 240 
diast 8,4 8,5 8,4 8,2 8,3 8,3 8,3 8,1 8,4 8,3 8,3 
syst 5,5 5,5 5,6 5,7 5,9 6,1 5,9 5,7 5,9 5,5 5,5 
LVID 
B-mode 
FS 34,3 34,7 33,7 31,0 28,1 26,9 29,4 29,4 30,9 33,5 33,5 
diast 8,2 8,3 8,3 8,2 8,1 8,2 8,3 8,2 8,3 8,3 8,4 
syst 5,5 5,6 5,6 5,8 5,9 6,0 5,9 5,8 5,6 5,7 5,5 LVID M-mode 
FS 32,8 32,5 32,6 28,4 27,6 27,5 28,8 28,8 32,0 32,3 33,8 
diast 2,5 2,3 2,3 2,3 2,3 2,2 2,2 2,3 2,3 2,4 2,4 
syst 3,2 3,2 3,2 3,1 2,9 3,0 3,0 3,0 3,0 3,1 3,2 
IVS 
B-mode 
FWT 23,8 29,2 28,8 25,6 21,5 24,2 24,7 24,6 23,3 24,1 25,1 
diast 2,6 2,5 2,4 2,4 2,4 2,4 2,3 2,3 2,4 2,5 2,4 
syst 3,4 3,3 3,2 3,0 3,0 3,0 3,0 3,0 3,2 3,3 3,3 IVS M-mode 
FWT 23,9 23,3 24,4 20,6 20,5 19,8 22,1 22,1 25,5 23,5 25,8 
diast 39,2 41,1 39,1 41,0 40,8 40,0 39,6 36,3 38,2 37,4 38,1 
syst 15,7 16,1 16,1 17,4 19,1 19,6 19,1 17,5 17,0 15,1 15,4 
LVA 
B-mode 
FAC 60,4 60,3 58,4 58,1 53,1 51,5 51,7 52,5 55,5 59,5 59,4 
LELE 6,0 6,0 6,0 6,0 6,0 6,0 6,1 6,0 6,0 6,1 6,0 Aorta 
B-mode IE 5,3 5,3 5,3 5,3 5,3 5,3 5,4 5,3 5,4 5,4 5,4 
Vmax 0,9 0,9 0,9 0,8 0,8 0,8 0,8 0,8 0,8 0,9 0,9 Aorta 
Doppler VTI 25,4 25,2 25,0 22,2 22,0 20,3 20,9 20,1 23,6 25,3 25,2 
FS: fractional shortening (%); FWT: fractional wall thickening (%); FAC: fractional 
area change (%); LELE: leading-edge to leading-edge technique (cm); IE: inner 
edge technique (cm); Vmax: maximal flow velocity (m/s); VTI: velocity time integral 
(cm) 
(bold, underlined values differ significantly from baseline p<0.05) 
Figure 7.6. Left 
ventricular fractional 
shortening (FS) and 
stroke volume (SV) 
are displayed. AF was 
maintained between 
day 0 and day180 
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Left atrium (Table 7.3) 
Left atrial diameters were determined during atrial pacing at both 
60 and 75 bpm. Due to the shorter diastolic time at a rate of 75 bpm, 
the rapid ventricular filling phase in early diastole was immediately 
followed by an atrial contraction. As both events occurred as a single 
smooth movement and could not clearly be distinguished, left atrial 
diameter before initiation of atrial contraction (LADp) could not be 
determined accurately at 75 bpm and was only measured during atrial 
pacing at 60 bpm. Consequently, left atrial shortening fraction was only 
calculated for the latter rate. 
Left atrial diameters obtained at different time points during the 
cardiac cycle, measured from the left parasternal as well as from the 
right parasternal views, at a rate of 60 as well as 75 bpm, showed a 
significant increase in diameter from day 10 or day 30 onward. Figure 
7.7 shows different atrial diameters obtained from a left parasternal 
view at a pacing rate of 60 bpm. At baseline, left atrial diameter at the 
onset of atrial contraction (LADp), at the end of ventricular diastole 
(LADdiast) and at the end of ventricular systole (LADsyst) was 7.8 ± 0.47, 
7.5 ± 0.36 and 8.9 ± 0.51 cm, respectively. After 6 months of 
maintained AF, diameters had increased to 8.6 ± 0.38, 8.9 ± 0.23, and 
9.6 ± 0.50 cm, respectively, which means an increase of 0.8, 1.4 and 
0.7 cm. The most obvious increase in diameter occurred for left atrial 
diameter during atrial contraction (LADa). At baseline this diameter 
was 6.7 ± 0.35 cm while at the end of the AF period it was 8.7 ± 0.39 
cm, an increase of 2.0 cm. During the control period, atrial contraction 
was able to decrease atrial diameter by 1.1 cm, representing a left 
atrial shortening fraction of 13.4 ± 3.2 % (Fig. 7.8). Ten days of AF 
were already sufficient to result in a significantly decreased atrial 
inotropy. Because of long-term AF, atrial contraction no longer resulted 
in a decrease in atrial diameter. Atrial shortening fraction became 
negative (-0.9 ± 1 %) indicating that a slight increase in atrial diameter 
occurred even though the atrium was contracting maximally.
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Table 7.3. At an atrial pacing rate of 75 bpm and 60 bpm, mean left atrial 
diameters (LAD; cm), measured at the end of ventricular diastole (diast) and 
systole (syst), immediately before the onset of atrial contraction (p) and at 
maximal atrial contraction (a), were recorded and atrial shortening fraction 
(FS; %) was calculated. 
  Control values Atrial fibrillation period Recovery 
Day -2 -1 0 10 30 60 120 180 190 210 240 
ATRIAL PACING RATE 75 BPM 
diast 6,4 6,2 6,6 6,7* 6,9* 6,9 7,0 7,2* 6,8 6,7 6,4 
syst 7,7 7,6 7,7 8,0* 8,0* 8,1* 8,3* 8,3* 7,8* 7,8 7,6 
LAD 
Right 
view 
a 5,6 5,5 5,7 6,1 6,6* 6,7* 6,6 7,2* 6,1 5,9 5,6 
diast 7,6 7,5 7,6 8,0* 8,1* 8,2* 8,3* 8,5* 8,2* 8,0 7,5 
syst 9,0 9,0 9,0 9,2* 9,2* 9,3* 9,2 9,4 9,1 9,0 8,9 LAD Left view 
a 6,7 6,8 6,7 7,5* 7,8* 7,9* 7,9* 8,3* 7,4* 7,2* 6,7 
ATRIAL PACING RATE 60 BPM 
diast 6,5 6,5 6,5 7,1* 7,2* 7,4* 7,5* 7,6* 7,0 6,8 6,5 
syst 7,8 7,9 7,9 8,2* 8,3* 8,4* 8,3* 8,6* 8,3 8,2 8,0 
p 6,4 6,3 6,4 6,7* 6,8* 6,8* 6,8* 7,1* 6,9* 6,7 6,5 
a 5,3 5,3 5,3 6,6* 6,6* 6,8* 6,8* 7,1* 6,2* 5,8 5,5 
LAD 
Right 
view 
FS 16,5 16,3 16,5 2,1* 2,1* 1,1* -0,1* -0,5* 10,5* 13* 15,6 
diast 7,4 7,7 7,5 8,5* 8,6* 8,6* 8,6* 8,9* 8,4* 8,0* 7,7 
syst 8,9 8,9 8,9 9,3* 9,3* 9,3 9,5* 9,6* 9,4 9,0 8,9 
p 7,8 7,8 7,8 8,0 8,1 8,2 7,9 8,6* 8,2 7,9 7,8 
a 6,7 6,7 6,7 8,0* 8,1* 8,2* 8,0* 8,7* 7,4* 7,1* 6,7 
LAD 
Left view 
FS 13,5 13,0 13,8 0,4* 0,6* 0,3* -0,5* -0,9* 9,4* 10,3* 13,6 
(* indicates statistically significant difference compared to control values p< 0.05) 
Figure 7.8. Left atrial 
shortening fraction (± 
standard error), obtained 
from a left view, is 
displayed in function of 
time. 
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Figure 7.7. Left atrial 
diameters obtained from a 
left parasternal view, at a 
pacing rate of 60. Left atrial 
diameter during atrial 
contraction (LADa) shows 
the largest increase in 
diameter. 
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After termination of fibrillation, atrial diameters and left atrial shortening 
fraction gradually returned to normal values after 1 to 2 months of SR. 
Invasive blood pressure monitoring 
Right ventricle (Table 7.4) 
During the induced fibrillation period, right ventricular pressure 
during atrial contraction (RVa), at end-diastole (RVdiast) and peak 
systolic pressure (RVsyst) showed a decrease at day 30 but was not 
significantly altered at day 180. Right ventricular maximal dP/dt was 
significantly decreased at day 180. 
Right atrium (Table 7.4) 
As a result of AF, right atrial pressure prior to atrial contraction 
(RAp), at the c-wave (RAc-wave) and at the v-wave (RAv-wave) showed an 
increased pressure although the increase did not reach significance. 
AF resulted in a significant decrease in the atrial pressure during atrial 
contraction (RAa-wave) and in the maximal dP/dt during atrial contraction 
(RAdP/dt). Calculation of the pressure difference produced by atrial 
contraction showed a significant decrease during the AF period.  
AF duration 
Although an increase in AF duration was associated with shorter 
AERP values, AERP had to drop below a critical value of about 258 
ms before AF paroxysms could persist for more than an hour (Fig. 
7.9). Above this value, shortening of AERP was not associated with an 
increase in AF duration. Yet, below an AERP of 258 ms, association 
between AERP and AF duration remained rather poor. 
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 Table 7.4. Right atrial and right ventricular pressure recordings (mm Hg) and 
dP/dt (mm Hg/s), measured during regular atrial pacing at 75 bpm.  
  Control AF period Recovery 
Day 0 30 180 210 240 
a 14,7 10,3* 14,7 12,6 15,2 
diast 13,7 10,0* 14,9 11,7 13,7 
syst 47,6 43,0* 45,8 45,5 46,2 
Right 
ventricle 
dP/dt 544 485 410* 527 522 
p 5,0 5,4 5,5 4,7 5,5 
a-wave 8,2 5,5* 5,5* 7,4 8,8 
c-wave 4,6 5,2 6,6 3,2 4,1 
v-wave 4,9 5,3 6,6 4,0 4,1 
pressure 
difference 
3,2 0,1* 0,0* 2,7 3,3 
Right 
atrium 
dP/dt 57,6 36,4* 26,3* 75,5 73,4 
a: measurement during atrial contraction; p: measurement at the onset of 
the P wave 
(*: significantly different from control value p< 0.05) 
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Pony 4 hardly showed any change in AERP although this was the 
animal with the longest AF duration, requiring defibrillation. In pony 2, 
longest AF paroxysms were not associated with shortest AERP 
values. 
Figure 7.10 compares AF duration and AFCL. As long as AFCL 
was longer than 215 ms, AFCL and AF duration were not associated 
and AF paroxysms remained short. Once AFCL further decreased 
below 215 ms as a result of repeated AF induction, a decrease of 
AFCL was associated with an increase in AF duration, and paroxysms 
of more than an hour could be induced. Sustained AF was only seen in 
pony 4 at an AFCL of 182 ms. In this animal AF became persistent at 
an AFCL of 153. Although in pony 3 AFCL shortens below 158 ms, 
paroxysms in this animal were short. 
The animals’ height and atrial size importantly influenced AF 
duration. Largest animals, showing the largest left atrial diameter at 
baseline, reached the longest AF duration during the study. In Figure 
7.11, for each animal, left atrial diameter at the onset of atrial 
contraction (LADp) obtained from a left view, is shown from baseline 
until day 180. An atrial diameter of less than 8.2 cm was associated 
with short paroxysms of AF (< 60 min). When atrial diameter 
exceeded this critical value as a result of maintained AF, atrial 
diameter was related to AF duration. Pony 3, with the smallest left 
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Figure 7.11. Comparison 
of AF duration and left 
atrial diameter (left view) 
measured at the onset of 
the P wave, during atrial 
pacing at a rate of 60 
bpm. 
CHAPTER 7: Results 
  185 
atrial diameter throughout the study, showed the shortest AF 
paroxysms. In pony 4, with the largest atrial size at the end of the 
fibrillation period, SR did not restore spontaneously and in this animal 
defibrillation was required. 
Recovery phase 
As described above, all variables from electrophysiology, 
echocardiography and blood pressure returned towards normal within 
2 months after restoration of SR. While electrophysiological values 
returned to normal within 10 days, atrial size and atrial contractile 
function gradually normalized over 1 to 2 months of time. AF duration 
decreased abruptly to less than a minute within 10 days after 
restoration of SR, although at that time atrial dilatation was still present 
(Fig. 7.12). 
 
Figure 7.12. Comparison of mean AF cycle length (AFCL), left 
atrial diameter (left view, pacing rate 60 bpm) and AF duration 
during the recovery phase. Ten days after cardioversion, AF 
duration is less than a minute although left atrial diameter has only 
slightly decreased. (Exact values for AF duration are not displayed 
because of the individual variation.) 
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DISCUSSION 
In the present study AF was maintained during 6 months in healthy 
ponies by applying burst pacing. AF resulted in a fast decrease in 
AERP and AERP rate-adaptation. Consequently, AFCL shortened and 
the atrial electrogram became more complex. A fast loss of atrial 
contractile function was observed, which resulted in an increased atrial 
pressure and a decreased ventricular function. Subsequently, a slow 
increase in atrial size occurred. As a result of these AF-induced 
electrophysiological and morphological alterations a progressive 
increase in AF duration was seen during the 6-month AF period. After 
restoration of sinus rhythm, all variables returned to normal. 
Electrophysiological changes and AF duration showed a short time 
course for normalization, while echocardiographic values needed 1 to 
2 months to recover.  
Study protocol 
This model proved to be efficient to induce and maintain long-term 
atrial fibrillation in healthy ponies. Implantation of a pacemaker allowed 
to perform programmed electrical stimulation in order to study atrial 
electrophysiologic characteristics. Type and rate of fibrillation could be 
determined from atrial electrogram recordings. Because the model 
required a minimally invasive implantation technique, reliable blood 
pressure recordings and echocardiographic studies could be carried 
out. 
Horses with naturally occurring AF mostly are presented with 
subacute or chronic AF. Therefore, to mimic more closely the natural 
state of the disease, we developed an equine model in which AF was 
maintained over a prolonged period of time by permanent implantation 
of an electrical pulse generator.  
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Many AF studies have been performed during anaesthesia, in 
opened-chest animals or in animals with induced pericarditis and 
these conditions are likely to have an important impact on cardiac 
function. A major advantage of the closed-chest pony model was that 
invasive surgery was avoided, thereby preserving normal cardiac 
function and allowing reliable blood pressure measurements and 
cardiac ultrasound to be performed. During the whole study, all 
measurements were performed in the conscious, unsedated animal, 
thereby avoiding any drug-related interference. 
It is known that AF is favoured by underlying cardiac pathology. 
Valvular insufficiency might cause atrial stretch and atrial dilatation 
leading to increased susceptibility and perpetuation of AF (Morillo et 
al., 1995; Allessie, 1998; Power et al., 1998). Local disorders of the 
myocardium, such as fibrosis, are known promoters of AF (Allessie et 
al., 2001). In humans, increasing age is strongly associated with an 
increased risk for atrial fibrillation. A survey in horses also 
demonstrated increased incidence of AF in aged animals (Else and 
Holmes, 1971). However, in many horses it is suggested that lone 
atrial fibrillation is present because cardiac ultrasound reveals no 
abnormalities or because the animals respond well to quinidine 
treatment and because they return to their previous level of exercise. It 
should be mentioned, however, that response to treatment and 
regaining athletic ability after cardioversion of AF not necessarily 
indicates absence of underlying cardiac pathology. Moreover, our 
present diagnostic facilities might be insufficient to detect distinct atrial 
pathology. 
The purpose of our research was to study lone AF in equines. 
Therefore, young and healthy animals were selected. These animals 
did not show any abnormalities on cardiologic examinations and were 
considered to be free of myocardial lesions. Subsequently, by artificial 
induction and long-term maintenance of AF in healthy subjects, any 
observed changes would be induced, simply and solely by the 
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arrhythmia, and would not be confounded by any other cardiac 
pathology. 
Although AF rarely occurs in ponies and is predominantly seen in 
mature horses (Else and Holmes, 1971; Bertone and Wingfield, 1987; 
Detweiler, 1989), we used ponies in our study. In a previous report we 
demonstrated that sustained AF could be successfully induced in the 
pony heart (van Loon et al., 2000). We suggested that spontaneous 
restoration of SR after long-term AF maintenance would occur more 
easily in ponies than in horses, which would be advantageous because 
during the 6-month AF period, spontaneous restoration of SR was 
required to perform measurements. Besides, during preliminary 
research we validated non-invasive echocardiographic cardiac output 
determination using the well-documented thermodilution technique 
(Blissitt et al., 1997), which could be performed more easily in smaller 
sized animals (unpublished data). 
AF is characterised by an irregularly irregular ventricular rate. As 
differences in diastolic times result in different preload and afterload 
conditions, important alterations in cardiac function occur, and 
confusing results might be found during AF (Leistad et al., 1993a; 
Leistad et al., 1993b; Hardman et al., 1998). In the present study, 
echocardiography and blood pressure recordings were performed after 
spontaneous reversion of sinus rhythm, and during regular atrial 
pacing. Subsequently, confounding effects of ventricular arrhythmia or 
changes in heart rate that might occur during the study were 
eliminated. The reason why a pacing rate of 75 bpm was chosen to 
perform blood pressure measurement and cardiac ultrasound was that 
some animals showed a SR of about 60 bpm during the study. To be 
sure that consistent atrial pacing occurred at any time, a rate of 75 
bpm was chosen to perform ultrasound and blood pressure 
measurements. However, at this rate, rapid ventricular filling phase in 
early diastole and atrial contraction were not clearly distinguishable. 
Consequently, left atrial diameter before initiation of atrial contraction 
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(LADp) could not be determined accurately at 75 bpm, which made 
calculation of left atrial shortening fraction impossible. Additional left 
atrial measurements were therefore performed at a pacing rate of 60 
bpm. 
In other animal models, induction of AF is often associated with an 
important increase in ventricular rate. When subsequently, alterations 
in electrophysiological properties, or in atrial or ventricular structure 
and function, are found, these might be biased by the ventricular rate 
or by ventricular tachycardiomyopathy. In the present study, heart rate 
during AF was only slightly higher than during SR and was unlikely to 
affect experimental results. 
Electrophysiologic changes induced by AF 
In animals, contrasting results about the effect of AF on sinus node 
function have been reported. While in the isolated rabbit heart, during 
atrial fibrillation, sinus automaticity was still present in the centre of the 
sinus node and hardly overdrive suppressed due to a high degree of 
sinoatrial entrance block (Kirchhof and Allessie, 1992), in dogs, 2 to 6 
weeks of maintained AF caused an impaired sinus node function 
(Elvan et al., 1996), confirmed by a prolongation of cSNRT. Also in 
humans, chronic AF can be associated with a depressed sinus node 
function (Manios et al., 2001). In our ponies, no significant changes in 
SNRT or cSNRT could be demonstrated after 6 months of AF. This 
could be partly explained by the technique for SNRT measurement in 
the present study. While in human medicine it is generally accepted 
that SNRT should be determined with an electrode that is positioned 
near to the sinus node (Fogoros, 1995), the exact position of the 
implanted atrial electrode in relation to the sinus node was not known. 
Electrode position too far away from the sinus node might have 
influenced our results. However, in each animal the permanently 
implanted electrode remained in the same position during the whole 
study, suggesting that alterations in sinus node function during the 
study still might be detected. To the best of our knowledge, information 
Effect of experimental chronic atrial fibrillation in equines 
190 
about SNRT determination in horses is not available in literature. It 
could be that, because measurements were performed in the 
conscious ponies, changes in autonomic tone occurred during these 
measurements, confounding the results. Determination of SNRT after 
autonomic blockade with propranolol and atropine might have provided 
more conclusive results. 
As a result of prolonged pacing-induced AF, the previously normal 
atrium now maintained longer paroxysms of AF. The increased AF 
duration might be explained, at least in part, by the shortening in 
AERP. Because the length of a reentry wavelet is defined as the 
product of AERP and conduction velocity, AERP shortening resulted in 
a shortening of the wavelength. According to Moe’s multiple wavelet 
hypothesis (Moe, 1962), a long wavelet may not permit reentry to 
sustain, causing fibrillation to terminate, whereas a short wavelength 
allows multiple wavelets to coexist in the atria, thereby favouring AF 
persistence. Although atrial conduction velocity could not be measured 
in this study, it presumably remained similar or even decreased as a 
result of AF, as it was shown in other species (Morillo et al., 1995; 
Wijffels et al., 1995; Elvan et al., 1996). 
It has been reported that in human patients a poor or absent rate 
adaptation of the AERP might be the cause of AF (Attuel et al., 1982; 
Boutjdir et al., 1986). Normal ponies used in the present study showed 
an adaptation of AERP to rate, which was attenuated by pacing-
induced AF. After cardioversion to SR the normal adaptation to 
changes in heart rate was restored within 10 days. The present 
observations thus suggest that maladaptation of AERP is rather the 
result of AF than the cause of it. 
Repeated AF induction resulted in a faster rate of fibrillation as 
evidenced by the decreased AFCL. Previous studies have 
demonstrated a high correlation between local fibrillation interval and 
refractory period (Wijffels et al., 1995). In that case AFCL could be 
used as an index for AERP estimation. Such an index would be 
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advantageous as it could be applied during AF and make restoration 
of SR during the study redundant. However, median fibrillation interval 
is not equal to local refractory period as during AF a small excitable 
gap is still present (Allessie et al., 1991; Kirchhof et al., 1993; 
Duytschaever et al., 2001).  
AF-induced changes in atrial size and function 
In our study, atrial diameters were measured rather close to the 
mitral valve annulus because apical views cannot be obtained in 
horses. Measurements of atrial area obtained from apical views more 
closely reflect true atrial size and might provide a higher sensitivity in 
exposing subtle changes in atrial dimension. However, in our study a 
significant gradual increase in atrial size could be demonstrated as a 
result of atrial fibrillation. It should be emphasized that we did not 
perform echocardiography during a fibrillating rhythm but during 
regular atrial pacing. Measurements of atrial size during AF are not 
only confounded by the irregular ventricular rate but also by decreased 
atrial compliance that reduces atrial diameter (White et al., 1982; 
Leistad et al., 1993a). The decreased compliance during AF is caused 
by the unsynchronised, continuous muscle fibre contractions, by 
higher intracellular calcium concentrations in atrial fibres during the 
noncontracting phase, or by a greater myocardial turgor due to an 
increase in atrial blood flow during fibrillation (Leistad et al., 1993a). 
The AF-induced increase in atrial size was suggested to be partly 
caused by an increase in atrial pressure (Oldham et al., 1967; White et 
al., 1982; Leistad et al., 1993a). In the present study, increase in atrial 
pressure did not reach statistical significance. The reason why atrial 
diameters changed significantly while pressure differences were less 
obvious, could be the limited number of animals, but could also be 
explained by the fact that pressures were measured in the right atrium 
while diameters were measured in the left atrium. It has been shown in 
other animals that AF-induced changes in pressure and size are less 
pronounced in the right heart compared to the left heart (White et al., 
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1982; Leistad et al., 1993a). In our study, pressures were measured in 
the right heart because left atrial catheterisation using a high-fidelity 
catheter is technically more difficult in horses, and echocardiographic 
variables were determined for the left heart because reliable 
echocardiographic landmarks for the right heart are lacking. 
As a result of maintained AF, atrial pressure during maximal atrial 
contraction, the a-wave, was decreased. Although this could suggest a 
decreased atrial contractility, a-wave was also influenced by pre- and 
afterload conditions, and did not reflect atrial contractile function. 
Therefore, in addition, atrial pressure immediately before the onset of 
atrial contraction was measured, which allowed calculating the 
pressure difference generated by atrial contraction. This generated 
pressure difference was completely abolished by pacing-induced AF, 
indicating that, even during the short restoration of SR, atrial 
contractility was almost completely lost. As right atrial a-wave nearly 
disappeared on the atrial pressure tracings, right atrial maximal dP/dt 
during atrial contraction was significantly depressed. However, it 
should be emphasized that maximal dP/dt in the right atrium only 
indicates the pressure rise generated by atrial contraction and does 
not provide a true reflection of atrial inotropic state, as the latter only 
applies for measurements performed during the isovolumetric phase 
of the contraction (Van den Bos et al., 1973; Brown and Holmes, 
1978), a condition that was not full-filled in the atrium. 
Left atrial contractions are difficult to visualize on echocardiography 
(Wingfield et al., 1980) and M-mode analysis of mitral valve movement 
has been used as an attractive alternative in visualising the effects of 
AF in horses. However, mitral valve movement is highly affected by 
atrial and ventricular loading conditions and thus poorly reflects atrial 
inotropic state. To the best of our knowledge, real estimation of atrial 
contractility in equines has not been reported in literature. In equine 
literature, ultrasonographic estimation of atrial size is generally 
performed at the end of ventricular diastole and systole, but does not 
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allow evaluation of atrial contractile function. In the present study, we 
introduced additional left atrial measurements at different timings 
during the cardiac cycle to estimate atrial contractility. By determining 
atrial diameter immediately prior to atrial contraction and again during 
maximal atrial contraction, shortening fraction of the left atrium was 
calculated by adapting the well-documented formula for left ventricular 
shortening fraction (Feigenbaum, 1986). The index proved to be 
sensitive in detecting changes in atrial inotropic state non-invasively. 
Ten days of AF already reduced left atrial shortening fraction from 
16.5% at baseline to 2.1%. After 6 months of AF a nadir of –0.5% was 
reached. The negative value of atrial fractional shortening indicates 
that passive atrial filling resulted in an increase in atrial diameter, even 
though the atrium was contracting maximally. 
Effect of AF on the ventricle 
Similar remarks as for the atria can be given concerning pressure 
measurement performed in the right ventricle and ultrasound 
completed on the left ventricle. 
A decreased diastolic ventricular diameter and area indicated an 
incomplete left ventricular filling caused by a loss of atrial contraction. 
By the Frank-Starling mechanism, the decreased ventricular preload 
resulted in a reduced inotropy, which was evidenced by the increased 
systolic diameter and area, and concomitant decreased fractional 
shortening and fractional area change, and also the reduced right 
ventricular maximal dP/dt. The depressed ventricular performance 
subsequently resulted in a lower ventricular peak pressure and a 
reduced aortic flow velocity. The final result was an obvious decrease 
in stroke volume and thus cardiac output. An AF episode as short as 
10 days was already sufficient to result in a significantly reduced 
ventricular performance. As ventricular rate during pacing-induced 
fibrillation was not markedly increased during our study, occurrence of 
ventricular tachycardiomyopathy could be prevented and reduced 
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ventricular function was predominantly attributed to the decreased 
preload. 
Other studies in equines described contradictory results concerning 
cardiac output. Muir et al. (1984) reported normal cardiac output 
values measured during AF in 7 horses with naturally occurring AF, 
provided that they didn’t show signs of congestive heart failure. In 4 of 
these horses, cardiac output was again measured after restoration of 
sinus rhythm. After cardioversion an increase in output was observed 
in one animal, while no changes were detected in the remaining 3 
horses. However, in none of these horses the duration of fibrillation 
was known. Furthermore, it remained unclear to what extent quinidine 
treatment, influenced hemodynamic results. In 1975, Kubo et al. 
investigated the effect of experimentally induced short-term AF 
paroxysms on cardiac output in 7 healthy horses. Compared to SR, 
they found increases as well as decreases in cardiac output after 
experimental AF induction. On the average, cardiac output increased 
by 12%, which turned out to be not significant. However, a significant 
increase in heart rate of 43% was observed, resulting in a significant 
decrease in stroke volume (22%). It should be stressed that in both 
above-mentioned reports measurements were performed during AF. 
Consequently, hemodynamic alterations are the result of multiple 
factors such as reduced atrial compliance during AF, AF-induced 
depressed atrial contractility, irregular ventricular rhythm and different 
ventricular rate.  
Reversibility of AF-induced changes 
Although AF resulted in important changes in atrial 
electrophysiology, size and function, all these changes appeared to be 
reversible within 2 months after restoration of sinus rhythm. A short 
time-course was observed for the electrophysiologic changes, 
normalizing within 10 days after cardioversion. Atrial size and 
contractility, and concomitant left ventricular function, needed 1 to 2 
months to recover after the 6 month AF period. These results are in 
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agreement with the findings of Allessie (1998) who suggested that 
metabolic changes, such as differences in ion concentrations or in ion 
pump activities, occurred and disappeared within seconds to minutes, 
while changes in electrical remodeling needed hours or days. Many 
studies reported a postfibrillatory atrial contractile dysfunction, 
requiring weeks to months to recover (Jordaens et al., 1993; Van 
Gelder et al., 1993; Manning et al., 1994; Allessie, 1998; Schotten et 
al., 2001). Cellular mechanisms responsible for AF-induced contractile 
dysfunction are still poorly understood. Alterations in atrial cellular 
ultrastructure and a reduction in L-type Ca2+ current have been 
suggested as plausible mechanisms (Ausma et al., 1997; Yue et al., 
1997; Bosch et al., 1999; Van Wagoner et al., 1999; Schotten et al., 
2001). 
What can we conclude about AF duration? 
Immediately after induction of AF, the AFCL started to shorten. 
Initially, the decrease in AFCL was not accompanied by an increase in 
AF duration. Only when AFCL had shortened to a critical value, AF 
duration started to increase. Similarly, only after an increase in atrial 
size above a critical value, AF paroxysms progressively increased. 
These findings are in agreement with the multiple wavelet hypothesis 
(Moe, 1962). Because of the shorter atrial refractoriness, and 
concomitant shorter wavelength and fibrillation CL, and because of the 
increase in atrial diameter, a larger number of wavelets wander around 
in the atria, decreasing the statistical probability of simultaneous 
extinction and favouring AF perpetuation. In the isolated Langendorff-
perfused canine hearts, the critical number of wandering wavelets for 
perpetuation of fibrillation was between 3 and 6 (Allessie et al., 1985). 
The lifetime of individual wavelets was very short, about a few hundred 
milliseconds. Continuously, ‘old’ wavelets extinguished by fusion or 
collision with another wavelet, by reaching the border of the atrium, 
and because the advancing depolarisation wave met an area where 
the myocardium had not recovered its excitability from a foregoing 
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activation. At the same time new wavelets were formed by division of 
an existing wave at an area of conduction block, an offspring 
traversing toward the other atrium, and possible sources of impulse 
formation. The approximate number of atrial wavelets during AF can 
be determined during mapping studies or can be estimated when 
conduction velocity, refractory period and atrial size are known. 
However, studies in dogs have shown a spatial dispersion and 
temporal inhomogeneity in AERP and, in addition, conduction velocity 
during AF was shown to vary from 20 to 139 cm per second in the 
same animal, resulting in a continuously changing wavelength and a 
varying number of wavelets (Allessie et al., 1994).  
Both a decrease in AFCL and an increase in atrial diameter 
appeared to be required in order for AF to become sustained. In dogs, 
a minimal reduction of 15% in AERP associated with an increase of at 
least 40% in atrial area was highly predictive of sustained AF (Morillo 
et al., 1995). This also explains the abrupt reduction in AF duration 
during the recovery period: although after restoration of SR, initially, 
atrial diameter had barely changed, the fast occurring increase in 
AERP and AFCL toward normal values, prevented AF to perpetuate. 
With these findings we can explain why naturally occurring AF is never 
seen in ponies: their atrial electrophysiological properties and their 
atrial size simply prevent sufficient wavelets to coexist in the atria. 
Surprisingly, after pacing-induced electrical and morphological 
remodeling, long-term AF could be induced in ponies. 
Clinical implications 
In equine medicine it is believed that AF often is present as ‘lone’ 
AF, i.e. without overt underlying heart disease. However, very little 
information is available on the initiation of AF, and what AF actually 
does in a healthy animal. The present model demonstrated the 
feasibility of developing a reproducible model of long-term AF in 
healthy equines to expand our understanding of the mechanisms 
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leading to AF. In the future, this model will facilitate the development of 
different therapeutic modalities in horses. 
In the present study adapted left atrial measurements were 
introduced in order to establish atrial contractile function non-
invasively. Such an index could be applied to reveal atrial disease in 
equines. Especially after cardioversion of AF, calculation of atrial 
shortening fraction is useful to assess restoration of atrial contractile 
function. 
The results of this study indicate that, after initiation of atrial 
fibrillation, changes in electrophysiological parameters develop fast to 
reach a plateau, and that they return quickly to normal after restoration 
of SR. Dilatation of the left atrium appears slower and continues to 
progress over a longer period of time, normalizing again about 2 
months after cardioversion. Therefore, it is suggested that after 
successful treatment of chronic atrial fibrillation, training should only be 
resumed after a period of about 1 to 2 months, i.e. after restitution of 
atrial electrophysiologic characteristics, atrial contractile function and 
atrial diameter. As atrial diameter seems to be an important predictor, 
not only for AF stability but also for successful restoration of SR and 
for the risk of AF recurrence, the atrial diameter is often determined 
prior to initiation of AF therapy, where horses with a dilated left atrium 
are given an unfavourable prognosis. As in the present study, AF-
induced atrial dilatation occurred in normal individuals, this parameter 
should be interpreted cautiously in chronic fibrillating animals without 
valvular disease. A long-term follow-up of animals with a normal left 
atrial diameter and recent onset lone AF should be performed to 
provide more information about changes in left atrial diameter in 
horses with naturally occurring AF. Furthermore, little information is 
currently available about the correlation between left atrial diameters 
measured during SR and during AF. The present model could be 
applied to study this relationship. 
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At present, little is known about the effect of high-level performance 
on the inducibility or persistence of AF. During high performance, 
cardiac load may be higher and this might affect atrial pressure, 
diameter and stretch, which might be important factors explaining AF 
susceptibility (Leistad et al., 1993a; Morillo et al., 1995; Sideris et al., 
1995). The time-course of the occurrence of electrophysiologic, 
pressure or echocardiographic alterations might therefore differ in 
horses that remain in training.  
As mostly seen in lone AF horses, AF-induced tachycardia at rest 
did not develop during the present study. The high vagal tone in 
equines results in a high degree of concealed conduction at the AV 
node. This confirms that in horses with lone atrial fibrillation rate 
control is not required and only rhythm control has to be considered. 
In humans, AF is associated with an increased risk of systemic 
thromboembolic complications, particularly strokes, although it has 
been reported that the risk would not be increased in patients with lone 
AF (Kopecky et al., 1987; Elvan et al., 1999). In the present study, 
during echocardiographic examinations special attention was paid to 
the presence of atrial thrombi, but none could be identified. Also in 
clinical cases thromboembolic events are not reported and seem to be 
negligible in horses, making anticoagulation therapy redundant. 
In human medicine, antiarrhythmic therapy is generally continued 
after restoration of SR to prevent early recurrence of AF. One of the 
possible explanations for the high incidence of early recurrence of AF 
could be the inversed rate adaptation curve of the AERP that can 
occur. When inversed rate adaptation is present, restoration of SR 
implies a decreased atrial rate and thus a shortening of the refractory 
period instead of an increase. The shorter refractory period again 
favours AF occurrence. As a reversed rate adaptation was not seen 
during our study, this might be a contributing factor for the low 
incidence of early AF recurrence seen in equines and might therefore 
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suggest that antiarrhythmic therapy after successful restoration of SR 
is not required in this species. 
Limitations of the study 
In the present study only 4 animals were implanted and followed 
during the 6-month AF period. Due to the limited number of animals, 
the results and statistical analyses must be interpreted cautiously. 
However, most variables altered similarly in all animals, suggesting 
that valuable conclusions could be drawn. 
Pacemaker output was set at 2 times diastolic threshold. In some 
studies, a stimulation output of 4 times threshold was used, yielding a 
more aggressive pacing protocol for AF induction. Furthermore, during 
our study, SR detection appeared during 3 to 4 consecutive sinus 
beats. As the resting sinus cycle length in the ponies was about 1200 
to 1500 ms, each SR episode persisted for about 4 to 6 seconds 
before AF was re-induced. As electrical reversed remodeling appeared 
fast, this short period of SR detection might have influenced induction 
and perpetuation of AF. Measurements of electrical parameters, 
echocardiography and blood pressures were performed after 
spontaneous reversion of SR. These periods of SR also might have 
influenced the experimental results. 
One atrial electrode was used for determination of 
electrophysiologic properties. It is known that, at a certain point in time, 
AERP and AFCL vary among the location in the atrium (spatial 
dispersion). In addition, a local area may show different AERP and 
AFCL values in time (temporal dispersion). Therefore, multiple 
electrodes are desirable to make detailed electrophysiological 
measurements. However, a continuing problem exists with chronic AF 
models in achieving a balance between the area from which 
information is gathered by electrode implantation and any effects of 
the implantation per se, which may be related to the epicardial area in 
contact with the electrodes (Power et al., 1998). 
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From this study we can conclude that, in healthy equines, AF 
induces changes in electrophysiological properties that lead to AF 
perpetuations. Furthermore, six months of maintained AF results in 
atrial dilatation and atrial contractile dysfunction, which needs 1 to 2 
months to recover after cardioversion. All AF-induced changes were 
fully reversible. 
 
Acknowledgements 
The authors wish to thank Prof. M. A. Allessie from the university 
Maastricht for his advise. The Special Research Fund, Ghent 
University, is acknowledged for the financial support.
CHAPTER 7: References 
  201 
REFERENCES 
Allessie, M., Kirchhof, C., Scheffer, G.J., Chorro, F. & Brugada, J. 
(1991). Regional control of atrial fibrillation by rapid pacing in 
conscious dogs. Circulation 84, 1689-1697. 
Allessie, M.A. (1998). Atrial electrophysiologic remodeling: another 
vicious circle? J Cardiovasc Electrophysiol 9, 1378-1393. 
Allessie, M.A., Boyden, P.A., Camm, A.J., Kleber, A.G., Lab, M.J., 
Legato, M.J., Rosen, M.R., Schwartz, P.J., Spooner, P.M., Van 
Wagoner, D.R. & Waldo, A.L. (2001). Pathophysiology and 
Prevention of Atrial Fibrillation. Circulation 103, 769-777. 
Allessie, M.A., Lammers, W.J., Bonke, F.I. & Hollen, J. (1985). 
Experimental evaluation of Moe's multiple wavelet hypothesis of 
atrial fibrillation. In Cardiac electrophysiology and arrhythmias, 
Zipes, D.P. & Jalife, J. (eds) pp. 265-275. Grune & Stratton: 
Orlando. 
Allessie, M.A., Wijffels, M.C. & Kirchhof, C.J. (1994). Experimental 
models of arrhythmias: toys or truth? Eur Heart J 15 Suppl A, 2-
8. 
Amada, A. & Kurita, H. (1978). Treatment of atrial fibrillation with 
Quinidine Sulphate in the racehorse. Exp Rep Equine Hlth Lab 
15, 47-61. 
Amada, A., Senta, T., Kubo, K., Oh-ishi, S. & Kiryu, K. (1974). Atrial 
fibrillation in the horse: clinical and histopathological studies of 
two cases. 1. Clinical study. Exp Rep Equine Hlth Lab 11, 51-
69. 
Attuel, P., Childers, R., Cauchemez, B., Poveda, J., Mugica, J. & 
Coumel, P. (1982). Failure in the rate adaptation of the atrial 
refractory period: its relationship to vulnerability. Int J Cardiol 2, 
179-197. 
Ausma, J., Wijffels, M., Thone, F., Wouters, L., Allessie, M. & Borgers, 
M. (1997). Structural changes of atrial myocardium due to 
sustained atrial fibrillation in the goat. Circulation 96, 3157-3163. 
Bertone, J.J. & Wingfield, W.E. (1987). Atrial fibrillation in horses. 
Comp Cont Educ Pract 9, 763-771. 
Blissitt, K.J. & Bonagura, J.D. (1995). Colour flow Doppler 
echocardiography in normal horses. Equine Vet J Suppl 19, 47-
55. 
Effect of experimental chronic atrial fibrillation in equines 
202 
Blissitt, K.J., Young, L.E., Jones, R.S., Darke, P.G. & Utting, J. (1997). 
Measurement of cardiac output in standing horses by Doppler 
echocardiography and thermodilution. Equine Vet J 29, 18-25. 
Bosch, R.F., Zeng, X., Grammer, J.B., Popovic, K., Mewis, C. & 
Kuhlkamp, V. (1999). Ionic mechanisms of electrical remodeling 
in human atrial fibrillation. Cardiovasc Res 44, 121-131. 
Boutjdir, M., Le Heuzey, J.Y., Lavergne, T., Chauvaud, S., Guize, L., 
Carpentier, A. & Peronneau, P. (1986). Inhomogeneity of 
cellular refractoriness in human atrium: factor of arrhythmia? 
Pacing Clin Electrophysiol 9, 1095-1100. 
Brown, C.M. & Holmes, J.R. (1978). Haemodynamics in the horse: 1. 
Pressure pulse contours. Equine Vet J 10, 188-194. 
Collatos, C. (1995). Treating atrial fibrillation in horses. Comp Cont 
Educ Pract 17, 243-245. 
Deem, D.A. & Fregin, G.F. (1982). Atrial fibrillation in horses: a review 
of 106 clinical cases, with consideration of prevalence, clinical 
signs, and prognosis. J Am Vet Med Assoc 180, 261-265. 
Detweiler, D.K. (1989). The mamalian electrocardiogram: comparative 
features. In Comprehensive electrocardiology, Macfarlane, P.W. 
& Veitch Lawrie, T.D. (eds), Vol. 2. pp. 1332-1377. Pergamon 
Press: New York. 
Else, R.W. & Holmes, J.R. (1971). Pathological changes in atrial 
fibrillation in the horse. Equine Vet J 3, 56-64. 
Elvan, A., Wylie, K. & Zipes, D.P. (1996). Pacing-induced chronic atrial 
fibrillation impairs sinus node function in dogs. 
Electrophysiological remodeling. Circulation 94, 2953-2960. 
Elvan, A., Ramanna, H. & Robles de Medina, E.O. (1999). New 
insights into the pathophysiology and treatment of atrial 
fibrillation. ACC Current Journal Review 8, 11-14. 
Feigenbaum, H. (1986). Echocardiography. Lea and Febiger: 
Philadelphia, 1-662. 
Fogoros, R.N. (1995). Electrophysiologic testing. Blackwell Science: 
Oxford, 1-270. 
Hardman, S.M., Noble, M.I., Biggs, T. & Seed, W.A. (1998). Evidence 
for an influence of mechanical restitution on beat-to-beat 
variations in haemodynamics during chronic atrial fibrillation in 
patients. Cardiovasc Res 38, 82-90. 
Irvine, C.H. (1975). Electrocardiographic anomalies in the racehorse. 
N Z Vet J 23, 262-269. 
CHAPTER 7: References 
  203 
Jordaens, L., Missault, L., Germonpre, E., Callens, B., Adang, L., 
Vandenbogaerde, J. & Clement, D.L. (1993). Delayed 
restoration of atrial function after conversion of atrial flutter by 
pacing or electrical cardioversion. Am J Cardiol 71, 63-67. 
Kirchhof, C., Chorro, F., Scheffer, G.J., Brugada, J., Konings, K., 
Zetelaki, Z. & Allessie, M. (1993). Regional entrainment of atrial 
fibrillation studied by high-resolution mapping in open-chest 
dogs. Circulation 88, 736-749. 
Kirchhof, C.J. & Allessie, M.A. (1992). Sinus node automaticity during 
atrial fibrillation in isolated rabbit hearts. Circulation 86, 263-271. 
Kopecky, S.L., Gersh, B.J., McGoon, M.D., Whisnant, J.P., Holmes, 
D.R., Jr., Ilstrup, D.M. & Frye, R.L. (1987). The natural history of 
lone atrial fibrillation. A population-based study over three 
decades. N Engl J Med 317, 669-674. 
Kubo, K., Senta, T. & Sugimoto, O. (1975). Changes in cardiac output 
with experimentally induced atrial fibrillation in the horse. Exp 
Rep Equine Hlth Lab 12, 101-108. 
Leistad, E., Christensen, G. & Ilebekk, A. (1993a). Effects of atrial 
fibrillation on left and right atrial dimensions, pressures, and 
compliances. Am J Physiol 264, H1093-1097. 
Leistad, E., Christensen, G. & Ilebekk, A. (1993b). Significance of 
increased atrial pressure on stroke volume during atrial 
fibrillation in anaesthetized pigs. Acta Physiol Scand 149, 157-
161. 
Long, K.J., Bonagura, J.D. & Darke, P.G. (1992). Standardised 
imaging technique for guided M-mode and Doppler 
echocardiography in the horse. Equine Vet J 24, 226-235. 
Manios, E.G., Kanoupakis, E.M., Mavrakis, H.E., Kallergis, E.M., 
Dermitzaki, D.N. & Vardas, P.E. (2001). Sinus pacemaker 
function after cardioversion of chronic atrial fibrillation: Is sinus 
node remodeling related with recurrence? J Cardiovasc 
Electrophysiol 12, 800-806. 
Manning, W.J., Silverman, D.I., Katz, S.E., Riley, M.F., Come, P.C., 
Doherty, R.M., Munson, J.T. & Douglas, P.S. (1994). Impaired 
left atrial mechanical function after cardioversion: relation to the 
duration of atrial fibrillation. J Am Coll Cardiol 23, 1535-1540. 
Moe, G.K. (1962). On the multiple wavelet hypothesis of atrial 
fibrillation. Arch Int Pharmacodyn 140, 183-188. 
Morillo, C.A., Klein, G.J., Jones, D.L. & Guiraudon, C.M. (1995). 
Chronic rapid atrial pacing. Structural, functional, and 
electrophysiological characteristics of a new model of sustained 
atrial fibrillation. Circulation 91, 1588-1595. 
Effect of experimental chronic atrial fibrillation in equines 
204 
Muir, W.W. & McGuirk, S.M. (1984). Hemodynamics before and after 
conversion of atrial fibrillation to normal sinus rhythm in horses. 
J Am Vet Med Assoc 184, 965-970. 
Nollet, H., van Loon, G., Deprez, P., Sustronck, B. & Muylle, E. (1999). 
Use of right ventricular pressure increase rate to evaluate 
cardiac contractility in horses. Am J Vet Res 60, 1508-1512. 
Ohmura, H., Nukada, T., Mizuno, Y., Yamaya, Y., Nakayama, T. & 
Amada, A. (2000). Safe and efficacious dosage of flecainide 
acetate for treating equine atrial fibrillation. J Vet Med Sci 62, 
711-715. 
Oldham, H.N., Vasko, J.S., Brawley, R.K., Henney, R.P. & Morrow, 
A.G. (1967). The hemodynamic effects of atrial fibrillation. J 
Surg Res 7, 587-590. 
Patteson, M.W., Gibbs, C., Wotton, P.R. & Cripps, P.J. (1995). 
Echocardiographic measurements of cardiac dimensions and 
indices of cardiac function in normal adult thoroughbred horses. 
Equine Vet J Suppl 19, 18-27. 
Power, J.M., Beacom, G.A., Alferness, C.A., Raman, J., Wijffels, M., 
Farish, S.J., Burrell, L.M. & Tonkin, A.M. (1998). Susceptibility to 
atrial fibrillation: a study in an ovine model of pacing-induced 
early heart failure. J Cardiovasc Electrophysiol 9, 423-435. 
Reef, V.B., Levitan, C.W. & Spencer, P.A. (1988). Factors affecting 
prognosis and conversion in equine atrial fibrillation. J Vet Intern 
Med 2, 1-6. 
Rose, R.J. & Davis, P.E. (1977). Paroxysmal atrial fibrillation in a 
racehorse. Aust Vet J 53, 545-549. 
Sahn, D.J., DeMaria, A., Kisslo, J. & Weyman, A. (1978). 
Recommendations regarding quantitation in M-mode 
echocardiography: results of a survey of echocardiographic 
measurements. Circulation 58, 1072-1083. 
Schiller, N.B., Shah, P.M., Crawford, M., DeMaria, A., Devereux, R., 
Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., 
Schnittger, I. & et al. (1989). Recommendations for quantitation 
of the left ventricle by two- dimensional echocardiography. 
American Society of Echocardiography Committee on 
Standards, Subcommittee on Quantitation of Two-Dimensional 
Echocardiograms. J Am Soc Echocardiogr 2, 358-367. 
Schotten, U., Ausma, J., Stellbrink, C., Sabatschus, I., Vogel, M., 
Frechen, D., Schoendube, F., Hanrath, P. & Allessie, M.A. 
(2001). Cellular Mechanisms of Depressed Atrial Contractility in 
Patients With Chronic Atrial Fibrillation. Circulation 103, 691-
698. 
CHAPTER 7: References 
  205 
Senta, T. & Kubo, K. (1978). Experimental induction of atrial fibrillation 
by electrical stimulation in the horse. Exp Rep Equine Hlth Lab 
15, 37-46. 
Senta, T., Kubo, K., Sugimoto, O. & Amada, A. (1975). Induction of 
atrial fibrillation by electrical stimulation in the horse. Exp Rep 
Equine Hlth Lab 12, 109-112. 
Sideris, D.A., Toumanidis, S.T., Tselepatiotis, E., Kostopoulos, K., 
Stringli, T., Kitsiou, T. & Moulopoulos, S.D. (1995). Atrial 
pressure and experimental atrial fibrillation. Pacing Clin 
Electrophysiol 18, 1679-1685. 
Stewart, G.A., Fulton, L.J. & McKellar, C.D. (1990). Idiopathic atrial 
fibrillation in a champion Standardbred racehorse. Aust Vet J 
67, 187-191. 
Van den Bos, G.C., Elzinga, C., Westerhof, N. & Noble, M.I. (1973). 
Problems in the use of indices of myocardial contractility. 
Cardiovasc Res 7, 834-848. 
Van Gelder, I.C., Crijns, H.J., Blanksma, P.K., Landsman, M.L., 
Posma, J.L., Van Den Berg, M.P., Meijler, F.L. & Lie, K.I. 
(1993). Time course of hemodynamic changes and 
improvement of exercise tolerance after cardioversion of chronic 
atrial fibrillation unassociated with cardiac valve disease. Am J 
Cardiol 72, 560-566. 
van Loon, G., Deprez, P., Sustronck, B., Muylle, E. & Muylle S. (1994). 
Ventricular Pressure Patterns in 2 Horses with an Augmented 
Ldh1 Isoenzyme Fraction. Vlaams Diergen Tijdschr 63, 54-59. 
van Loon, G., Duytschaever, M., Tavernier, R., Fonteyne, W., 
Jordaens, L. & Deprez, P. (2001). An equine model of chronic 
atrial fibrillation: methodology. The Veterinary Journal, 
submitted. 
van Loon, G., Tavernier, R., Duytschaever, M., Fonteyne, W., Deprez, 
P. & Jordaens, L. (2000). Pacing-induced sustained atrial 
fibrillation in a pony. Can J Vet Res 64, 254-258. 
Van Wagoner, D.R., Pond, A.L., Lamorgese, M., Rossie, S.S., 
McCarthy, P.M. & Nerbonne, J.M. (1999). Atrial L-type Ca2+ 
currents and human atrial fibrillation. Circ Res 85, 428-436. 
Wells, J.L., Jr., Karp, R.B., Kouchoukos, N.T., MacLean, W.A., James, 
T.N. & Waldo, A.L. (1978). Characterization of atrial fibrillation in 
man: studies following open heart surgery. Pacing Clin 
Electrophysiol 1, 426-438. 
White, C.W., Kerber, R.E., Weiss, H.R. & Marcus, M.L. (1982). The 
effects of atrial fibrillation on atrial pressure-volume and flow 
relationships. Circ Res 51, 205-215. 
Effect of experimental chronic atrial fibrillation in equines 
206 
Wijffels, M.C., Kirchhof, C.J., Dorland, R. & Allessie, M.A. (1995). 
Atrial fibrillation begets atrial fibrillation. A study in awake 
chronically instrumented goats. Circulation 92, 1954-1968. 
Wingfield, W.E., Miller, C.W., Voss, J.L., Bennett, D.G. & Breukels, J. 
(1980). Echocardiography in assessing mitral valve motion in 3 
horses with atrial fibrillation. Equine Vet J 12, 181-184. 
Yue, L., Feng, J., Gaspo, R., Li, G.R., Wang, Z. & Nattel, S. (1997). 
Ionic remodeling underlying action potential changes in a canine 
model of atrial fibrillation. Circ Res 81, 512-525. 
Zipes, D.P. (1992). Genesis of cardiac arrhythmias: 
electrophysiological considerations. In Heart Disease, 
Braunwald, E. (ed) pp. 588-627. W. B. Saunders: Philadelphia.
    
CONCLUDING REMARKS 
CONCLUDING REMARKS 
  209 
This thesis shows that temporary and permanent pacing can be 
readily achieved in equines opening new perspectives to diagnose, 
treat and understand equine dysrhythmias. Temporary atrial pacing 
cannot be applied to terminate atrial fibrillation (AF) (Allessie et al., 
1994), but it can successfully entrain and interrupt atrial flutter 
(Kantharia and Mookherjee, 1995; Osborn, 1996). Atrial flutter 
sometimes occurs as intermediate rhythm during quinidine treatment 
in AF horses (Betsch, 1991; Matsuda, 1992; van Loon et al., 1998). 
Because of the vagolytic action of quinidine and its ability to slow flutter 
rate, quinidine therapy facilitates atrioventricular (AV) conduction and 
occasionally results in a 1:1 ventricular response to atrial flutter, 
initiating ventricular tachycardia or even ventricular fibrillation (Fregin, 
1982; Zipes, 1992). This could be a possible explanation for the death 
of some horses during quinidine therapy (Brooijmans, 1957; Deem 
and Fregin, 1982; Betsch, 1991). In this context, overdrive pacing 
might well be an aid in the treatment in AF. It is well known that 
quinidine has a narrow therapeutic index (Bouckaert et al., 1994). 
During AF treatment in horses, the quinidine plasma level is 
progressively increased toward therapeutic but also toxic levels. In 
case atrial flutter would occur during the quinidine treatment, overdrive 
pacing could be applied to terminate atrial flutter. As such, conversion 
to sinus rhythm might be achieved earlier during the AF treatment, 
reducing the quinidine dose and thereby the risk of lethal arrhythmias 
or other toxic side effects. 
The presence of atrial flutter or atrial fibrillation is not always 
identifiable on a surface ECG. The use of a temporary pacing catheter 
allows distinguishing between AF and atrial flutter, and determining AF 
type and AF cycle length (Gallagher and Camm, 1998; van Loon et al., 
1998). The temporary pacing technique can be applied for further 
research in normal horses and horses with AF in order to determine 
atrial electrophysiological characteristics, such as sinus node recovery 
time, atrial effective refractory period and rate adaptation of atrial 
refractoriness, and in order to develop pacing protocols for estimating 
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atrial vulnerability for AF. The latter would be useful in horses 
suspected of having paroxysmal AF during high performance and in 
horses treated for AF in order to estimate the risk for relapse into 
fibrillation. 
Permanent pacemaker implantation expands our ability to treat 
equine rhythm disturbances. Nowadays, refurbished pacemakers 
intended for veterinary use only, are available and reduce the cost of 
the device. This thesis describes a transvenous implantation technique 
that is applicable for implantation of single chamber as well as dual 
chamber pacemakers, with or without rate-responsiveness. 
Consequently, the pacemaker type that best meets the patient’s needs 
can be selected for implantation. 
The simplest implantation is the one of a single chamber model 
with a ventricular lead. Such a pacemaker could be applied to 
preserve a minimal ventricular rate in cases of symptomatic 
bradycardia. Absent AV synchrony, however, results in a loss of atrial 
contribution to ventricular filling, decreasing ventricular preload and 
thereby stroke volume (Reynolds, 1996). Because presystolic valve 
closure is lacking, mitral valve regurgitation may occur early in systole, 
further reducing cardiac output (Hayes and Osborn, 1996). The 
ventricular demand pacemaker only ascertains a minimal heart rate 
and cannot adapt its rate to exercise. The use of a rate-adaptive 
ventricular pacemaker with a built-in sensor, allows achieving a heart 
rate that varies in response to exercise. 
In patients suffering from sinus node dysfunction but with a normal 
AV conduction, a single chamber atrial pacemaker could theoretically 
be applied. But atrial lead displacement is a potential complication of 
transvenous leads (Sisson, 1989; Sisson et al., 1991; Darke, 1992; 
Flanders et al., 1999) and such a dislocation would result in loss of 
pacing. Therefore, symptomatic horses should rather receive a dual 
chamber pacemaker programmed in dual chamber pacing mode to 
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preserve ventricular pacing in case atrial lead dislodgement would 
occur. 
Dual chamber models have the capability to perform both pacing 
and sensing in atrium and ventricle, which is advantageous in a variety 
of situations. Four different rhythms can be observed as a result of 
normal dual chamber pacemaker function: (1) normal sinus rhythm, 
which inhibits atrial and ventricular pacing; (2) atrial pacing as a result 
of sinus (atrial) bradycardia with intact AV conduction; (3) AV 
sequential pacing when atrial and ventricular bradycardia exist 
independently; and (4) atrial synchronous pacing, which occurs in case 
of heart block with normal atrial (sinus node) activity (Hayes and 
Osborn, 1996). The latter means that ventricular pacing is performed 
each time an atrial activity is sensed, thus producing an atrial-triggered 
adaptation of ventricular rate, for example in response to exercise. 
This also means that in patients with paroxysmal atrial 
tachyarrhythmias automatic mode switching to a non-tracking mode 
must be present to avoid ventricular pacing at the upper rate limit 
during an inappropriately rapid atrial rhythm (Hayes and Levine, 1996; 
Provenier et al., 1994; Reynolds, 1996). When normal sinus node 
function is lost, in the presence of chronotropic incompetence, the use 
of a rate-adaptive pacemaker model is recommended to obtain a heart 
rate that varies according to physical activity. 
Although the main purpose of pacemaker implantation is the 
treatment of bradycardia, pacemakers have been used in numerous 
cardiac studies in dogs, pigs, goats and sheep (Morillo et al., 1995; 
Wijffels et al., 1995; Elvan et al., 1996; Yue et al., 1997; Qi et al., 2000; 
Willems et al., 2000). Indeed, pacemaker programmability and 
availability of different pacing modalities allow emulating acute or 
chronic arrhythmias and studying electrophysiologic variables over 
time. In this thesis pacemakers were used to develop a model for 
chronic AF in equines. Although AF can be induced by delivering 
single extrastimuli, preliminary results indicated that AF in ponies could 
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not be consistently maintained in this way. Pacemaker adaptation with 
a fibrillation-induction program applying atrial burst pacing was needed 
to maintain AF continuously. As horses with naturally occurring AF are 
often only presented after days, weeks or months, a chronic AF model 
was essential to study AF pathophysiology. A major advantage of the 
equine model is the non-invasive character, which implies that 
accurate blood pressure measurements and cardiac ultrasonography 
can still be performed. Both the absence of iatrogenic cardiac 
pathology, such as pericarditis, and the normal ventricular rate during 
AF, make the model an excellent means to study the effects simply 
and solely induced by AF, without other interfering factors. The equine 
model may therefore contribute to the understanding of AF and may 
provide additional information transferable to human cardiology. 
During AF, cardiac output is generally decreased (Kubo et al., 
1975; Deegen and Buntenkotter, 1976; Wingfield et al., 1980; Deem 
and Fregin, 1982; Miller and Holmes, 1984; Muir and McGuirk, 1984; 
Deegen, 1986; Betsch, 1991; Marr et al., 1995). Output is defined by 
heart rate and stroke volume, and stroke volume depends on the 
inotropic state of the myocardium and on pre- and afterload conditions. 
As in equines little or no increase in ventricular rate is seen during AF, 
ventricular tachycardiomyopathy is unlikely to be the cause of the 
decreased output. There is also little reason to believe that noticeable 
differences in afterload, other than the varying diastolic intervals, are 
present. A decreased cardiac output can therefore be attributed to 
changes in heart rate and, by the Frank-Starling mechanism, to an 
altered ventricular filling. AF results in an irregular ventricular rate and 
in consequence in varying diastolic intervals that alter ventricular filling 
and thereby stroke volume (Miller and Holmes, 1984; Prystowsky et 
al., 1996). First, regardless of irregular heart rate, ventricular filling is 
reduced by a decreased atrial emptying. During AF, waves of 
excitation circle continuously around the atria causing independent 
contraction of individual muscle fibres rather than a synchronous 
contraction of the atria. Consequently, the atria fail to contract as a 
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whole and ventricular filling, and thereby stroke volume, is reduced 
(Kubo et al., 1975; Blissitt, 1999). Secondly, the inotropic state of the 
atrial myocardium might play a role in the reduced ventricular filling. In 
order to estimate the importance of atrial contractile function per se, 
not biased by the irregular atrial and ventricular activity, measurements 
at a regularly paced rhythm were performed. During the maintained 
fibrillation period this could be achieved after spontaneous restoration 
of sinus rhythm. It was shown that not only chaotic atrial and 
ventricular rhythm but also atrial contractile dysfunction importantly 
contributes to the depressed ventricular function. In this study, atrial 
contractile function was estimated by intra-atrial pressure 
measurements, but, in addition, adapted echocardiographic variables 
were introduced to establish atrial contractility non-invasively. It should 
be mentioned that due to technical limitations, atrial diameter was 
measured not at the largest atrial cross-section but rather close to the 
mitral valve annulus, possibly reducing the sensitivity of the variables. 
However, atrial shortening fraction showed a highly significant 
decrease, even after a short AF episode, suggesting that it is a 
valuable means to estimate atrial contractile function in clinical 
patients. A last factor influencing cardiac output is AV valve function. 
Under normal conditions, atrial contraction increases ventricular 
pressure sufficiently during early atrial diastole to reverse the AV 
pressure gradient, thus placing the AV valve leaflets in approximation 
before or at the onset of ventricular systole (Hayes and Osborn, 1996). 
Deficient atrial contraction prevents presystolic AV valve closure. As a 
result, further reduction of stroke volume may occur due to AV valve 
regurgitation (Holmes et al., 1969; Leistad et al., 1993). In humans, 
however, this kind of AV valve incompetence is thought to be of 
negligible importance and in the pony model no evidence of significant 
AV valve regurgitation could be observed on colour flow Doppler.  
In horses with AF, loss of performance is the major clinical sign 
(Bertone and Wingfield, 1987; Reef et al., 1988; Reef et al., 1995; 
Mitten, 1996). The decreased athletic ability is predominantly ascribed 
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to a reduced cardiac output caused by an insufficient ventricular filling. 
At rest, passive ventricular filling and compensatory mechanisms are 
mostly sufficient to retain cardiac output. During exercise, atrial 
contribution to ventricular preload becomes increasingly important. 
Under normal circumstances, atrial contraction is reported to 
contribute up to 20 to 30% in the filling of the ventricles (Brooijmans, 
1957; Nolan et al., 1969; Hayes and Osborn, 1996). During AF, 
ventricular filling is not only altered by the irregular rhythm but also by 
the reduced atrial contraction. Because of the atrial contractile 
dysfunction and possibly AV valve regurgitation (Leistad et al., 1993) 
atrial pressure rises. Consequently, venous return is reduced and 
systemic and pulmonary venous congestion might occur. Especially 
during exercise, left atrial hypertension may arise and cause exercise-
induced epistaxis associated with some cases of AF (Deem and 
Fregin, 1982). Left atrial hypertension may also lead to the occurrence 
of lung oedema, which hampers oxygen exchange and further reduces 
performance. Although in equine literature little attention is paid to the 
influence of heart rate, this should not be underestimated. From 
literature data and clinical observations it is known that, even during 
slight efforts, heart rate in the AF horse increases disproportionately to 
work (Deegen and Buntenkotter, 1976; Steel et al., 1976; Maier-Bock 
and Ehrlein, 1978). In part, this tachycardia might be a compensatory 
mechanism for the decreased cardiac output. However, tachycardia is 
often excessive, which might have a negative effect on cardiac output 
due to the short diastolic intervals, hampering ventricular filling, 
especially in the absence of atrial contribution (Miller and Holmes, 
1984). AF-related tachycardia could also be attributed to a change in 
autonomic tone. Unless underlying cardiac pathology is present, 
ventricular rate in the resting horse with atrial fibrillation is normal 
because of a high degree of concealed conduction, caused by the high 
vagal tone and the size of the AV node (Meijler and van der Tweel, 
1987; Meijler, 1990; Prystowsky et al., 1996; Kuwahara et al., 1998). In 
contrast, increased resting heart rates are often associated with AF in 
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man and dogs (Ruffy, 1995; Prystowsky et al., 1996). During moderate 
exercise, the decreased vagal tone and the predominance of the 
sympathetic tone reduce the concealed conduction (Prystowsky et al., 
1996). Many atrial depolarisation waves are suddenly conducted 
through the AV node and a disproportionately high ventricular rate is 
observed. 
To be maintained, AF requires a critical number of wavelets 
simultaneously present in the atria (Allessie et al., 1985). A large 
number of wavelets can coexist when the atria are large, the 
conduction velocity is slow and the refractory period is short, and 
additionally, when there is heterogeneity in conduction velocity and 
refractoriness (Wijffels et al., 1995; Zipes, 1997; Allessie, 1998). In 
horses, AF is favoured both by the large atrial mass and the high vagal 
tone. A high vagal tone shortens the refractory period of individual 
cells to a varying degree and consequently causes differences in the 
length and phase of the action potential (Moe, 1962; Bertone and 
Wingfield, 1987; Moore and Spear, 1987; Liu and Nattel, 1997; Wijffels 
et al., 1997; Zipes, 1997; Blissitt, 1999). In addition, some authors 
suggest that in large mammals (such as horses), wavelength of the 
atrial impulse does not increase proportionally to the size of the atria 
(Allessie et al., 1990). Horses are so vulnerable to AF that most of the 
AF horses don’t need any underlying cardiac pathology to develop the 
disease but present the so-called lone AF (Fregin, 1971; Rose and 
Davis, 1977; Amada and Kurita, 1978; Deem and Fregin, 1982; Reef 
et al., 1988; Detweiler, 1989; Collatos, 1995). In the study of Reef et al. 
(1988), almost 60% of the horses with AF were diagnosed to suffer 
from lone AF. The high occurrence of lone AF in horses could be 
supported by the high vagal tone. In man, it is known that lone 
fibrillators often present attacks during predominant parasympathetic 
stimulation (Huang et al., 1998), while paroxysms in patients with 
structural heart disease more frequently occur in a sympathetic setting 
(Allessie et al., 2001). Horses are diagnosed of having lone AF when 
no cardiac disease other than AF is found during examinations, or 
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when they respond well to quinidine treatment and are able to return to 
work after successful cardioversion (Deem and Fregin, 1982; Reef et 
al., 1988; Detweiler, 1989). It should be stressed, however, that lone 
AF is AF without evidence of other cardiac or systemic disease known 
to promote AF (Evans and Swann, 1954), and like any diagnosis of 
exclusion, its quality varies according to how rigorously one searches 
for an alternative (Gallagher and Camm, 1998). In a series of 230 
human patients referred to a specialized AF clinic, all were found to 
have some predisposing condition (Hurst et al., 1964). A more recent 
study in man evidenced that all patients with lone AF presented 
abnormal atrial histology (Frustaci et al., 1997). Literature data 
describing atrial pathology in normal horses and horses with AF are 
limited. In a survey of 45 horses with AF, post-mortem examination of 
the atria revealed both macroscopic changes, such as dilatation, and 
microscopic lesions, such as fibrosis (Else and Holmes, 1971). 
Overexertion and strain were suggested to belong to the possible 
mechanisms leading to these atrial lesions. In another study, 
histopathological examination on 2 AF horses revealed myocardial 
fibrosis in both of them (Kiryu et al., 1974). In a study on 19 horses 
without arrhythmias, however, 4 normal animals also presented focal 
fibrosis in the atrial myocardium (Kiryu et al., 1981). The precise 
importance of such lesions in the occurrence of AF therefore still 
remains uncertain (Bertone and Wingfield, 1987). In horses, 
successfully treated for ‘lone’ AF, recurrence rates of 25% have been 
reported (Reef et al., 1995). It should be noticed that these animals 
might present distinct microscopic lesions that were not diagnosed. 
Besides, recurrence of AF is said to be more likely in horses that are 
brought back into training (Glendinning, 1965; Kroneman and 
Breukink, 1966). This could be explained by exercise-related changes 
in heart rate and autonomic tone. Additionally, during exercise, 
increase in atrial pressure is significantly higher in horses than in other 
species (Manohar et al., 1994). Consequently, a higher increase in 
atrial diameter and stretch is to be expected, which is known to have 
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profibrillatory effects (Zipes, 1997; Allessie, 1998; Janse et al., 1998; 
Franz, 2000). As a result, electrical remodeling, increase in AF 
duration, atrial dilatation and atrial contractile dysfunction might be 
more pronounced or show a different time course when the animals 
continue high-level performance. 
Apart from the influence of atrial lesions on AF occurrence, it has 
been shown in other animal models that AF itself also induces 
changes in atrial structure, such as myolysis, fragmentation of 
sarcoplasmatic reticulum, and loss of myofibrils. (Morillo et al., 1995; 
Ausma et al., 1997a; Ausma et al., 1997b; Thijssen et al., 2000). To 
what extent structural remodeling occurs in horses with AF is yet 
unknown. 
As induced fibrillation in ponies results in electrical remodeling and 
atrial dilatation further leading to AF perpetuation, the present work 
supports the concept of ‘AF begets AF’ (Wijffels et al., 1995). These 
findings explain why animals with longstanding AF are more difficult to 
convert to SR (Deem and Fregin, 1982; Reef et al., 1988; Reef et al., 
1995). However, research in horses will have to prove whether or not 
AF leads to a similar atrial dilatation as in ponies, because thickness of 
the atrial wall might play a role in occurrence of dilatation. 
Future research should focus on the question whether horses 
actually present ‘lone’ fibrillation and whether AF occurrence or 
recurrence is predictable in an individual horse. Ultrasonography and 
estimation of atrial contractile function might help identifying animals 
with overt atrial fibrosis. In cardioverted horses atrial contractile 
function should be restored before training is recommenced. If proper 
restoration is not observed an underlying atrial disease might be 
present and relapse of AF could be more likely. In this thesis it was 
shown that atrial size importantly contributes to AF perpetuation. In the 
pony model, a difference in atrial diameter of 1 cm resulted in an 
obvious increase in AF duration. In horses, reference values for atrial 
diameter show a large variation. Slight increases in atrial diameter, as 
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observed in the pony model for AF, probably would fall within normal 
limits. It should therefore be attempted to narrow reference values for 
horses by examining a large number of them and by clearly 
differentiating between breeds. If horses are presented with AF, 
echocardiography is always performed prior to the onset of treatment 
to intercept patients with congestive heart failure. Further studies are 
also needed to clarify the correlation between atrial diameter 
measured during SR or measured during AF. 
Some animals possibly present a faint balance between atrial size 
and refractory period, favouring AF occurrence. Application of 
temporary pacing to perform electrophysiologic studies in a large 
number of normal horses will permit to compare reference values for 
refractoriness and adaptation of refractory period with those of AF 
converted animals. Individual electrophysiological differences might 
thereby indicate an increased risk for AF. A pacing protocol, adapted 
to horses, will enable assessment of atrial fibrillation threshold, which 
will be an additional aid in identifying animals suspected of having 
paroxysmal AF during strenuous work. The combination of 
electrophysiologic characteristics and atrial size might provide a 
predictive value for the likelihood of AF occurrence in an individual 
animal. 
Although in human medicine AF has been intensively studied and 
has been called the ‘darling arrhythmia’ of the past decade (Zipes, 
1997), many questions still remain to be answered. The present pony 
model affords a glance behind the scenes of AF pathophysiology in 
equines and could be applied in future to gain further insight into this 
mystifying arrhythmia. 
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SUMMARY 
Cardiac pacing has become a mainstay in human cardiology for 
diagnosis and treatment of many dysrhythmias and has been applied 
in numerous animal models to study the pathophysiology of rhythm 
disturbances. In equines, however, little research has been performed 
concerning rhythm disturbances and in this species diagnostic and 
therapeutic modalities are limited. Cardiac pacing has hardly been 
studied in equines, and therefore research on its applicability was 
tempting, especially to study pathophysiological aspects of atrial 
fibrillation (AF), clinically the most important arrhythmia in horses. 
In this thesis a General introduction discusses general features of 
atrial pacing and AF. The first part of the introduction gives an 
overview of physiologic aspects and required equipment to perform 
pacing. The use of cardiac pacing in man is summarized, discussing 
therapeutic and diagnostic features. Subsequently, a review is 
presented of all available literature data on cardiac pacing in equines. 
Reports describing therapeutic pacing as well as pacing during cardiac 
studies are briefly discussed. In the second part of the introduction, 
general electrophysiological aspects on AF are summarized and an 
overview about knowledge on AF in equines is given. It is obvious that 
AF results in exercise intolerance. However, the association between 
AF and pathologic changes such as atrial dilatation, atrial contractile 
dysfunction, ventricular dysfunction, histological changes and 
electrophysiologic alterations remains unclear. 
 
The research of the thesis consists of two major sections. The first 
section (Chapters 1 – 4) describes the development of a technique to 
perform temporary as well as permanent atrial pacing. Both 
techniques are applied to treat clinical patients. 
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In the second section (Chapters 5 - 7) the atrial pacing techniques 
are applied to develop an equine model for chronic atrial fibrillation. 
This model was subsequently used to study the pathophysiology of 
AF. 
The first Chapter of the thesis describes how temporary pacing in 
horses can be performed. A pacing catheter, connected with an 
external electrical pulse generator, is introduced in the external jugular 
vein and advanced into the right atrium. Electrogram recordings and 
echocardiography are used to verify the position of the catheter tip. 
Once the electrodes of the catheter tip make contact with the atrial 
endocardium, cardiac pacing can be performed.  
One must be aware that, in order to initiate a cardiac depolarisation 
in excitable myocardial tissue, i.e. in order to achieve capture, the 
electrical pulse must be of sufficient intensity to exceed the threshold 
for stimulation. The intensity of the electrical pulse is determined both 
by the pulse strength (amplitude) and by the duration (width) of the 
pulse. The strength-duration curve describes which combinations of 
pulse strength and duration are sufficient to reach the threshold for 
stimulation. In the study, three different approaches were used to 
determine the atrial strength-duration curve. With the fixed pulse width 
method, at a series of pulse widths, minimal amplitudes were 
determined to achieve capture. The strength-duration curve is 
obtained by connecting the different points. With the fixed amplitude 
method, the corresponding threshold pulse widths were determined at 
several fixed amplitudes. The third method proved to be the best one 
and was a combination of both aforementioned methods. At high 
amplitude the minimal pulse width was determined and at long pulse 
duration the minimal pulse strength was determined. From these two 
points the strength-duration curve was calculated using a 
mathematical equation.  
Chapter 2 describes how the pacing technique was subsequently 
used to treat a horse with atrial flutter. This horse was a 5-year-old 
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Warmblood mare that was presented with loss of performance due to 
atrial fibrillation. Cardiac ultrasound indicated mild tricuspid valve 
insufficiency with right atrial enlargement. A standard treatment with 
quinidine sulphate changed the atrial rhythm from AF into atrial flutter 
but, because toxic effects occurred, the treatment had to be 
discontinued. After side effects had abolished, atrial flutter persisted 
and the horse was not able to return to work.  
In man, termination of atrial flutter can be achieved by rapid atrial 
pacing. Seven months after the occurrence of atrial flutter, rapid atrial 
pacing was performed in the horse and sinus rhythm was successfully 
restored. Re-examination after a rest period indicated that sinus 
rhythm was still present and that tricuspid valve insufficiency and right 
atrial enlargement were less pronounced. The horse was brought back 
into training and returned to its previous level of athletic performance. 
At present, 5 years after the pacing procedure, sinus rhythm is still 
maintained and no complaints are reported.  
The study proofs that atrial pacing provides an alternative treatment 
for atrial flutter in equines.  
After research on temporary atrial pacing, the study was extended 
to perform permanent pacing. Chapter 3 illustrates the development of 
a feasible and safe technique to perform permanent pacing in 6 
healthy equines by implantation of a pacemaker. Dual chamber 
pacemakers were used, which means that an atrial as well as a 
ventricular electrode were implanted, allowing stimulation of both 
cardiac chambers. A major advantage of the technique was that the 
whole implantation procedure could be performed in the standing, 
sedated animal, thereby avoiding a general anaesthesia. Atrial and 
ventricular leads were transvenously inserted through the cephalic vein 
and a subcutaneous pacemaker pocket was created between the 
lateral pectoral groove and the manubrium sterni. Positioning of each 
lead was guided by echocardiography and by measuring the electrical 
characteristics of the lead. The implantation procedure lasted about 4 
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hours in each animal and was well tolerated. In all animals dual 
chamber pacemaker function was obtained and results remained good 
throughout the follow-up period. At the time of implantation atrial and 
ventricular sensing were between 2.1 and 7.2 millivolt and 7.8 and 
16.8 millivolt, respectively, and atrial and ventricular pacing thresholds 
at 0.5 millisecond varied from 0.5 to 0.7 volt and 0.3 to 1.0 volt, 
respectively. Six months after the implantation sensing values varied 
from 2 to 10 millivolt for the atrial lead and from 2 to 16 millivolt for the 
ventricular lead, while pacing thresholds at 0.5 millisecond varied from 
less than 0.5 to 2.5 volt for the right atrium and from less than 0.5 to 
5.0 volt for the right ventricle. Atrial lead dislodgement occurred in 2 
animals, requiring insertion of a new lead. Ventricular lead 
dislodgement was not observed.  
The current research opens new prospects in the treatment of 
cardiac rhythm disturbances in equines. 
Because now, implantation of a dual chamber pacemaker could be 
performed in a reproducible manner, the technique was put into 
practice by treatment of a horse with symptomatic bradycardia 
(Chapter 4). The horse was a 5-year-old gelding that presented 
syncope at termination of exercise. A 24-hour ECG recording revealed 
intermittent pauses in the sinus rhythm of up to 10 seconds, without 
any ventricular escape beat, indicating sinus node disease. Especially 
at termination of exercise, pauses in sinus rhythm were repeatedly 
present.  
We assumed that implantation of a dual chamber pacemaker 
would prevent further syncope by preserving a minimal heart rate. 
However, this would be a fixed minimal rate and would not allow the 
horse to perform exercise. Therefore, a dual chamber pacing system 
with rate-adaptive function was implanted. Rate-adaptive pacing based 
on a built-in activity sensor, prevented excessive post-exercise 
bradycardia and syncope, allowing the horse to perform exercise. The 
location of the pacemaker at the level of the pectoral muscles proved 
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to be suitable resulting in appropriate sensor activation. At present, 
one year after initial admission, proper pacemaker function has 
allowed the horse to return back to its normal work. 
This chapter illustrates that pacemaker implantation is a feasible 
therapy in horses and the use of a rate-adaptive pacing system further 
expands our treatment possibilities. 
 
In the second section of the thesis, atrial pacing was applied to 
perform research on AF in horses. Lone AF, i.e. AF without underlying 
heart disease, is thought to be present in many AF horses and most of 
the time it is encountered in a subacute or chronic form. However, little 
information is available on the cause and effect of AF in horses. In the 
second section of the thesis, first a model for chronic AF is developed, 
trying to mimic the natural state of the disease as close as possible. 
Subsequently the AF model was applied to study AF pathophysiology 
in equines. 
The first model for chronic AF, discussed in Chapter 5, consisted of 
the implantation of an electrical pulse generator, connected with a 
transvenous screw-in electrode that had been positioned in the right 
atrium of a healthy pony. The pulse generator was programmed to 
deliver every 4 seconds a burst of electrical stimuli to the right atrium 
to induce bouts of AF. Each burst consisted of a 2-second lasting train 
of electrical stimuli (20 Hz, 2 volt in amplitude and 0.5 millisecond 
pulse width). Initially, cessation of burst pacing resulted in short (less 
than 1 minute) self-terminating episodes of AF. As burst pacing 
continued, the duration of induced AF paroxysms became longer. After 
3 weeks of atrial pacing, AF became sustained (56 hours). Although 
AF is hardly ever seen in healthy ponies, this model supports the 
concept that once AF starts it sets up changes in the electrical 
characteristics of the atrium that favour AF perpetuation. 
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This model of pacing-induced AF can be used to study the 
mechanisms of AF occurrence, its perpetuation and possible 
therapies.  
In order to study the electrophysiologic aspects that contribute to 
AF pathophysiology, a new equine model for chronic AF was 
developed (Chapter 6). In 4 healthy ponies a dual chamber 
pacemaker, with an adapted pacemaker program, was implanted 
transvenously in the standing animal. The fibrillation program 
continuously analysed the intra-atrial and intraventricular electrogram. 
Below a ventricular rate of 80 beats per minute, an algorithm was 
activated that analysed atrioventricular synchrony. Sinus rhythm was 
defined as 1/1 atrioventricular synchrony during 3 to 4 consecutive 
heart cycles. Upon SR detection, a 2 second burst of stimuli (42 Hz) 
was delivered to the right atrium at double threshold in order to induce 
AF paroxysms. As a result of repeated pacing, the heart was kept 
continuously in AF. The advantage of this model is that simultaneous 
with a surface ECG, the intra-atrial electrogram can be recorded to 
determine the atrial electrogram morphology and rate of fibrillation. 
Programmed electrical stimulation can also be used to determine 
sinus node recovery time and atrial effective refractory period. By 
measuring atrial refractoriness at different pacing rates, rate 
adaptation of refractoriness can be assessed. The number of atrial 
depolarisations following the first captured extrastimulus during 
refractory period measurement estimates atrial vulnerability. 
In conclusion, this model is suited to study AF in equines because it 
reflects closely the natural appearance of the disease and because it 
provides an excellent means to analyse electrophysiologic alterations 
that might be induced by AF. 
The latter model was applied to study the effect of experimentally 
induced AF on healthy equines (Chapter 7). Four ponies, with the 
above-mentioned fibrillation pacemaker implanted, were used in this 
study. With the pulse generator, atrial fibrillation was maintained during 
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6 months by applying intermittent burst pacing. Electrophysiologic 
measurements, determination of intracardiac blood pressure and 
echocardiography were performed at baseline, at several time points 
during the 6 months of fibrillation and after the fibrillation period. In the 
present study, additional left atrial measurements were introduced to 
estimate atrial contractility. To avoid confounding effects of irregular 
heart rate and to obtain reproducible results for pressure and cardiac 
ultrasound, heart catheterisations and cardiac ultrasound were 
performed during sinus rhythm when the atrium was paced at a fixed 
rate. During the fibrillation period, this could be achieved by 
temporarily disabling the fibrillation program in order to allow sinus 
rhythm to restore spontaneously. 
As a result of maintained AF, atrial refractoriness decreased and 
the adaptation to rate was attenuated. Fibrillation rate increased and 
the atrial electrogram morphology became more complex. No change 
in sinus node function was demonstrated. A slight increase in right 
atrial pressure was observed and a significant left atrial dilatation 
became apparent. Non-invasive assessment of atrial shortening 
fraction indicated a total loss of atrial contractile function as a result of 
fibrillation. These findings were confirmed by blood pressure values: 
pressure change and rate of pressure rise during atrial contraction 
were both significantly decreased. Because of atrial contractile 
dysfunction, ventricular filling was decreased. Consequently, a 
depressed ventricular function by the Frank-Starling mechanism 
resulted in a decreased stroke volume. 
During the fibrillation period, the duration of the induced atrial 
fibrillation paroxysms increased progressively and became persistent 
in one animal, requiring defibrillation. Duration of the fibrillation 
episodes was associated with atrial diameter, atrial refractory period 
and rate of fibrillation. 
After restoration of SR, the electrophysiological variables returned 
to normal within 10 days. Atrial size and atrial contractile function only 
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normalized after 1 to 2 months of SR. The duration of the induced AF 
paroxysms abruptly decreased to less than a minute. All fibrillation-
induced alterations were reversible within 2 months after 
cardioversion.  
 
The final conclusion of the thesis is that atrial pacing can be 
successfully applied in equines and that the pacing procedure is well 
tolerated, even without application of sedatives. Temporary as well as 
permanent pacing techniques open new perspectives on the diagnosis 
and treatment of equine rhythm disorders. The chronic AF model 
provided essential information on AF pathophysiology and can be used 
for future research developing new therapeutic strategies. 
  SAMENVATTING 
  237 
SAMENVATTING 
In de humane cardiologie is elektrische stimulatie van het hart, 
meestal kortweg ‘pacing’ genoemd, een onmisbare techniek geworden 
voor de diagnosestelling en de behandeling van verschillende 
aritmieën. Om de pathofysiologie van hartritmestoornissen bij de mens 
beter te bestuderen wordt het pacen vaak toegepast in experimentele 
diermodellen. Paarden worden echter slechts zelden gebruikt voor 
dergelijke modellen en omdat bij het paard ook nauwelijks diepgaand 
onderzoek wordt verricht op gebied van hartritmestoornissen zijn 
zowel de diagnostische als de therapeutische mogelijkheden bij deze 
diersoort sterk gelimiteerd. 
Bij het paard is atriale fibrillatie (AF) klinisch de belangrijkste 
hartaritmie, maar zelfs van deze aandoening is de onderliggende 
pathofysiologie nog grotendeels onbekend. Deze doctoraatsthesis 
heeft dan ook als doel om door middel van het ontwikkelen van een 
techniek om het paardenhart te pacen, de pathofysiologie van 
hartritmestoornissen op te helderen en zo nieuwe perspectieven te 
openen voor de behandeling ervan. 
De algemene aspecten van atriale pacing en van atriale fibrillatie 
worden uiteengezet in de introductie van dit proefschrift.  
In het eerste gedeelte ervan wordt een overzicht gegeven van de 
prikkelbaarheid van het hart en van het materiaal dat nodig is om een 
hart elektrisch te kunnen stimuleren. Het gebruik van elektrische 
hartstimulatie in de humane geneeskunde wordt aangehaald waarbij 
vooral nadruk wordt gelegd op de diagnostische en de therapeutische 
toepassingen. Vervolgens worden de beschikbare literatuurgegevens 
over elektrische hartstimulatie bij paarden weergegeven. Er wordt 
hierbij zowel ingegaan op pacen met therapeutische doeleinden als op 
pacen toegepast tijdens cardiale studies. 
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Het tweede deel van de introductie bespreekt de 
elektrofysiologische aspecten van atriumfibrillatie in het algemeen en 
gaat vervolgens dieper in op atriale fibrillatie bij het paard in het 
bijzonder. Klinische gegevens wijzen erop dat AF aanleiding geeft tot 
verminderde prestaties. Het juiste verband echter tussen AF en 
pathologische veranderingen aan het hart, zoals bijvoorbeeld atriale 
dilatatie, verminderde atriale contractiliteit, ventriculaire disfunctie, 
histologische en elektrofysiologische veranderingen, blijft nog altijd 
onopgehelderd. 
 
Het onderzoek van deze doctoraatsthesis bestaat uit twee grote 
onderdelen. De eerste sectie (Hoofdstukken 1-4) beschrijft de 
totstandkoming van een techniek om het paardenhart elektrisch te 
stimuleren. Zowel tijdelijke als permanente stimulatie komen hierbij 
aan bod en beiden worden gebruikt ter behandeling van klinische 
patiënten. In de tweede sectie van de thesis (Hoofdstukken 5-7) 
worden de pacingtechnieken aangewend om een experimenteel 
paardenmodel voor chronische atriale fibrillatie te ontwikkelen. Dit 
model wordt ten slotte gebruikt om de pathofysiologische aspecten 
van AF bij het paard te bestuderen. 
Het eerste Hoofdstuk van de thesis beschrijft de ontwikkeling van 
een techniek om temporaire pacing bij paarden uit te voeren door 
middel van een pacing-katheter. Ter hoogte van de top van de 
katheter zitten twee elektrodes ingebouwd. Het andere uiteinde van de 
katheter is voorzien van connecties die verbonden worden met een 
elektrische pulsgenerator. De top van de katheter wordt in de vena 
jugularis externa ingebracht en vervolgens intraveneus opgeschoven 
naar het rechter atrium tot de elektrodes contact maken met het atriale 
endocard. De juiste positie van de kathetertop wordt gecontroleerd 
door middel van echocardiografie en een intracardiaal elektrogram. 
Een belangrijke voorwaarde om een hart elektrisch te kunnen 
stimuleren, dus om een depolarisatie van myocardiaal weefsel te 
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kunnen veroorzaken, is het toedienen van een elektrische prikkel die 
sterk genoeg is om de drempel voor stimulatie te overschrijden. De 
intensiteit van een elektrische prikkel wordt bepaald door zowel de 
amplitude (strength) als de duur (duration) van de prikkel. In 
Hoofdstuk 1 worden drie verschillende manieren beschreven om een 
strength-duration curve op te stellen. Dit is een curve die beschrijft 
welke combinaties van amplitude en duur geschikt zijn om de 
stimulatiedrempel te bereiken. Bij de vaste-prikkelduur-methode 
worden minimale amplitudes bepaald die nodig zijn om bij een 
welbepaalde prikkelduur de drempel te bereiken. Bij de vaste-
prikkelamplitude-methode wordt vastgesteld welke minimale 
prikkelduur nodig is om bij een welbepaalde prikkelamplitude de 
stimulatiedrempel te bereiken. Bij een derde methode worden twee 
punten op de strength-duration curve bepaald met behulp van beide 
voorgaande methodes: voor een hoge amplitude wordt de 
overeenkomstige pulsduur bepaald en voor een lange pulsduur wordt 
de amplitude bepaald om de drempelwaarde voor stimulatie te 
bereiken. Aan de hand van deze 2 punten wordt de rest van de curve 
berekend op basis van een formule. 
Het wordt duidelijk dat temporaire atriale pacing wel degelijk kan 
toegepast worden bij het paard mits de prikkelintensiteit de 
drempelwaarde voor stimulatie overschrijdt. 
Hoofdstuk 2 beschrijft hoe de temporaire pacing techniek kan 
gebruikt worden om een paard met atriale flutter te behandelen. Een 
5-jarige warmbloed merrie werd aangeboden wegens verminderde 
prestaties ten gevolge van boezemfibrilleren. Echocardiografie toonde 
een milde insufficiëntie aan van de tricuspidaalklep met vergroting van 
het rechter atrium. De standaardbehandeling met quinidinesulfaat 
veranderde het hartritme van atriale fibrillatie in atriale flutter, maar 
aangezien toxische neveneffecten optraden, moest de therapie 
gestaakt worden. 
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In de humane geneeskunde kan atriale flutter stopgezet worden 
door middel van snelle atriale pacing. Omdat een medicamenteuze 
therapie uitgesloten was, werd bij de warmbloedmerrie eveneens de 
snelle atriale pacing techniek toegepast. Zeven maand na het 
ontstaan van de atriale flutter werd met behulp van snel atriaal pacen 
het normaal sinusritme weer hersteld. Na een rustperiode toonde 
grondig hartonderzoek aan dat sinusritme nog steeds aanwezig was 
en dat zowel de tricuspidaalinsufficiëntie als de rechter atriumdilatatie 
minder uitgesproken waren. Daarop werd het paard weer in training 
gebracht waarbij het opnieuw zijn vorig prestatieniveau bereikte. Nu, 
vijf jaar na de pacing procedure, slaat het hart nog steeds in 
sinusritme en zijn er verder geen klachten. 
Deze casuï stiek bewijst dat atriale pacing gebruikt kan worden als 
alternatieve behandelingsmethode voor atriale flutter. 
In een volgende fase van de studie werd getracht om naast 
temporaire pacing eveneens een permanente pacing techniek voor het 
paard op punt te stellen. Hoofdstuk 3 illustreert de ontwikkeling van 
een reproduceerbare en tevens veilige techniek om door middel van 
pacemakerimplantatie het hart permanent elektrisch te stimuleren. 
In deze studie werd bij zes gezonde dieren een tweekamer 
pacemaker geï mplanteerd, wat betekent dat zowel een atriale als een 
ventriculaire elektrode worden ingeplant zodat zowel het atrium als het 
ventrikel apart gestimuleerd kunnen worden. De implantatie werd 
uitgevoerd op gesedeerde doch rechtstaande dieren, waardoor een 
algemene anesthesie kon vermeden worden. Zowel de atriale als de 
ventriculaire lead werden ingeplant via de vena cephalica en de 
pacemaker zelf werd subcutaan ingebracht tussen het manubrium 
sterni en de zijdelingse borstgroeve. Beide leads werden in het hart 
gepositioneerd met behulp van echocardiografie en met behulp van 
metingen van sensing- en pacingvoltage en leadweerstand. De 
implantatieprocedure duurde gemiddeld vier uur en werd goed 
verdragen door alle dieren. Bij allen werd een tweekamer pacemaker 
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functie verkregen en de meetresultaten waren bevredigend gedurende 
de ganse follow-up periode. Op het tijdstip van implantatie waren de 
atriale en de ventriculaire sensing waarden respectievelijk 2,1 tot 7,2 
millivolt en 7,8 tot 16,8 millivolt. De atriale en de ventriculaire 
drempelwaarden voor stimulatie bij 0,5 milliseconden varieerden van 
0,5 tot 0,7 volt en van 0,3 tot 1 volt, respectievelijk. Zes maanden na 
de implantatie varieerden de sensingwaarden van de atriale lead van 2 
tot 10 millivolt en van de ventriculaire lead van 2 tot 16 millivolt. Pacing 
drempelwaarden bij 0,5 milliseconden varieerden dan van minder dan 
0,5 tot 2,5 volt voor het rechter atrium en van minder dan 0,5 tot 5 volt 
voor het rechter ventrikel. 
Bij twee dieren kwam de atriale lead terug los en werd een nieuwe 
lead ingebracht. Loslating van een ventriculaire lead werd bij geen 
enkel dier geobserveerd. 
In Hoofdstuk 4 werd de hierboven beschreven techniek voor een 
permanente pacemakerimplantatie aangewend als therapie bij een 
paard met symptomatische bradycardie. Een 5-jarige ruin werd 
immers aangeboden op de kliniek met de klacht van syncope na 
inspanning. Een 24-uur ECG toonde intermitterende pauzes in het 
sinusritme aan die tot 10 seconden duurden zonder dat er enig 
ventriculair escaperitme optrad, gegevens die wijzen op een 
aandoening van de sinusknoop. Vooral vlak na inspanning waren er 
herhaaldelijk pauzes in het sinusritme te zien. 
Implantatie van een tweekamer pacemaker zou verdere syncopes 
kunnen vermijden door steeds een minimaal hartritme te garanderen. 
Zo'n constant maar laag hartritme zou echter geen fysieke 
inspanningen toelaten. Daarom werd hier geopteerd voor een 
tweekamer pacemaker met een ritmerespons. Pacing met 
ritmerespons, steunend op een ingebouwde activiteitssensor, 
verhinderde succesvol bradycardie en syncopes na inspanning, en 
maakte het mogelijk om het paard terug op een normale manier in 
training te brengen. De lokalisatie van de pacemaker ter hoogte van 
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de voorste oppervlakkige borstspier bleek geschikt te zijn om een 
gepaste sensor activatie te verkrijgen. Momenteel, 1 jaar na de 
implantatie, zorgt het goed functioneren van de pacemaker ervoor dat 
het paard nog steeds zonder problemen bereden kan worden. 
Pacemaker implantatie is dus een haalbare therapie bij het paard 
en door de toepasbaarheid van de ritmerespons functie kan de 
pacemaker functie nog beter afgestemd worden aan de behoefte van 
het individu waardoor zelfs fysieke inspanning opnieuw mogelijk wordt. 
 
In de tweede sectie van dit doctoraatswerk werd atriale pacing niet 
therapeutisch maar experimenteel aangewend om verder onderzoek 
uit te voeren met betrekking tot atriale fibrillatie bij het paard.  
Bij de meeste paarden met ‘natuurlijke’ AF wordt de aandoening in 
het subacuut of chronisch stadium vastgesteld en vaak kan er geen 
onderliggende hartafwijking aangetoond worden. Tot op heden is er 
slechts weinig informatie voorhanden over de oorzaak van AF bij het 
paard en de gevolgen ervan op de hartspier op langere termijn. 
In het tweede deel van de huidige studie was het daarom de 
bedoeling eerst een experimenteel model te ontwikkelen om 
chronische AF bij het paard te induceren en daarbij het natuurlijke 
ziekteproces zo getrouw mogelijk na te bootsen. Vervolgens werd dit 
model dan gebruikt om de pathofysiologische gevolgen van AF op het 
paardenhart te bestuderen. 
Het eerst ontwikkelde model voor chronische atriale fibrillatie 
(Hoofdstuk 5) werd toegepast bij een gezonde pony en bestond uit 
een ingeplante elektrische pulsgenerator, verbonden met een 
transveneuze schroefelektrode ter hoogte van het rechter atrium. De 
pulsgenerator was geprogrammeerd om elke vier seconden een trein 
(burst) van elektrische stimuli (20 Hz, 2 volt en 0,5 milliseconden) in 
het rechter atrium te genereren met de bedoeling een AF episode te 
induceren. Initieel resulteerde een stopzetting van burst pacing in korte 
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(<1 minuut) zelfuitdovende episodes van AF. Hoe langer burst pacing 
echter werd toegepast hoe langer het geï nduceerde AF paroxisme 
bleef bestaan. Na drie weken van atriaal pacen bleek de 
geï nduceerde fibrillatie episode gedurende een periode van 56 uur op 
zichzelf verder bestaan. Hoewel AF zelden voorkomt bij gezonde 
pony’s doen deze bevindingen vermoeden dat AF, eens aanwezig in 
een hart, zodanige veranderingen teweegbrengt in de elektrische 
eigenschappen van het atrium, dat AF als het ware zichzelf in stand 
houdt. 
Om het onderzoek toe te spitsen op de elektrofysiologische 
aspecten die bijdragen tot de pathofysiologie van fibrillatie werd een 
nieuw model voor chronische AF ontwikkeld (Hoofdstuk 6). 
Bij 4 gezonde pony’s werd een tweekamer pacemaker, die van 
aangepaste software voorzien was, ingeplant. Deze software 
analyseerde voortdurend het intra-atriaal en intraventriculair 
elektrogram. Wanneer het ventriculair ritme van de pony’s lager lag 
dan 80 slagen/min werd een algoritme geactiveerd dat de 
atrioventriculaire doorgeleiding analyseerde. Sinusritme werd 
gedefinieerd als 1/1 atrioventriculaire doorgeleiding gedurende 3 à 4 
opeenvolgende hartcycli. Bij detectie van sinusritme werd een twee 
seconden durende burst van elektrische stimuli (42 Hz) gegenereerd 
ter hoogte van het rechter atrium met een intensiteit van twee maal de 
drempelwaarde voor stimulatie, en dit om telkens een AF paroxisme te 
induceren. Door dit herhaald pacen werd het hart dus continu in AF 
gehouden. 
Het grote voordeel van dit model is dat, tegelijkertijd met een 
oppervlakte ECG, een intra-atriaal elektrogram kan opgenomen 
worden ter bepaling van de morfologie van dit atriaal elektrogram en 
van de snelheid van fibrilleren. Het toedienen van geprogrammeerde 
stimuli kan eveneens gebruikt worden om de sinusknoop activiteit 
(recovery-time) evenals de atriale effectieve refractaire periode te 
bepalen. Door het meten van de atriale refractaire periode bij 
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verschillende pacing frequenties kan ook de aanpassing van de 
refractaire periode aan het atriale ritme bepaald worden. Het meten 
van het aantal atriale depolarisaties volgend op de eerste ‘gevolgde’ 
extrastimulus tijdens de refractaire periode kan gebruikt worden om de 
atriale gevoeligheid in te schatten.  
Omdat al deze metingen gemakkelijk uitvoerbaar zijn, mag men 
concluderen dat dit chronisch AF-model de ideale middelen verschaft 
voor de studie van elektrofysiologische veranderingen die mogelijks 
een 'natuurlijke' AF induceren of in stand houden. 
Het model werd daarom gebruikt om bij gezonde paarden het 
effect van experimenteel geï nduceerde AF na te gaan (Hoofdstuk 7). 
Bij de vier gezonde pony’s die voor deze proefopzet werden gebruikt 
werd, met bovengenoemde pacemaker implantatie, AF gedurende zes 
maand in stand gehouden met behulp van intermitterende burst 
pacing. Elektrofysiologische metingen, intracardiale 
bloeddrukmetingen en echocardiografie werden uitgevoerd voor, 
tijdens en na de fibrillatieperiode. Bij deze proefopzet werden tevens 
nieuwe metingen geï ntroduceerd om gedurende elke hartcyclus de 
atriale contractiliteit te kunnen beoordelen. Om storende effecten van 
een onregelmatig hartritme hierbij te vermijden en om 
reproduceerbare resultaten qua bloeddruk en echocardiografie te 
bekomen, werden de hartkatheterisaties uitgevoerd bij een sinusritme 
terwijl het atrium gestimuleerd werd aan een vooraf vastgelegde 
snelheid. Gedurende de fibrillatieperiode kon dit gebeuren door het 
fibrillatieprogramma tijdelijk uit te schakelen en te wachten tot 
sinusritme spontaan heroptrad. 
Op basis van de meetresultaten werd vastgesteld dat tengevolge 
van de langdurige AF de atriale refractaire periode verkort was en de 
frequentierespons verminderd. De fibrillatiesnelheid verhoogde en de 
morfologie van het atriale elektrogram werd steeds complexer. In de 
sinusknoopfunctie zelf konden geen veranderingen aangetoond 
worden. Een lichte stijging van de rechter atriale bloeddruk werd 
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waargenomen evenals een significantie dilatatie van het linker atrium. 
De niet-invasieve bepaling van de atriale verkortingsfractie duidde op 
een totaal verlies van atriale contractiliteit ten gevolge van de fibrillatie. 
Deze bevindingen werden tevens bevestigd door de gemeten 
bloeddrukwaarden: de gegenereerde druk en de snelheid van de 
bloeddrukstijging gedurende een atriale contractie waren beiden 
significant gedaald. Ten gevolge van de atriale contractiele disfunctie 
was de ventriculaire vulling eveneens gedaald. De daardoor 
verminderde ventriculaire functie (Frank-Starling mechanisme) 
resulteerde in een verminderd slagvolume. Gedurende de 
fibrillatieperiode nam de duur van de geï nduceerde AF progressief 
toe en werd bij 1 dier zelfs blijvend. In dit laatste geval moest 
defibrillatie uitgevoerd worden om het sinusritme te herstellen. De duur 
van de fibrillatie-episodes was gecorreleerd met de atriale diameter, 
de atriale refractaire periode en de fibrillatiesnelheid. Na herstel van 
het sinusritme keerden de elektrofysiologische variabelen terug naar 
de normaalwaarden binnen een periode van 10 dagen. Ook de duur 
van het geï nduceerde AF paroxisme daalde abrupt tot minder dan 1 
minuut. Atriale diameter en atriale contractiliteit normaliseerden pas na 
1 à 2 maand.  
Uit de studie is dus gebleken dat AF verscheidene veranderingen 
teweegbrengt ter hoogte van het hart maar dat ze volledig reversibel 
blijken te zijn en dit binnen de twee maand na cardioversie. 
 
De globale conclusie van dit doctoraal proefschrift is dat atriale 
pacing wel degelijk kan uitgevoerd worden bij paarden en dat de 
gehele pacing procedure, zelfs zonder gebruik van sedativa, goed 
verdragen wordt. Zowel tijdelijke als permanente pacing technieken 
openen nieuwe perspectieven wat betreft diagnosestelling en 
behandelingsmogelijkheden voor hartritmestoornissen bij het paard. 
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Het chronisch AF model verschaft essentiële informatie over de 
pathofysiologie van AF en kan zeker gebruikt worden bij de 
ontwikkeling van nieuwe therapeutische strategieën. 
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